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Abstract
Slowing down climate change is probably the biggest current global challenge for mankind.
The two main strategies to achieve this are the development of new sustainable energy sources
and new or improved technologies that are less energy consuming. Inorganic transition metal
complexes are the basis for two technologies that address both energy production and en-
ergy saving: dye-sensitised solar cells (DSCs) and light emitting electrochemical cells (LECs).
Promising results were obtained for devices based on scarce metal complexes, such as iridium
and ruthenium, but the rarity of these metals is a big drawback in terms of their widespread
use and commercialisation. Therefore, complexes with more abundant metals, such as zinc and
copper, are now being investigated.
Since chromium(III) complexes are known to be emitting and kinetically inert, we chose
[Cr(2,2′-bipyridine)3]3+ as a model for our approach to use chromium(III) complexes as active
compounds in LECs. A series of both new and known homoleptic and heteroleptic {Cr(bpy)3}3+
containing complexes were synthesised. However they showed no electroluminescence in the de-
vice configuration, even though they exhibited photoluminescence in solution.
The main part of this thesis focuses on the synthesis and characterisation of {Cr(tpy)2}3+ com-
plexes, which have been rarely investigated so far. A new synthetic route was developed to
synthesise homoleptic and heteroleptic {Cr(tpy)2}3+ complexes. The presence of heteroleptic
complexes could be shown with X-ray structures. Suprisingly, the d3 complexes were found to
be labile in solution, although chromium(III) complexes are generally considered to be kineti-
cally inert. Ligand exchange in these complexes in alkaline solution or in the presence of F−
was investigated. Absorption and emission spectroscopic properties of the complexes have been
studied. The complexes containing at least one 4′-diphenylaniline tpy ligand showed a broad
and solvatochromic absorption band. They were further tested in DSC devices, but tended to
be very inefficient.
Chapter 1: Introduction
Chapter 1 gives background information about chromium, polypyridyl ligands and their chro-
mium(III) complexes. The photophysical properties of chromium(III) are introduced, along
with possible applications in LECs and DSCs.
Chapter 2: Tris(diimine)chromium(III) complexes
In this chapter the synthesis and characterisation of tris(diimine)chromium(III) complexes are
presented. The photophysical properties, electrochemical measurements, LEC trials and X-ray
structures are discussed.
Chapter 3: Bis(terpyridine)chromium(III) complexes
In the main chapter of this thesis, the synthesis and characterisation of
bis(terpyridine)chromium(III) complexes are presented. The photophysical properties, elec-
trochemistry measurements, DSC trials and X-ray structures are reported. Furthermore, the
lability and ligand exchange reactions of the {Cr(tpy)2}3+ complexes are discussed.
x
Chapter 4: Bis(terpyridine)cobalt(III) complexes
The synthesis of the bis(terpyridine)cobalt(III) complexes and one X-ray structure are pre-
sented. These cobalt complexes were needed to prepare magnetically diluted samples for the
EPR measurements.
Chapter 5: Terpyridine ligand synthesis
The synthesis routes for the tpy ligand syntheses are discussed in chapter 5.
Chapter 6: Experimental
The experimental details for all the syntheses are reported.
Parts of this work have been published:
E. C. Constable, C. E. Housecroft, M. Neuburger, J. Schönle and J. A. Zampese, Dalton Trans.,
2014, 43, 72277235.
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Abbreviations and Explanations
A A Ampere
a, b, c lattice parameters (X-ray)
ATR attenuated total reflection (IR)
a.u. arbitrary units
aq. aqueous
B bpy 2,2′-bipyridine
C ◦C degree Celsius (0 ◦C = 273.15 K)1
CCDC Cambridge Crystallographic Data Centre
CFSE crystal field stabilisation energy
CHF Swiss franc
conc. concentration/ concentrated
COSY correlation spectroscopy (NMR)
CSD Cambridge Structural Database
D D Debye (1 D = 3.335 64·10−30 C m)2
Dc calculated density (X-ray)
d doublet (NMR)
ddd doublet of doublets of doublets (NMR)
DEPT distortionless enhancement by polarisation
transfer
DFT density functional theory
DMF dimethylformamide
DMSO dimethylsulfoxide
DSC dye-sensitised solar cell
dt doublet of triplets (NMR)
E e.g. exempli gratia (Latin) = for example
EA elemental analysis
ECD electrochemically doped (LEC)
ECL electrochemiluminescence
ED electrodynamic (LEC)
edn. edition
EPR electron paramagnetic resonance
eq. equivalent
ESSADI estimated safe and adequate daily dietary intake
et al. et alii (Latin) = and others
ex. excitation
F FF fill factor (DSC)
FR# failed reaction
FTO fluorine doped tin oxide
G GTF glucose tolerance factor
GWh gigawatt hour
H HDPE high density polyethylene
HMBC heteronuclear multiple bond correlation
HMQC heteronuclear multiple quantum correlation
HOMO highest ocupied molecular orbital
Hppy 2-phenylpyridine
Hz Hertz (1 Hz = 1 s−1)1
I IC internal conversion
IR infrared
xii
IL interligand transition
ISC intersystem crossing
ISC short-circuit current (DSC)
iTMC ionic transition-metal complex
ITO indium tin oxide
J JSC short-circuit current density (DSC)
K K Kelvin
L LC ligand-centred
LEC light emitting electrochemical cell
LED light emitting diode
LMCT ligand to metal charge transfer
LN−N general diimine ligand (bpy or phen)
LN−N−N general tpy ligand
LT# ligand tpy, derivatives of 2,2′:6′,2′′-terpyridine
(LT1 to LT11, compare table 2)
LUMO lowest unoccupied molecular orbital
M m multiplet (NMR) or medium (IR)
MALDI matrix-assisted laser desorption/ionisation
MC metal-centred
MLCT metal to ligand charge transfer
MS mass spectrometry
Mt megaton
mw microwave reactor
m/z mass-to-charge ratio (MS)
N naph naphthalene
NIR near infrared
NMR nuclear magnetic resonance
NN general diimine ligand (bpy and phen)
NNN general tpy ligand
norm. normalised
N719 standard for DSC measurements (figure 3.48, p. 66)
O OLED organic light-emitting diodes
overn. overnight
P P# precursor (ligand synthesis)
PIN intensity of the incident light
p. page
phen 1,10-phenanthroline
PLEC polymer light emitting electrochemical cell
ppm parts per million
PPV poly(1,4-phenylene vinylene)
py pyridine
R R1 agreement factor (X-ray)
refl. reflections
rel. relative
rt. room temperature
S s singlet (NMR) or strong (IR)
sh shoulder (UV-VIS)
sp. grp. space group
SSL solid state lighting
T T temperature
xiii
t triplet (NMR)
td triplet of doublets (NMR)
TOF time of flight (MS)
tpy 2,2′:6′,2′′-terpyridine
tt triplet of triplets (NMR)
U U volume of the unit cell (X-ray)
UV ultraviolet
UV-VIS ultravioletvisible spectroscopy
V V volt
(
1V =
kg ·m2
A · s3
)
1
VOC open-circuit photovoltage (DSC)
vbpy 4-vinyl-4′-methyl-2,2′-bipyridine
W w weak (IR)
wR2 weighted agreement factor (X-ray)
Z z formula units (X-ray)
Å Ångström (1 Å = 10−10 m)
α, β, γ interaxial angles (X-ray)
η energy conversion efficiency (DSC)
λ wavelength
λex wavelength of the excitation wavelength
λmax wavelength of the emission maximum
µ(M-Kα) absorption coefficient of the radiation source M
(X-ray)
4′-(3,5-tBu2phenyl)tpy 4′-(3,5-di-tert-butylphenyl)-2,2′:6′,2′′-terpyridine
4-dmc dimethyl [2,2′-bipyridine]-4,4′-dicarboxylate
4′-(4-tolyl)tpy 4′-(p-tolyl)-2,2′:6′,2′′-terpyridine
4,4′-Me2bpy 4,4′-dimethyl-2,2′-bipyridine
5,5′-Me2bpy 5,5′-dimethyl-2,2′-bipyridine
5,5′′-Me2bpy 5,5′′-dimethyl-2,2′:6′,2′′-terpyridine
Explanations:
- The complex cations were enclosed with two different sorts of brackets:
{Cr(tpy)2}3+ Curly brackets indicate general complexes of this
type, including derivatives of the ligands. Also
heteroleptic complexes are included in this label.
[Cr(tpy)2]3+ Square brackets refer to the specific complex.
- Protonated ligands are abbreviated with the corresponding number of protons in front
of the abbreviation, e.g.:
HLT11+ monoprotonated ligand LT11
H2tpy2+ bisprotonated tpy ligand
xiv
Table 2: Overview abbreviations 2,2′:6′,2′′-terpyridine ligands.
N
N
N
N
N
N
N
N
N
R
5,5''-Me2bpy
LT4
compare table
label: R: label: R:
tpy H
4′-(4-tolyl)tpy LT7 CN
LT1 LT8
O
LT2 LT9 S
LT3 LT10
COOH
COOH
LT5 N LT11/ HLT11
N
N H
LT6 N
OMe
OMe
P3 Br
xv

Chapter 1
Introduction
1.1 Chromium
Louis Nicolas Vauquelin (1763 - 1829), a french chemist and pharmacist, discovered chromium in
1797. He isolated chromium(III)oxide (Cr2O3) by treating the mineral crocoite (PbCrO4) with
hydrochloric acid.3,4 One year later, in 1798, Vaquelin succeeded in reducing chromium(III)oxide
with charcoal to elemental chromium, which was impure.4 He chose the name chromium,
from the Greek term chroma meaning colour, since all compounds containing chromium are
coloured.5 Berzelius named, in honour ofVauquelin, in 1818 the mineral Pb2Cu(CrO4)(PO4)(OH)
Vauquelinit.4 Nearly 100 years after the discovery, Goldschmidt succeeded in isolating pure el-
emental chromium applying the aluminothermic process:68
Cr2O3 + 2Al
2100◦C−−−−→ 2Cr +Al2O3 (1.1)
In the lithosphere chromium is not available in its elemental form, but mainly as chromite
(FeO·Cr2O3), rarer as crocoite (PbCrO4) and chromium(III)oxide (Cr2O3).8 The first applica-
tions of chromium compounds were as pigments for dyeing (e.g. wallpaper or wool).9 Common
examples are chrome red (PbCrO4·PbO), green chromium oxide (Cr2O3) and chrome yellow
(PbCrO4).3,10 Chrome yellow was used for many years as the official colour for the school buses
in the United States.11 In the "Compendium of Pigments"3 over 60 chromium containing pig-
ments are listed. Nowadays chromium is mainly mined as chromite (FeO·Cr2O3), where South
Africa (6.8 Mt in 2011), India (4.3 Mt in 2011) and Kazakhstan (3.6 Mt in 2011) are the main
mining countries. In Europe Finland is the only remaining country mining chromite. In 2011
worldwide, 23.3 Mt chromite were mined.12 The world resources of chromite are estimated to
be greater than 12·109 tonnes, where 95 % are located in Kazakhstan and South Africa.13
Chromite is converted into dichromate (equation 1.2 and 1.3), which is the starting material for
the production of the majority of chromium compounds and pure chromium metal.9
4FeO · Cr2O3 + 8Na2CO3 + 7O2 1000
◦C−−−−→ 8Na2CrO4 + 2Fe2O3 + 8CO2 (1.2)
2Na2CrO4 + 2H
+ → Na2Cr2O7 +H2O + 2Na+ (1.3)
A further important starting material, above all for the production of stainless steel, is fer-
rochrome which is produced directly from chromite by carbo-thermic reduction.8
The main applications of chromium compounds are:5
- production of stainless steel
- surface treatment (to improve the appearance and/ or the resistance)
- manufacture of chemicals
An important application of chromium is in stainless steels, where corrosion resistant alloys, also
1
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combined with other metals like vanadium, nickel and cobalt, have been developed.5 Chromium
is also used to treat surfaces and give them an excellent hardness, protection against corrosion
and an attractive appearance. To coat surfaces two methods are used: electroplating and
chromising at high temperatures.5
Chromium compounds with chromium in several oxidation states (II, III, IV, V and VI) are
known. Compounds with oxidation states IV and V are rare.14 chromium(II) compounds tend
to oxidise to chromium(III) and are therefore strong reducing agents. Further they tend to form
dinuclear complexes (e.g. [Me4Cr CrMe4]4−) with multiple bonds.8 The chromium(VI) salts
chromate (CrO4)2− and dichromate (Cr2O7)2− are both strong oxidising agents.15
The Philips catalyst, SiO2 supported chromium oxide, is important in the production of high
density polyethylene (HDPE). The catalyst is prepared by impregnation of an aqueous solution
of chromate on amorphous silica gel. By calcination the catalyst Cr(II)Ox/SiO2 is formed.
This catalyst is applied for the production of 1·106 tonnes HDPE per year, or around half of the
world's market.16 In 1960 the first ruby (Al2O3) lasers were produced,17,18 where the Al2O3 is
doped with Cr3+, whose spin forbidden transitions (4A2 → 2T1 and 4A2 → 2E) are responsible
for the emission of the laser.19 Elemental chromium has few applications but is used as the base
material for the production of high quality alloys, for example for the production of gas-turbines
for aircraft.6,8 Around 90 % of the leather tanning is done nowadays with chromium(III) salts,
where the collagen coordinates to the chromium(III).20
Whether trivalent chromium is an essential trace element or not has been a controversial dis-
cussion for over 50 years.21,22 In the 1990s a chromium(III) containing glucose tolerance factor
(GTF) was proposed and chromium picolinate ([Cr(C6H4NO2)3]) was sold as nutritional sup-
plement to promote weight loss and increase muscle mass. Recent studies disagree with this and
show that chromium(III) is not essential for mammals.21,22 Therefore the ESADDI (estimated
safe and adequate daily dietary intake) was reduced from up to 200 mg in the 1990s to 30 mg in
2009.21 Compounds containing hexavalent chromium are skin and mucous membrane irritants
and classified as toxic and carcinogenic.14
1.2 Coordination chemistry
Coordination chemistry concerns compounds where a central metal atom or ion is surrounded
by a certain number of ligands. The ligands (from latin ligare = bind) share a pair of electrons
with the metal centre and are therefore coordinatively bonded to the metal centre. The ligands
act as Lewis bases and form a coordination bond with the Lewis acid (the metal cation). The
coordination number of a metal centre specifies the possible number of coordinative bonds. A
ligand can be mono- or polydentate, the latter means that one ligand provides more than one
donor atom.23,24 If at least one polydentate ligand coordinates to a metal ion it is referred to
as chelated complex. The thermodynamic stability of a chelated complex is greater than that
of a complex containing comparable monodentate ligands.23
Coordination chemistry, as we know it today, was first described in 1893 by the Swiss chemist
Alfred Werner. Several attempts to describe the observed complexes were already done before
Werner. The most regarded theories beforeWerner's were Blomstrand's and Jørgensen's. Blom-
strand supposed that the coordination number is equal to the valency. He ordered all "ligands"
in short chains on the metal centre (scheme 1.1a), where the number of chains was equivalent
with the valence number. Jørgensen proposed in 1884 the chain theory (scheme 1.1b), an ad-
vancement of Blomstrand's proposition. After Jørgensen the "ligands" are ordered in chains of
different length on the metal centre. Jørgensen justified his adaptations with the observation
that one chloride precipitates much more rapidly and has therefore less influence from the cobalt
central ion.2426
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Scheme 1.1: Constitutional formula of [Co(NH3)6]Cl3, proposed by Blomstrand (a), Jørgensen
(b) and Werner (c).
In 1892 Werner postulated his theory without any experimental investigations and proved it
afterwards experimentally. He proposed the concept of primary and secondary valence. The
primary valence, nowadays known as oxidation state, corresponded to the number of chains
in Blomstrand's and Jørgensen's chain model. In the [Co(NH3)6]Cl3 example (scheme 1.1c)
the three chloride counter anions are in the primary valence, the secondary valence, nowadays
called coordination number, defines the number of coordinative bonds and the geometry of the
complex. In the [Co(NH3)6]Cl3 example the coordination number is 6 and the six edges of the
octahedron are occupied by one monodentate ammonia ligand each.2426
In 1913 Werner was awarded the Nobel Prize in Chemistry for this achievement. This Nobel
Prize was the first for an inorganic chemist and the first Nobel Prize in Chemistry for a Swiss
scientist.26
Several compounds which were known at this time from dyes used in ancient times to observa-
tions made by alchemists and itarochemists, could be described applyingWerner's coordination
chemistry.26
Chromium(III) complexes were already studied at the very beginning of the research on coor-
dination chemistry. Werner for example investigated the exchange of ammonia with water in
[Cr(NH3)6]3+ (figure 1.1). These studies were also part of his Nobel Lecture
(December 11, 1913).26,27 Pfeiffer studied the isomerism of trivalent chromium complexes.28
Figure 1.1: Replica of the ligand exchange experiments on [Cr(NH3)6]3+ reported in Werner's
Nobel Lecture.27
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1.2.1 Oligopyridine ligands and complexes thereof
2,2′-Bipyridine (bpy) and 1,10-phenanthroline (phen) were first reported by Blau in 1888,29
and 2,2′:6′,2′′-terpyridine (tpy) was first synthesised by Morgan and Brustall in 1932.30 The
oligopyridines bpy, phen and tpy and derivatives thereof (scheme 1.2) are counted among the
most common polydentate ligands. Currently, more than 40'000 publications have been pub-
lished containing the term "1,10-phenanthroline", over 39'000 for "2,2′-bipyridine" and over
5000 for "2,2′:6′,2′′-terpyridine" (SciFinder31 research 11th May 2014). Bpy, phen and tpy
and multiple derivatives thereof3234 have been continuously and intensively used in both an-
alytical35,36 and preparative coordination chemistry,32 including the detection of iron in wa-
ter (Fe2+ complexes),35,36 dyes for DSCs (Ru2+, Fe2+, Zn2+ and Cu+ complexes),3739 active
medium for LECs (Ir3+, Ru2+ and Cu+ complexes),40 and solar energy water splitting (Ru2+).41
Complexes with various metals are known to form complexes with bpy, phen and tpy ligands
and derivatives thereof. Schubert et al.34 showed recently that complexes with tpy ligands have
been described for 63 metals i: most of the recorded complexes have ruthenium as metal centre,
followed by iron and copper.
Octahedral complexes (coordination number 6) of the type {M(tpy)2}n+ have advantages over
{M(NN)3}n+- complexes (NN= bpy or phen), namely better stability of the {M(tpy)2}n+ motif.
Since the number of chelate rings increases from 3 ({M(NN)3}n+) to 4 ({M(tpy)2}n+). Also
the {M(tpy)2}n+ complexes are achiral if the ligands are symmetrically substituted, whereas
the {M(NN)3}n+ complexes are chiral and give ∆ and Λ enantiomers.42
N N
N
N
N
N
N
bpy phen tpy
Scheme 1.2: Structures of the discussed oligopyridines 2,2′-bipyridine (bpy), 1,10-phenanthroline
(phen) and 2,2′:6′,2′′-terpyridine (tpy).
1.2.2 Chromium(III) complexes with polypyridyl ligands
Complexes containing the {Cr(bpy)3}3+ core have been investigated much more intensively
compared to complexes containing the {Cr(tpy)2}3+ core (figure 1.2). The peak of the re-
search activity on {Cr(bpy)3}3+ was in the 1980s. The studies on {Cr(bpy)3}3+ were mainly
focused on electrochemical processes,43,44 the photochemical45,46 and photophysical47,48 prop-
erties including emission quenching49 with O2 and photoaquation reactions. The focus on the
investigation of {Cr(tpy)2}3+ lay on the electrochemical properties.5052
i- all alkali metals, except francium - all alkaline earth metals, except radium - all d-block metals (rows 4 - 6),
except hafnium - all lanthanides and the actinides uranium, neptunium, plutonium, americium and curium - and
also aluminium, gallium, indium, tin, thallium, lead and bismuth, (based on a SCIFinder research by Schubert
et al. on 31st December 2010 including 3890 papers).34
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Figure 1.2: Number of papers containing tris(bipyridine)chromium(III) (grey) and
bis(terpyridine)chromium(III) (black), based on a structure search with SciFinder31
(22th March 2014).
1.3 Photophysics of octahedral chromium(III) complexes
Nearly 150 years ago Ed Becquerel described the first luminescent Cr(III) containing com-
pounds.53,54 The photophysics and photochemistry of octahedral chromium(III) complexes are,
besides ruthenium(II) complexes, the most intensively investigated of all transition metal com-
plexes.55 The electronic configuration of Cr3+ ions is [Ar]3d3. The electronic configuration of
the quartet ground state (4A2g) is (t2g)3, according to Hund's first rule23 (figure 1.3). The
crystal field stabilisation energy (CFSE) for octahedral d3-complexes is -1.2 ∆oct.23 Three
quartet excited states (4T2g, 4T1g ((t2g)2(eg)) and 4T1g ((t2g)(eg)2)) are generated. In ab-
sorption measurements only two broad absorptions are typically observed, for 4T2g ←4 A2g
and 4T1g ((t2g)2(eg)) ← 4A2g , whereas the third ligand field band (4T2g ((t2g)(eg)2)← 4A2g is
often obscured by more intense charge transfer transitions.54 The 4T1g excited state undergoes
a fast and non radiative internal conversion (IC) to 4T2g. Fluorescence from the 4T2g state
(4T2g →4 A2g) is rarely observed (in solution at room temperature), whereas intersystem cross-
ing (ISC) to 2Eg occurs efficiently. The doublet states 2T1g and 2Eg (electronic configuration:
(t2g)3) are the lowest-lying excited states. The emissions (2E2g → 4A2g and 2T1g → 4A2g) are
assigned as phosphorescence. The excitations (4T2g ← 4A2g) and (4T1g ← 4A2g) often lead
to a facile substitution of ligands by solvent (at room temperature). In both excited states an
electron resides in an antibonding eg orbital (σ∗).55,56
The photophysics of {Cr(bpy)3}3+ is introduced in section 2.3.2 (p. 20).
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Figure 1.3: Energy level diagram for chromium(III) complexes, where IC stands for internal
conversion and ISC for intersystem crossing.
1.4 Sustainable materials
Recently pinpointed by the Swiss Federal Assembly, the key points for the climate policy after
the year 2020 are as follows: reducing of the energy consumption and reducing of greenhouse
gas emissions.57
The principal strategies to accomplish these objectives are:
- alternative sustainable energy sources
- new technologies which are less energy consuming
In the following sections two promising applications of ionic transition metal complexes cover-
ing each one of the above mentioned strategies are discussed: dye-sensitised solar cells (DSC)
(section 1.4.1) and light emitting electrochemical cells (LEC) (section 1.4.2, p. 9). Both tech-
niques were intensively investigated and developed but they have a significant common dis-
advantage: they are based on ionic transition metal complexes (iTMC) of the scarce metals
ruthenium and iridium. Since these metals are counted among the scarcest elements in the
Earth's crust they are very expensive (table 1.1) and as such a wide application is not possible.
Therefore recently the replacement of the platinum group elements by first row transition met-
als has become a growing research area. Promising results were obtained with DSCs based on
copper(I) and zinc(II) complexes.39 In LEC devices ionic copper(I) complexes are a promising
alternative to iridium(III) complexes, but still very little explored.40,58
Chromium, also an abundant and relatively cheap transition metal, is known to form light emit-
ting complexes in trivalent oxidation state.54,56 The potential of chromium(III) complexes to
do solar energy conversion was already discussed for quite some time.61,62 Chromium(III) (d3)
complexes are a text-book example of kinetically inert compounds.23 Therefore chromium(III)
complexes with polypyridyl ligands could be potential candidates as emitting materials in LECs
and sensitisers in DSCs.
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Table 1.1: Abundances and market prices of the elements used in LEC and DSC devices
element abundance in Earth's
crust [ppm]59
market price [CHF/kg]
(April 2014)60
iridium 3.7·10−5 ∼ 29948
ruthenium 3.7·10−5 ∼ 2543
zinc 72 ∼ 1.8
copper 27 ∼ 6.2
chromium 135 ∼ 8.5
1.4.1 Dye-sensitised solar cels (DSC)
Photovoltaic energy production is a rapidly increasing market, with the solar energy production
in Switzerland increasing by more than 220 times between 1990 and 2012, but the total produc-
tion of 320 GWh (2012) is only around 0.5 % of the total electrical energy consumption.63,64
Silicon-based systems are the dominant photovoltaic devices on the market. The energy con-
sumption and therefore expensive production of these cells is a big disadvantage.65 One promis-
ing alternative is the dye-sensitised solar cell (DSCii). It was first reported by Grätzel et al. in
1991,66 and is also kown as the Grätzel cell. One of the crucial parts of these cells is the dye.
Therefore several categories of dyes have been investigated:
Transition metal complexes:
This category of dyes has been investigated intensively, in particular for Ru(II) dyes. Further
sensitisers with Os(II), Re(I), Fe(II), Pt(II) and Cu(I) have been investigated.67,68
Porphyrins and phthalocyanines:
In contrast to the metal complex dyes, porphyrin and phthalocyanine dyes have intense spec-
tral response bands in the near-IR region. Both metal free compounds and complexes (mainly
Zn(II)) were applied.68
Organic dyes:
The main advantage of organic dyes is that they are usually cheaper and more environmentally
friendly than metal complex dyes, especially compared with the scarce metals ruthenium and
osmium.
The architecture (figure 1.4) of a DSC consists of two electrodes. The anode, FTO (fluorine
doped tin oxide) or ITO (indium tin oxide) coated conducting glass, is covered with a TiO2
layer upon which the dye is absorbed. The counter electrode, usually platinised conducting
glass, is connected to the anode via an electrolyte.68,69 The photosensitiser, or simplified: dye,
is excited by sunlight ¬. The excited electron is then injected into the conduction band of the
semiconductor ­ and forwarded to the conducting glass ®. The sensitiser is regenerated by
oxidation of the electrolyte ±, which is then reduced at the cathode °. The circuit is closed by
electron migration from the anode through the external load to the cathode ¯.68,69
iiThe abbrevation DSSC is also used.
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Figure 1.4: Architecture and working principle of a DSC: ¬: The dye is excited by sunlight. ­:
The electron is injected into the conducting band of the TiO2. ®: The electron is forwarded
to the conducting glass. ¯: The circuit is closed trough an external load. °: The electrolyte
is reduced at the cathode. ±: The dye is regenerated by oxidation of the electrolyte. (figure:
adapted from Grätzel 69).
Solar cells are characterised by the following parameters:68
JSC short-circuit current density
The current which flows through the external circuit when the electrodes are short
circuited is the short circuit current, ISC . The short circuit current density is the
current produced per unit area.
⇒ maximum current density that a solar cell can deliver
VOC open-circuit voltage
The voltage at which no current flows through the external circuit.
⇒ maximum voltage that a solar cell can deliver
FF fill factor
The maximum power generated by the solar cell (Pmax) per unit area divided by the
product of JSC and VOC .
FF =
Pmax
JSC · VOC
η conversion efficiency
The efficiency of the conversion from solar to electrical energy (Pin: intensity of incident
light).
η =
JSC · VOC · FF
Pin
=
Pmax
Pin
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1.4.2 Light emitting electrochemical cell (LEC)
The main lighting techniques which are currently under development are based on the solid-
state lighting (SSL) principle. In traditional light sources (e.g. light bulbs or fluorescent lamps)
the light emission is only a byproduct of heating or discharging, leading to low efficiency. In
SSL a semiconducting material emits light upon stimulation by an electric field, which injects
electrons (on the cathode) and generates holes (on the anode). Holes and electrons migrate
through the film and form an excited state when they meet. In this electrochemiluminescence
(ECL) process, a photon is released upon recombination to the ground state. A considerable
advantage of SSL is the possibility to tune the spectrum, the polarisation, the colour tempera-
ture, the modulation and the emission pattern.40,7072
LEDs (light-emitting diodes) based on light emitting inorganic semiconductors and OLEDs
(organic light-emitting diodes) derive the ECL from a non charged compound (light emitting
layer) which is embedded in charge transport and injection layers. LEDs and OLEDs have in
common that they are much more efficient then conventional light sources, but also that the
production is complex and therefore expensive. Apart from the widespread and applied LED
and OLED technologies, LECs (light emitting electrochemical cells iii) have been developed as
a possible alternative technique40,71,72
The advantage of LECs is the much simpler architecture (figure 1.5) and in contrast to OLEDs,
they do not have to be rigorously encapsulated as the components are not air and moisture
sensitive. This leads to simpler and easier production.40 In the LEC device the light emitting
layer is sandwiched between the two electrodes. Two rationales were proposed to explain the
mechanism of operation:40
Electrodynamical (ED):
Formation of electrical double layers at the electrodes which cause a drop in the electrical po-
tential near the electrodes and simplify charge injection. The light emission occurs in the region
between the electrodes (field free region) where the anions and cations are still joined.
Electrochemically doped (ECD):
Accumulation of ions on the anode and cathode leads to the formation of negatively and posi-
tively doped regions around the electrodes. In the junction region between the the two doped
regions the potential drops. This favours charge recombination with light emission.
The LEC application was first presented by Pei et al. in 1995.73,74 They presented a LEC,
nowadays categorised as a polymer-LEC (PLEC), based on a semiconducting and emitting
polymer (e.g. poly(1,4-phenylene vinylene) (PPV)).40,73,74 In the second group of LECs, re-
ferred to as iTMC- LECs, an ionic transition-metal complex (iTMC) is the luminescent ma-
terial.40 The first approach to iTMC-LEC was reported by Murry, Wightmann et al. using
poly[Ru(vbpy)3][PF6]2 (vbpy = 4-vinyl-4′-methyl-2,2′-bipyridine) as luminescent material.75
The best investigated iTMC-LEC are those with iridium(III) as the metal centre and mainly
derivatives of the archetypal complex {Ir(ppy)2(bpy)}+ (Hppy = 2-phenylpyridine). The first
Ir-iTMC-LEC was reported 10 years ago by Bernhard, Malliaras et al.76 The major advan-
tage of Ir-iTMC-LECs is that the emission colour can be readily tuned, and thanks to in-
tensive research in recent years, the hole visible range can be covered.40,7682 Besides Ir- and
Ru-iTMC-LECs8386, copper(I) complexes as light emitting materials have also been investi-
gated. The first LECs with copper as the metal ion were reported by Armaroli et al.,87 using
homoleptic copper(I) diphenylphosphines. Several attempts were tried with heteroleptic com-
plexes containing a bpy ligand and one diphenylphosphine or two phosphane ligands. The
iiiThe abbrevation LEEC is also used.
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performance levels achieved with copper(I) complexes are moderate, but are comparable to
ruthenium(II) and iridium(III) complexes based LECs with similar luminance levels.58,8891
Figure 1.5: Architecture of a LEC (figure: adapted from Armaroli, Bolink et al.40).
Chapter 2
Tris(diimine)chromium(III) complexes
2.1 Synthesis of tris(diimine)chromium(III) complexes
CrCl3.3 H2O
Zn, HCl
in H2O
Cr2+(aq)
NaOAc Cr Cr
O O
O O
O O
O O
.2 H2O
H2SO4
Cr2+(aq)
LN-N[Cr(II)(LN-N)3]2+oxidation:air or H2O2[Cr(III)(LN-N)3]
3+
[NH4][PF6]
[Cr(III)(LN-N)3][PF6]3
LN-N
I)II)
A
B
CD
Scheme 2.1: First synthetic approaches, where LN−N stands for the diimine (bpy or phen)
ligand.
The majority of the reported synthesis strategies contain at least an intermediate with per-
chlorate as counter anion.92,93 Since complexes with perchlorate counter anions are poten-
tially explosive94 the aim was to use an alternative synthesis approach. The first approaches
(scheme 2.1, variant I) to synthesise {Cr(bpy)3}3+ started with chromium(III) chloride trihy-
drate. In the first step chromium(II) acetate was synthesised following the protocol of Block
et al.95 Chromium(III) is reduced in the presence of zinc to chromium(II). In the presence of
sodium acetate the dinuclear chromium(II) acetate ([Cr(CH3COO)2(H2O)]2) forms. The din-
uclear chromium(II) acetate is stable under air.96 After treatment with sulfuric acid, instead
of perchloric acid, the bipyridine ligand was added to produce a tris(bipyridine)chromium(II)
intermediate which was then oxidised with air or H2O2. In the final step the counter anion
(Cl−) was exchanged with NH4PF6 to PF−6 .
92
As an alternative to the reaction pathway shown in variant I an approach with a shortcut
(scheme 2.1, variant II) was performed in which the bipyridine ligand was added directly to the
Cr2+ after the reduction step.
The above described approaches starting with CrCl3·3H2O did not work well or reproducibly.
11
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Therefore an alternative synthesis strategy was applied.
CrCl3
LN-N
EtOH, 
Zn cat,
reflux
1) LN-N                
MeCN, reflux
2) NH4PF6
[Cr(LN-N)2Cl2]Cl [Cr(LN-N)2(CF3SO3)2]CF3SO3 +3 HCl
[Cr(LN-N)2(LN-N)]PF6
CF3SO3H
overnight, rt
A B
C
Scheme 2.2: Applied synthesis strategy for the synthesis of tris(diimine)chromium(III) com-
plexes.
This three step synthesis (scheme 2.2) starts with anhydrous chromium(III) chloride. In the
first step CrCl3 and the bipyridine ligand are refluxed in EtOH in the presence of catalytic
amounts of zinc.97 The metal centre of intermediate A coordinates two diimine ligands and
two chlorides, and an additional chloride acts as counter anion. This intermediate, was usually
not characterised, but was used directly in the next step. The good elemental analyses for
[Cr(5,5′-Me2bpy)2Cl2]Cl and [Cr(4,4′-Me2bpy)2Cl2]Cl gave evidence for the synthesis of the de-
sired intermediates {Cr(bpy)Cl2}Cl. Almost all single crystal growing trials were not successful
(see below).
In the next step the chloride ions were exchanged by stirring A overnight at room temperature
in trifluoromethanesulfonic acid.98 Intermediate B, was not characterised, and used directly in
the next step. In the third step, B and the third equivalent of bipyridine ligand were refluxed in
acetonitrile and in the final step the CF3SO−3 anions were exchanged with NH4PF6 to PF
−
6 .
99 A
merit of this synthetic strategy is the possibility to synthesise heteroleptic complexes. An other
alternative was to perform the last step in the microwave reactor instead of heating under reflux.
From one crystal growing trial of [Cr(bpy)2Cl2]Cl two differently coloured (yellow and red) types
of crystals were obtained. The crystals grew by storing an EtOH solution of [Cr(bpy)2Cl2]Cl
during 6 weeks in the fridge. Both structures were of poor quality, but the preliminary data
confirmed the gross structural features of the cations.
The structural data for the reddish crystals show that beside the two bpy ligands, one chloride
and one oxygen atom coordinate to the metal centre. The oxygen containing ligand could not
be determined conclusively as OH− or H2O (figure 2.1). The overall charge of the complexes is
therefore either 3+ of 2+. Since the solvent molecules and counter ions could not be determined
it was not possible to match a charge to the complex.
The second, yellow, type of crystals (figure 2.2), contained the [Cr(bpy)3]3+ cation. The pre-
liminary data show unambiguously the structure of the cation core. Three anions (Cl−) balance
the charge on the cation. But the solvent molecules could not be identified.
The structure determination confirmed that [Cr(bpy)3]3+ can be formed directly from CrCl3 in
one step. Since an excess of bpy (3.1 eq.) was used in this synthesis one possibility is that some
[Cr(bpy)3]3+ was formed in the first step of the reaction. Or as a second possibility, a ligand
exchange between two complexes happened in the EtOH solution (single crystal growing trial).
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Table 2.1: Crystallographic data of solvated [Cr(bpy)3][Cl]3
formula moiety C120H123Cl12Cr4N24O16 µ(Mo-Kα) [mm−1] 0.658
formula weight 2790.82 T [K] 173(2)
crystal colour and habit yellow, block refln. collected 94136
crystal system orthorhombic unique refln. 6744
space group Pnma refln. for refinement 6410
parameters 459
23.223(5)
a, b, c [Å] 20.329(6) threshold I>2.0σ
13.448(3) R1 (R1 all data) 0.0553 (0.0577)
90 wR2 (wR2 all data) 0.1637 (0.1681)
α, β, γ [◦] 90 goodness of fit 1.054
90 crystal growing: EtOH (fridge)
U [Å3] 6349(3)
Dc [Mg m−3] 1.46
Figure 2.1: Structure of the cation [Cr(bpy)2(OH or H2O)Cl]+/2+ with ellipsoids plot-
ted at 50 % probability level. H atoms, counter ions and solvent molecules are omit-
ted for clarity. Selected bond lengths [Å]: Cr1-O1 = 1.976(5), Cr1-N1 = 2.052(6),
Cr1-N3 = 2.041(5), Cr1-N2 = 2.053(5), Cr1-N4 = 2.067(6), Cr1-Cl1 = 2.279(2), and bond an-
gles [◦]: N1-Cr1-N2 = 79.3(2), N3-Cr1-N4 = 79.4(2). Angle between the two bpy (least squares
planes): 86.48◦.
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Figure 2.2: Structure of the cation in solvated [Cr(bpy)3]Cl3 with ellipsoids plotted at 50 % prob-
ability level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected bond
lengths [Å]: Cr1-N1 = 2.049(2), Cr1-N2 = 2.047(2), Cr1-N3 = 2.041(2), Cr1-N4 = 2.046(2),
Cr1-N5 = 2.050(2), Cr1-N6 = 2.046(2), and bond angles [◦]: N1-Cr-N2 = 79.99(9),
N3-Cr-N4 = 79.93(9), N5-Cr-N6 = 80.00(9); angles between the bpy (least squares planes)[◦]:
between bpy containing N1 and N3: 80.83, N3 and N5: 85.08, N1 and N5: 59.62.
A microwave reaction (2.5 h, 110 ◦C, 8 bar, solvent: CH2Cl2) with
[Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3] and 2.5 eq. of bpy yielded an unexpected product.
Single crystals grew by slow diffusion of Et2O in a MeCN solution of the crude product. The
preliminary data (figure 2.3) show unambiguously a dimer core of the cation. The position of
the two ligands is disordered (0.503 : 0.497) in the coordination sphere of Cr1, therefore an
anisotropic refinement of the methyl groups of 5,5′-Me2bpy was not possible. Since the asym-
metric unit contains four anions (PF−6 ) per dimeric cation, the charge is equalised if the bridging
ligands are interpreded as OH−: (Cr(bpy)(5,5′-Me2bpy))2(µ-OH)2][PF6]4.
The two monomers {Cr(bpy)(5,5′-Me2bpy)}3+ are additionally connected by pi-pi interactions
between the pyridine rings containing N1 and N8 (angle between the least squares planes:
9.4◦, distance between the centroids: 3.68 Å, shortest distance between a centroid and a least
squares plane: 3.15 Å) plus N4 and N5 (angle between the least squares planes: 5.0◦, distance
between the centroids: 3.80 Å, shortest distance between a centroid and a least squares plane:
3.17 Å). In the coordination sphere of Cr1 is the position of the two bpy units disordered in a
ratio of 0.503(19) to 0.497(19). Also one of the four anions is disordered (0.519(9) : 0.481(9)).
The distance between the two chromium(III) centres is 3.02 Å. The distances and angles in
[(Cr(bpy)(5,5′-Me2bpy))2(µ-OH)2][PF6]4 are consistent with the data published for the phenan-
throline complex [(Cr(phen)(5,5′-Me2phen))2(µ-OH)2][PF6]4.100,101
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Figure 2.3: Structure of the cation in [(Cr(bpy)(5,5′-Me2bpy))2(µ-OH)2][PF6]4 with ellipsoids
plotted at 50 % probability level. H atoms, counter ions and solvent molecules are omitted for
clarity. Selected bond lengths [Å]: Cr1-N1 = 2.063(6), Cr1-N2 = 2.048(6), Cr1-N3 = 2.063(5),
Cr1-N4 = 2.054(6), Cr1-O1 = 1.950(5), Cr1-O2 = 1.951(4), Cr2-N5 = 2.059(5), Cr2-N6 =
2.075(5), Cr2-N7 = 2.068(6), Cr2-N8 = 2.055(5), Cr2-O1 = 1.947(4), Cr2-O2 = 1.940(5), and
bond angles [◦]: Cr2-O1-Cr1 = 101.5(2), Cr2-O2-Cr1 = 101.7(2), N1-Cr1-N2 = 78.2(3), N3-
Cr1-N4 = 78.5(2), N5-Cr2-N6 = 78.1(2), N7-Cr2-N8 = 78.9(2), angles between the bpy (least
squares planes)[◦]: between bpy containing N1 and N3: 65.90, N5 and N7: 60.39.
Table 2.2: Crystallographic data of [(Cr(bpy)(5,5′-Me2bpy))2(µ-OH)2][PF6]4
formula sum C34H32CrF18N6OP3 µ(Mo-Kα) [mm−1] 0.574
formula weight 1027.57 T [K] 173(2)
crystal colour and habit red, block refln. collected 98671
crystal system monoclinic unique refln. 12716
space group P21/n refln. for refinement 9549
parameters 737
13.671(3)
a, b, c [Å] 21.231(4) threshold I>2.0σ
19.973(4) R1 (R1 all data) 0.1125 (0.1346)
90 wR2 (wR2 all data) 0.3182 (0.3430)
α, β, γ [◦] 107.18(3) goodness of fit 1.042
90 crystal growing overlaying
U [Å3] 5538.6(19) Me2CO/ Et2O
Dc [Mg m−3] 1.848
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Table 2.3: Synthesised tris(diimine)chromium(III) complexes (exp. = link to the experimental
part, str. = link to the structure discussion).
Cr
N
N
N
N N
N
3+
3PF6-
Cr
N
N
N
N
N
N
3+
3PF6-
Cr
N
N
N
N N
N
3+
3PF6-
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(bpy)3][PF6]3 [Cr(bpy)2(phen)][PF6]3
[Cr(bpy)2(5,5
′-
Me2bpy)][PF6]3
[Cr(bpy)2(4,4
′-
Me2bpy)][PF6]3
exp.: 6.3.3.1 (p. 117) exp.: 6.3.3.2 (p. 117) exp.: 6.3.3.3 (p. 118) exp.: 6.3.3.4 (p. 118)
str.: 2.5.1 (p. 28) str.: 2.5.2 (p. 29) str.: 2.5.3 (p. 29)
known, e.g. Hallok et
al.102
known, Kane-Maguire
et al.99
Cr
N
N
N
N
N
N
3+
3PF6-
Cr
N
N
N
N
N
N
3+
3PF6-
Cr
N
N
N
N
N
N
3+
3PF6-
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(phen)3][PF6]3
[Cr(phen)2(5,5
′-
Me2bpy)][PF6]3
[Cr(phen)2(4,4
′-
Me2bpy)][PF6]3
[Cr(5,5′-
Me2bpy)3][PF6]3
exp.: 6.3.3.5 (p. 119) exp.: 6.3.3.6 (p. 119) exp.: 6.3.3.7 (p. 120) exp.: 6.3.3.8 (p. 120)
str.: 2.5.5 (p. 31)
known, e.g. Kane-
Maguire et al.99
known as ClO−4 -salt:
Ronco et al.43
Cr
N
N
N
N
3+
3PF6-
N
N
Cr
N
N
N
N
3+
3PF6-
N
N
Cr
N
N
N
N
3+
3PF6-
N
N
Cr
N
N
N
N
3+
3PF6-
N
N
[Cr(5,5′-
Me2bpy)2(phen)][PF6]3
[Cr(5,5′-
Me2bpy)2(4,4
′-
Me2bpy)][PF6]3
[Cr(4,4′-
Me2bpy)2(bpy)][PF6]3
[Cr(4,4′-
Me2bpy)2(5,5
′-
Me2bpy)][PF6]3
exp.: 6.3.3.9 (p. 121) exp.: 6.3.3.10 (p. 121) exp.: 6.3.3.11 (p. 122) exp.: 6.3.3.12 (p. 122)
str.: 2.5.4 (p. 30)
known, e.g. Kane-
Maguire et al.99
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2.2 Unsuccessful synthetic trials
Besides the successful synthesis of tris(diimine)complexes, several additional attempts with
mono- and bidentate ligands were done. All the trials were unsuccesssful (FR1a - FR2) with
bipyridine substituted in the 6-position (table 2.4). With 6-methyl-2,2′-bipyridine several trials
in different solvents and using both reflux and microwave techniques (FR1a-e) were executed.
But the desired product could not be isolated. As obvious reason could be the steric hindrance
of the methyl groups which are adjacent to the N-coordination sites.
In a further series two monodentate ligands were inserted: pyridine (FR4a-c) and 2,6-lutidine
(FR5). Also in these trials no desired product could be isolated.
Dreves reported the synthesis of the neutral homoleptic Cr(ppy)3,103 where Hppy stands for
2-phenylpyridine. On tried therefore to coordinate one ppy− instead of a bipyridine in the last
step of the reaction. But all attempts (FR3a-c) were unsuccessful.
The bipyridine ligands (6-methyl-2,2′-bipyridine and 6-phenyl-2,2′-bipyridine) were synthesised
by Ewald Schönhofer ,104107 all the other ligands were available commercially.
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Table 2.4: Overview of the unsuccessful synthetic trials:
Cr
N
N
N
N O3SCF3
O3SCF3
+
CF3SO3-
A X
R
R
R
R
label: A: R= eq. of A: solvent: reaction conditions:
FR1a N
N
H 2.0 CH2Cl2 refluxing for 7 h
FR1b see FR1a H 3.0 MeCN refluxing for 6 h
FR1c see FR1a H 3.0 MeCN refluxing for 10 h
FR1d see FR1a H 3.0 CH2Cl2 microwave 100 ◦C, 8 bar, 3 h
FR1e see FR1a H 3.0
CH2Cl2/
MeCN
refluxing for 5.5 h
FR2a N
N
Ph
H 1.5 MeCN refluxing for 6 h
FR2b see FR2b H 3.0 MeCN microwave 140 ◦C, 11 bar, 2 h
FR3a
N
H 3.0 MeCN refluxing for 6 h
FR3b see FR3a H 2.5 CH2Cl2 microwave 110 ◦C, 9 bar, 2 h
FR3c see FR3a H 1.5 THF refluxing for 2 h
FR4a
N
H 12 MeCN refluxing for 5.5 h
FR4b see FR4a H 8.2 CH2Cl2 microwave 110 ◦C, 9 bar, 2 h
FR4c see FR4a H 2.5 CH2Cl2 microwave 110 ◦C, 9 bar, 1.5 h
FR5
N
Me 2.1 MeCN refluxing for 6 h
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2.3 Photophysical properties
Data reported in the literature as wavenumbers have been converted to wavelengths
(
υ =
1
λ
)
and the original value reported in brackets.
2.3.1 Absorption spectra
The tris(diimine)chromium(III) complexes are all yellow coloured and absorb in the UV and
in the visible range. The absorption spectra are well structured (figure 2.4). Kliger et al.
assigned the absorptions for [Cr(bpy)3]3+ as dd- transitions, intraligand transitions (IL), ligand
to metal charge transfers (LMCT) and metal to ligand charge transfers (MLCT) (table 2.5).48
In the absorption spectrum a significant difference in the UV region is noticeable between the
complexes containing a phen ligand and those not. The complexes containing phen show a
broad absorption at around 270 nm, illustrated by [Cr(phen)3]3+ (figure 2.5, dashed line). This
is consistent with the UV-VIS for [Cr(phen)3]3+ by Marusak et al.108 In contrast to the free
bpy ligand, the free phen ligand also shows a broad absorption band at 269 nm (in MeCN).
Table 2.5: Assignment of the ground state transitions of [Cr(bpy)3]3+ according to
Kliger et al .48
λ [nm] assignment
466 4dd (4A2 → 4T2)
455, 427, 398 3IL (pipi∗\4,2d)
359, 346, 330 4LMCT (pi → t2)
312, 299 1IL (1pipi∗)
281, 265 4LMCT (pi → e), 4MLCT (t2 → e)
237 1IL (1pipi∗)
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Figure 2.4: Absorption spectra in aqueous solution (1·10−5M) of [Cr(bpy)3][PF6]3 (black, solid
line), [Cr(5,5′-Me2bpy)3][PF6]3 (blue, solid line), [Cr(bpy)2(5,5′-Me2bpy)][PF6]3 (orange, solid
line), [Cr(phen)2(5,5′-Me2bpy)][PF6]3 (black, dashed line), [Cr(phen)2(4,4′-Me2bpy)][PF6]3
(blue, dashed line).
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Figure 2.5: Absorption spectra in MeCN solution (1·10−5 M) of [Cr(bpy)3][PF6]3 (solid line)
and [Cr(phen)3][PF6]3 (dashed line).
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2.3.2 Photoluminescence of the tris(diimine)chromium(III) complexes
The photoluminescence spectra of the reported {Cr(bpy)3}3+ complexes all have similar emis-
sion maxima, independent of the substituents on the bpy ligand (table 2.6 and figure 2.6). They
are also consistent with the data reported109 for [Cr(bpy)3][PF6]3 (699 nm (14'300 cm−1) and
728 nm (13'740 cm−1)), measured in CH2Cl2/water 1:147,110 and [Cr(phen)3][PF6]3 (700 nm
and 730 nm), measured in water.108
This is consistent with the fact that the emission originates from the transitions of two metal-
centred excited states (2T1 and 2E). In so much as the lifetimes of the two emission peaks
(at v700 nm and v730 nm) are identical, these two excited states are thermally equilibrated
(figure 2.7).47,108,110 Balzani, Hofmann et al. showed that the emission is not dependent from
the excitation wavelength (312 to 450 nm, figure 2.7 A - D) and that the inter system crossing
(ISC) 4T2  2E takes place with almost unitary efficiency.47
An additional emission band at higher energies was observed if the complexes in this investi-
gation were excited at higher energies (≤ 280 nm). If [Cr(5,5′-Me2bpy)3][PF6]3 was excited at
280 nm, an additional emission band was also observed (figure 2.8). The additional emission
band showed two maxima (λmax = 343 and 384 nm) and these wavelengths do not correspond
to half of the wavelengths of the bands observed at 700 nm and 731 nm (figure 2.8). The relative
intensities (figure 2.8) of the 343/384 nm and 700/731 nm bands also indicate that the two sets
of bands are not related as harmonics. Exciting (λex = 280 nm) free 5,5′-Me2bpy in MeCN
results in an emission with λmax = 343 nm. This leads to the supposition that this emission
is ligand based. Since a decomposition of the complex in solution is likely to occur. (compare
2.3.2.1, p. 22), the presence of free ligand in solution is also possible. We could find no evidence
for the second emission maximum at 384 nm.
The photoluminescence lifetimes of the excited states 2T1 and 2E were long (in the µs range)111
and surpass the measurement and evaluation range of our instruments. Using the following
approach we were nevertheless able to estimate the lifetimes. The logarithmic number of counts
of the accessible part of the decay, using the longest possible time range (50 µs), was plotted
against the time. The slope (D) of the decay was determined by linear regression and the life-
time determined using equation 2.1.112
D = −1
τ
(2.1)
Applying the above procedure, we determined for [Cr(bpy)3][PF6]3 in aqueous solution a photo-
luminescence lifetime of 58 µs, which is consistent with the reported value of 60 µs.111 Also the
photoluminescence lifetimes of some additional complexes were determined, using the approach
described above: [Cr(5,5′-Me2bpy)3][PF6]3: 107 µs, [Cr(bpy)2(5,5′-Me2bpy)][PF6]3: 71 µs and
[Cr(bpy)2(4,4′-Me2bpy)][PF6]3: 107 µs (all in N2 degassed aqueous solution).
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Table 2.6: Overview of photoluminescence data for four different {Cr(NN)3}3+ complexes in
different solvents and excited at different wavelengths.
complex λex [nm] λem [nm] solvent concentration
[Cr(bpy)3][PF6]3 280 703, 730 water 1.0·10−4 M
313 702, 727 MeCN 1.0·10−4 M
330 701, 728 MeCN 1.0·10−4 M
[Cr(bpy)2(5,5′-Me2bpy)][PF6]3 280 701, 730 water 5.0·10−5 M
320 703, 730 water 5.0·10−5 M
[Cr(5,5′-Me2bpy)3][PF6]3 280 703, 731 water 1.0·10−4 M
320 702, 730 water 1.0·10−4 M
280 701, 730 MeCN 1.0·10−4 M
[Cr(phen)2(5,5′-Me2bpy)][PF6]3 280 702, 730 water 1.0·10−4 M
320 705, 731 water 1.0·10−4 M
325 702, 730 MeCN 1.0·10−4 M
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Figure 2.6: Typical band shapes of the photoluminescence band of the {Cr(NN)3}3+ complexes.
a) [Cr(bpy)3][PF6]3 (1.0·10−4 M in MeCN, ex. 330 nm); b) [Cr(phen)2(5,5′-Me2bpy)][PF6]3
(1.0·10−4 M in water, ex. 320 nm).
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Figure 2.7: Energy level diagram of [Cr(bpy)3]3+. Where MC stands for metal-centred states,
LC for ligand-centred, IC for internal conversion and ISC inter system crossing. The excitation
arrows stand for λex: 313 nm (a), 365 nm (b), 405 nm (c) and 465 nm (d). The figure is adapted
from Balzani, Hoffman, et al.47
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Figure 2.8: Photoluminescence spectrum for [Cr(5,5′-Me2bpy)3][PF6]3 excited at 280 nm in
water (1.0·10−4 M). The first harmonic of the excitation is omitted and its position is marked
with an asterisk.
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2.3.2.1 Additional emission band - possible decomposition of the complexes
An additional emission band was observed at around 660 nm in aged aqueous and MeCN so-
lutions. Therefore was the following experiment performed: A cuvette, containing an MeCN
solution of [Cr(bpy)3][PF6]3, was gently heated at 50 °C in an air stream (figures 2.9a and 2.9b).
The heating was interrupted every 10 minutes and a photoluminescence spectrum taken. An
increase in the emission band at 660 nm and a decrease in the signal at 730 nm (figure 2.9a)
was observed. The increase of the band at 660 nm compared with the initial emission (730 nm)
is presented in figure 2.9b. Figure 2.9c shows the photoluminescence spectra for a reference
sample, which was not heated between the measurements. In this sample only minimal changes
in the intensity of the band at 660 nm could be observed.
A corresponding experiment was also performed using an MeCN solution of
[Cr(5,5′-Me2bpy)3][PF6]3 (figures 2.10a and 2.10b), here an increase in the emission band be-
tween 650 and 710 nm could also be observed. However the increase of the emission band at
around 660 nm is less compared with [Cr(bpy)3][PF6]3. This suggests that the Cr(III) com-
plexes with sterically more demanding ligands are less labile than those with bpy, since the
metal ion is less available for solvent attack.
A possible explanation is decomposition of the complex. Base-catalysed ligand loss (equation 2.2)
is known and is proposed to follow an associative mechanism involving a seven coordinate in-
termediate [Cr(bpy)3OH][PF6]2.113,114
[Cr(bpy)3]
3+
(aq) + 2[OH]
−
(aq) → [Cr(bpy)2(OH)2]+(aq) + bpy (2.2)
The additional emission band may be assigned as the first harmonic of the emission of monopro-
tonated bpy ligand (Hbpy+, λmax = 335 nm, in MeCN)115 and/or the hydrate (bpy·H2O, λmax
= 328 nm, in water).115 The emission of Hbpy+ is observed even in very dilute solutions as re-
ported by Hoffmann et al.115 (measured in H2SO4 at < 10−6 M). Since the emission maximum
of the additional emission lies at 657 nm (= 2·328.5 nm, figure 2.9) it could be associated with
the reported emission for bpy·H2O. The presence of protonated Hbpy+ is also a contradiction
of the presence of base needed for the base-catalysed ligand loss (equation 2.2).
No further investigations were performed and therefore we have no definitive evidence for the
postulated decomposition. However for the {Cr(tpy)2}3+ we could prove the decomposition
and determine {Cr(tpy)(OH)3} as the residue of the decomposition (compare 3.2, p. 38).
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Figure 2.9: Photoluminescence spectra of [Cr(bpy)3][PF6]3 in MeCN (5·10−6 M), and excited
at 300 nm. Between the measurements the sample was heated gently in an air stream (50 ◦C).
Spectrum a) shows the crude data whereas spectrum b) is normalised at 730 nm. Spectrum c)
shows a spectrum where the sample was not heated between the measurements.
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Figure 2.10: Photoluminescence spectra of [Cr(5,5′-Me2bpy)3][PF6]3 in MeCN (1·10−5 M), ex-
cited at 300 nm. Between the measurements the sample was heated gently in an air stream (50
◦C). Spectrum a) shows the raw data whereas spectrum b) is normalised at 730 nm.
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2.3.3 Electroluminescence of tris(bipyridine)chromium(III) complexes
Two of our complexes ([Cr(bpy)3][PF6]3 and [Cr(5,5′-Me2bpy)3][PF6]3) were tested in LEC con-
figuration (LEC = Light Emitting Electrochemical Cell, see section 1.4.2, p. 9).40,73 This work
was carried out by the group of Dr. Henk Bolink (Instituto de Ciencia Molecular, University
of Valencia, Spain). Neither of the complexes showed any electroluminescence in the device
configuration. But photoluminescence was also measured in the LEC configuration, with the
emission maximum at 728 nm.116
2.4 Electrochemical measurements
The electrochemical processes of some of the {Cr(bpy)3}3+ complexes were studied using cyclic
voltammetry and square wave techniques (table 2.7). The complexes show four reversible one-
electron transfer waves (figures 2.11, 2.12, 2.13). For two complexes square wave measurements
were necessary to determine the potential of the fourth reduction. All complexes showed no
oxidation peaks and the reported reduction potentials correspond to the literature.43,44
The small changes in the reduction potentials of the complexes are negligible. Figures 2.12 and
2.13 show that the one-electron transfer waves of the complexes are often broad or express a
shoulder. A possible explanation for this observation is that the reduction potentials for the
two different ligands of the heteroleptic complexes are slightly different.
The observed redox processes were, in the literature, commonly assigned as reductions of both
the metal centre and the ligands.43,117,118 Wieghardt et al.44 recently published that the re-
duction processes are all ligand centred and the oxidation state of the metal centre does
not change. As a model compound, these authors selected [Cr(tBu2bpy)3][PF6]3 (tBu2bpy
= 4,4′-di-tert-butyl-2,2′-bipyridine). tBu2bpy was chosen since higher quality X-ray crystals
could be grown compared to the complex with an unsubstituted tpy ligand. In addition to
X-ray structures, magnetic susceptibility measurements, UV-VIS/NIR spectra and DFT cal-
culations were performed to determine the composition of the different oxidation states of
{Cr(bpy)3}n (table 2.8). The bpy ligand can exist in three different oxidation levels: neutral
(bpy0), pi- radical monoanionic (bpy•)− or as dianionic (bpy−2)−2.44 We have not confirmed
whether this formulation will also hold for the complexes discussed in this thesis.
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Table 2.7: Cyclic voltammetric data for {Cr(bpy)3}3+ complexes. Measured in MeCN with
[nBu4N][PF6] as supporting electrolyte and a scan rate of 0.1 V s−1. Referenced to Fc/Fc+.
compound E3+/2+1/2 [V] E
2+/1+
1/2 [V] E
1+/0
1/2 [V] E
0/1−
1/2 [V]
[Cr(bpy)3][PF6]3 -0.549 -1.068 -1.634 -2.256
[Cr(5,5′-Me2bpy)3][PF6]3 -0.744 -1.299 -1.901 (-2.216)*
[Cr(phen)2(5,5′-Me2bpy)][PF6]3 -0.694 -1.213 -1.762 -2.207
[Cr(phen)2(4,4′-Me2bpy)][PF6]3 -0.675 -1.195 -1.763 (-2.291)*
[Cr(5,5′-Me2bpy)2(bpy)][PF6]3 -0.670 -1.257 -1.839 -2.443
[Cr(5,5′-Me2bpy)2(phen)][PF6]3 -0.683 -1.214 -1.798 -2.315
*: determined using square wave measurement
Table 2.8: The composition of {Cr(tBu2bpy)3}n (n = 3+, 2+, 1+ and 0) according toWieghardt
et al..44
3+ 2+ 1+ 0
[CrIII(tBu2bpy)3][PF6]3 [CrIII(tBu2bpy)3][PF6]2 [CrIII(tBu2bpy)3][PF6] [CrIII(tBu2bpy)3]
S = 3/2 S = 1 S = 1/2 S = 0
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Figure 2.11: Cyclic voltammogram for [Cr(bpy)3][PF6]3, measured in MeCN solution with
[nBu4N][PF6] as supporting electrolyte, with respect to Fc/Fc+ and a scan rate of 0.1 V s−1.
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Figure 2.12: Cyclic voltammogram for [Cr(phen)2(5,5′-Me2bpy)][PF6]3, measured in MeCN
solution with [nBu4N][PF6] as supporting electrolyte, with respect to Fc/Fc+ and a scan rate
of 0.1 V s−1.
-3.30E-05
-2.80E-05
-2.30E-05
-1.80E-05
-1.30E-05
-8.00E-06
-3.00E-06
2.00E-06
7.00E-06
-2.8 -2.3 -1.8 -1.3 -0.8 -0.3
cu
rr
en
t 
[A
]
potential [V]
Figure 2.13: Cyclic voltammogram for [Cr(5,5′-Me2bpy)2(bpy)][PF6]3. Measured in MeCN
solution with [nBu4N][PF6] as supporting electrolyte, with respect to Fc/Fc+ and a scan rate
of 0.1 V s−1.
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2.5 Tris(diimine)chromium(III) complexes: X-ray structures
Single crystals of several cations out of the tris(diimine)chromium(III) series were received.
They were grown using the overlaying technique. The complex was dissolved in either MeCN
or acetone and then overlaid in a thin vial with Et2O or n-hexane (for details compare tables
2.9 and 2.10).
All examples show no interactions between the cations, since the distances between them are
too big.119 Because the space between the cations is filled with anions and solvent molecules,
the main interactions in the packing are therefore CH...N and CH...F. The angles between the
diimine ligands are between 71.6◦ and 90.0◦ (table 2.11).
Table 2.9: Crystallographic data of {Cr(NN)3}3+ complexes, part I
compound [Cr(bpy)3][PF6]3 [Cr(bpy)2(phen)][PF6]3 [Cr(4,4′-
Me2bpy)2(bpy)][PF6]3
formula moiety C32H24CrN6,
3(F6P), C2H3N
4(C32H24CrN6),
12(F6P), 11(C2H3N)
4(C34H32CrN6),
12(F6P),
12(C2H3N), H2O
formula weight 996.52 4369.52 4556.93
crystal colour and habit yellow, block yellow, block yellow, block
crystal system rhombohedral monoclinic monoclinic
space group R3c P21/c C2/c
31.535(5) 10.2863(9) 24.4712(17)
a, b, c [Å] 31.535(5) 34.025(4) 12.9795(8)
21.523(4) 13.0344(12) 31.013(2)
90.00 90.00 90.00
α, β, γ [◦] 90.00 94.356(7) 95.608(6)
120.00 90.00 90.00
U [Å3] 18536(10) 4548.8(8) 9803.4(12)
Dc [Mg m−3] 1.607 1.595 1.543
Z 18 1 2
µ(Mo-Kα) [mm−1] 0.511 0.471 0.476
T [K] 173(2) 173(2) 173(2)
refln. collected 69367 43616 14484
unique refln. 8531 9061 8641
refln. for refinement 7726 8430 7928
parameters 572 681 720
threshold I>2.0σ I>2.0σ I>2.0σ
R1 (R1 all data) 0.0569 (0.0633) 0.0487 (0.0521) 0.0684 (0.0730)
wR2 (wR2 all data) 0.1502 (0.1558 ) 0.1632 (0.1607) 0.1632 (0.1607)
goodness of fit 1.085 1.131 1.131
crystal growing overlaying
MeCN/ Et2O
overlaying
MeCN/ Et2O
overlaying
MeCN/ Et2O
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Table 2.10: Crystallographic data of {Cr(NN)3}3+ complexes, part II
compound [Cr(4,4′-
Me2bpy)2(bpy)][PF6]3
[Cr(5,5′-
Me2bpy)3][PF6]3
Cr[(bpy)2(5,5′-
Me2bpy)][PF6]3
formula moiety C34H32CrN6,
3(F6P), 2(C2H3N)
2(C36H36CrN6),
6(F6P), 2(C3H6O),
(H2O)
2(C33H30CrN6),
6(F6P), 5(C3H6O)
formula weight 1093.65 2211.39 2285.47
crystal colour and habit yellow, plate yellow, block yellow, block
crystal system monoclinic trigonal monoclinic
space group P21/c P3221 P21/c
19.290(2) 19.115(3) 11.174(2)
a, b, c [Å] 13.2160(16) 19.115(3) 18.538(4)
18.703(3) 23.453(5) 24.374(5)
90.00 90.00 90.00
α, β, γ [◦] 109.351(4) 120.00 90.78(3)
90.00 90.00 90.00
U [Å3] 4498.7(10) 7421(2) 5048.3(17)
Dc [Mg m−3] 1.615 1.484 1.504
Z 4 3 2
µ(Mo-Kα) [mm−1] 0.476 0.435 0.430
T [K] 123 173(2) 173(2)
refln. collected 25201 209659 56481
unique refln. 10115 8763 8943
refln. for refinement 5222 7871 6257
parameters 613 629 831
threshold I>1.0σ I>2.0σ I>2.0σ
R1 (R1 all data) 0.1457 (0.2564) 0.0668 (0.0741) 0.0946 (0.1255)
wR2 (wR2 all data) 0.0982 (0.1819) 0.1716 (0.1776) 0.2502 (0.2813)
goodness of fit 1.0892 1.098 1.052
crystal growing overlaying
MeCN/ Et2O
overlaying
hexane/ acetone
overlaying
hexane/ acetone
Table 2.11: Angles between the bipyridine ligands, where A represents the ligand containing
N1, and similarly B(N3) and C(N5).
compound A and B [◦] B and C [◦] A and C [◦]
[Cr(bpy)3][PF6]3 85.6 85.7 80.3
[Cr(bpy)2(phen)][PF6]3 71.6 88.1 85.8
[Cr(4,4′-Me2bpy)2(phen)][PF6]3 (sp. grp.: C2/c) 89.4 81.6 89.6
[Cr(4,4′-Me2bpy)2(phen)][PF6]3 (sp. grp.: P21/c) 86.4 85.7 89.4
[Cr(5,5′-Me2bpy)2(phen)][PF6]3 89.1 85.6 90.0
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2.5.1 Structure of [Cr(bpy)3][PF6]3·MeCN
[Cr(bpy)3][PF6]3·MeCN crystallises in the rhombohedral space group R3c (figure 2.14). The unit
cell contains 18 cations (Z = 18) (figure 2.15). A pseudo-polymorphic structure has already
been reported by Petersen et al.120 with the same space group however without solvent in the
lattice and with a smaller Z value (Z = 6). An additional structure in the space group R32 of
[Cr(bpy)3][PF6]3 has been reported earlier by Ferguson et al.93
Figure 2.14: Structure of the cation in [Cr(bpy)3][PF6]3·MeCN with ellipsoids plotted at 50 %
probability level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected
bond lengths [Å]: Cr1-N1 = 2.048(4), Cr1-N2 = 2.042(4), Cr1-N3 = 2.047(4), Cr1-N4 = 2.047(4),
Cr1-N5 = 2.046(4), Cr1-N6 = 2.067(4); and bond angles [◦]: N1-Cr1-N2 = 80.06(16), N3-Cr1-N4
= 79.99(15), N5-Cr1-N6 = 79.99(15).
Figure 2.15: Unit cell packing of [Cr(bpy)3][PF6]3·MeCN. Colour code: cations (red), anions
(PF−6 , blue) and solvent molecules (MeCN, green).
2.5. TRIS(DIIMINE)CHROMIUM(III) COMPLEXES: X-RAY STRUCTURES 33
2.5.2 Structure of 4{[Cr(bpy)2(phen)][PF6]3}·11MeCN
4{[Cr(bpy)2(phen)][PF6]3}·11MeCN crystallises as yellow blocks (figure 2.17) in the monoclinic
space group P21/c (figure 2.16). Two of the MeCN molecules in the asymmetric unit are
disordered and have been modelled over two sites. The third solvent position has a fractional
occupancy.
Figure 2.16: Structure of the cation in [Cr(bpy)2(phen)][PF6]3 with ellipsoids plotted at 50 %
probability level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected
bond lengths [Å]: Cr1-N1 = 2.0506(19), Cr1-N2 = 2.0527(19), Cr1-N3 = 2.0361(18), Cr1-N4
= 2.0373(19), Cr1-N5 = 2.0494(19), Cr1-N6 = 2.0468(18); and bond angles [◦]: N1-Cr1-N2 =
79.53(8), N3-Cr1-N4 = 79.81(8), N5-Cr1-N6 = 80.75(8).
Figure 2.17: Picture (optical microscope) of a crystalline block of [Cr(bpy)2(phen)][PF6]3.
2.5.3 Structure of [Cr(bpy)2(5,5
′-Me2bpy)][PF6]3·3Me2CO
[Cr(bpy)2(5,5′-Me2bpy)][PF6]3·3Me2CO crystallises in the monoclinic space group P21/c
(figure 2.18). Preliminary data confirmed the gross structural features of the cation. How-
ever, there was disordering of the methyl group over two positions. In figure 2.18 the cation
with the 5,5′-Me2bpy ligand containing N1 and N2 is presented. The second position includes
N5 and N6. The PF−6 anions were heavily disordered and could not be modelled in a satisfactory
manner.
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Figure 2.18: Structure of the cation in [Cr(bpy)2(5,5′-Me2bpy)][PF6]3·Me2CO with ellipsoids
plotted at 50 % probability level. H atoms, counter ions and solvent molecules are omitted for
clarity. Selected bond lengths [Å]: Cr1-N1 = 2.042(3), Cr1-N2 = 2.041(3), Cr1-N3 = 2.050(3),
Cr1-N4 = 2.039(4), Cr1-N5 = 2.037(3), Cr1-N6 =2.049(4); and bond angles [◦]: N1-Cr1-N2 =
80.38(13), N3-Cr1-N4 = 79.49(14), N5-Cr1-N6 = 80.16(14).
2.5.4 Structure of Cr[(4,4′-Me2bpy)2(bpy)][PF6]3
The heteroleptic complex Cr[(4,4′-Me2bpy)2(bpy)][PF6]3 crystallised in two different space groups
depending on the number of solvent molecules in the lattice.
4{Cr[(4,4′-Me2bpy)2(bpy)][PF6]3}·12MeCN·H2O crystallises in the monoclinic space group C2/c
(figure 2.19), whereas [Cr(4,4′-Me2bpy)2(bpy)][PF6]3·2MeCN crystallises in the monoclinic space
group P21/c (figure 2.20).
Figure 2.19: Structure of the cation in 4{Cr[(4,4′-Me2bpy)2(bpy)][PF6]3}·12MeCN·H2O (space
group: C2/c) with ellipsoids plotted at 50 % probability level. H atoms, counter ions and
solvent molecules are omitted for clarity. Selected bond lengths [Å]: Cr1-N1 = 2.044(3), Cr1-N2
= 2.044(3), Cr1-N3 = 2.038(3), Cr1-N4 = 2.031(3), Cr1-N5 = 2.041(3), Cr1-N6 = 2.032(3);
and bond angles [◦]: N1-Cr1-N2 = 79.56(12), N3-Cr1-N4 = 80.15(13), N5-Cr1-N6 = 79.34(13).
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Figure 2.20: The structure of the cation in [Cr(4,4′-Me2bpy)2(bpy)][PF6]3·2MeCN (space group:
P21/c) with ellipsoids plotted at 50 % probability level. H atoms, counter ions and solvent
molecules are omitted for clarity. Selected bond lengths [Å]: Cr1-N1 = 2.038(7), Cr1-N2 =
2.068(6), Cr1-N3 = 2.027(7), Cr1-N4 = 2.059(7), Cr1-N5 = 2.039(6), Cr1-N6 = 2.048(7); and
bond angles [◦]: N1-Cr1-N2 = 80.1(3), N3-Cr1-N4 = 79.4(3), N5-Cr1-N6 = 80.1(3).
2.5.5 Structure of [Cr(5,5′-Me2bpy)3][PF6]3
Since the crystals were highly twinned, the structure was difficult to solve. Preliminary data
confirmed the structure (figure 2.21) of the cation as well as the number and identity of the
anions. The presence of solvent (Me2CO) could also be confirmed, but the molecules could not
be modelled completely.
Figure 2.21: Structure of the cation in [Cr(5,5′-Me2bpy)3][PF6]3 with ellipsoids plotted at 50 %
probability level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected
bond lengths [Å]: Cr1-N1 = 2.050(4), Cr1-N2 = 2.041(4), Cr1-N3 = 2.052(4), Cr1-N4 = 2.043(4),
Cr1-N5 = 2.050(4), Cr1-N6 = 2.048(4); and bond angles [◦]: N1-Cr1-N2 = 80.14(15), N3-Cr1-N4
= 79.93(17), N5-Cr1-N6 = 80.01(15).

Chapter 3
Bis(terpyridine)chromium(III)
complexes
3.1 Synthesis of bis(terpyridine)chromium(III) complexes
The majority of the previously reported syntheses start with a chromium(II) compound and in-
clude a [Cr(tpy)2]2+-intermediate.51,52,121,122 Wallace et al. published a protocol starting with
CrCl3·H2O which was treated with zinc amalgam to form a chromium(II) intermediate and
following the same procedure as the examples above.123
We developed a new synthesis based on the synthesis strategy known for the synthesis of
tris(bipyridine)chromium(III) complexes (scheme 2.2, p. 12). This three step synthesis
(scheme 3.1) starts with anhydrous chromium(III) chloride. In the first step CrCl3 and the
first equivalent of the terpyridine ligand are refluxed in EtOH in the presence of catalytic
amounts of zinc. Since the intermediate is neutral and poorly soluble, the separation of the zinc
powder and intermediate A by recrystallisation, analogous to {Cr(bpy)2Cl2}+, is not possible.
Therefore granular zinc was used in place of the zinc powder. As a consequence, the amount
had to be increased. The separation was now possible since the intermediate A precipitates as
a fine powder and could be filtered carefully, however the granular zinc remained in the reaction
flask. [Cr(tpy)]Cl3 was first synthesised by Broomhead et al.124
CrCl3 
(anh.)
LN-N-N
EtOH, 
Zn (cat.),
reflux LN-N-N           
MeCN, reflux
[Cr(LN-N-N)Cl3] [Cr(LN-N-N)(CF3SO3)3] +3 HCl
[Cr(LN-N-N)(LN-N-N)][CF3SO3]3
CF3SO3H
overnight, rt
A B
C
[Cr(LN-N-N)(LN-N-N)][PF6]3
D
NH4PF6
MeOH
Scheme 3.1: Three step synthesis strategy to homoleptic and heteroleptic
bis(terpyridine)chromium(III) complexes.
In the following step the chlorides were exchanged by stirring A overnight at room temperature
in trifluoromethanesulfonic acid. Since the intermediate B was sometimes not stable while
storing in an oxygen containing atmosphere, the reaction strategy was adapted and intermediate
B no longer isolated. InsteadB was, after it was precipitated with Et2O, filtered in a Schlenk -frit
and redissolved directly in the reaction flask for step three. Also the third step was performed
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Figure 3.1: Calculated structure for [Cr(6,6′′-Me2tpy)2]3+ (Spartan ′4 V.1.1.3).
in an analogous manner to the tris(bipyridine)chromium(III) synthesis. B and the second
equivalent tpy ligand were refluxed in actetonitrile. The third step could also be performed
using the microwave reactor instead of refluxing the reaction mixture.
Since the two tpy ligands were introduced in two separate steps it is also possible to synthesise
heteroleptic {Cr(tpyA)(tpyB)}3+ complexes. To the best of our knowledge, no heteroleptic
complexes with {Cr(tpy)2}3+ cores have been reported before.
We achieved the synthesis of heteroleptic complexes with the sterically demanding ligand
X N NNNN N Cr
3+
3PF6-
N
N
N
Cr
Cl
Cl
Cl
1) CF3SO3H, overn., rt
2) LT4, MeCN, reflux 9 h
3) NH4PF6, MeOH, rt
[Cr(LT4)Cl3]
Scheme 3.2: Attempted route to the homoleptic complex with the sterically demanding ligand
LT4, which could not be isolated.
LT4 ([Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3 and [Cr(LT1)(LT4)][CF3SO3]3), but the homoleptic
complex [Cr(LT4)2]3+ could not be isolated (scheme 3.2). The colour of the reaction mixture
changed from greenish to yellow suggesting the formation of [Cr(LT4)2]3+ in solution, but after
anion exchange with NH4PF6 in MeOH, a dark green precipitate formed and there was no
evidence for the formation of the desired complex.
Calculations for [Cr(6,6′′-Me2tpy)2]3+ show that the tpy units have to be quite deformed to fit
in the complexes. The structure was modelled using molecular mechanics (Spartan ′4 V.1.1.3)
and the modelled structure is shown in figure 3.1.
Anion exchange with an excess of NH4PF6 in MeOH was not complete with all complexes. An
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example is the crystal structure of [Cr(HLT11)(tpy)][PF6]3[CF3SO3] (3.9.2.2 , p. 86). In this
example only three of the four anions were exchanged. The second reason is that all complexes
containing at least one of the N,N -diphenylanyline tpy were too soluble to precipitate them
with NH4PF6.
The analysis methods to determine the composition of the complexes were limited to elemental
analysis and X-ray structures. As presented in section 3.7 (p. 63) EPR measurements were
unsuccessful. All attempts to use mass spectrometry (ESI-MS and MALDI-MS) to characterise
the {Cr(tpy)2}3+ complexes failed.
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Table 3.1: Synthesised bis(terpyridine)chromium(III) complexes, part I: homoleptic complexes
(exp. = link to the experimental part, str. = link to the structure discussion)
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
[Cr(tpy)2][PF6]3 [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3
exp.: 6.4.3.1 (p. 130); str.: 3.9.1.1 (p. 73) exp.: 6.4.3.2 (p. 130); str.: 3.9.1.4 (p. 79)
reported by Wieghardt et al.52 reported as CF3SO3 salt by Nair et al.51
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
[Cr(4′-(4-tolyl)tpy)2][PF6]3 [Cr(LT3)2][PF6]3
exp.: 6.4.3.3 (p. 131); exp.: 6.4.3.4 (p. 131); str.: 3.9.1.3 (p. 77)
reported as CF3SO3 salt by Nair et al.51
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N N
[Cr(5,5′′-Me2tpy)2][PF6]3 [Cr(LT5)2][CF3SO3]3
exp.: 6.4.3.5 (p. 132); str.: 3.9.1.2 (p. 75) exp.: 6.4.3.6 (p. 132)
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr
4+
4PF6-
NN H
[Cr(LT2)2][PF6]3 [Cr(HLT11)(LT11)][PF6]4
exp.: 6.4.3.21 (p. 139); exp.: 6.4.3.7 (p. 133); str.: 3.9.1.6 (p. 81)
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Table 3.2: Synthesised bis(terpyridine)chromium(III) complexes, part II: heteroleptic complexes
I (exp. = link to the experimental part, str. = link to the structure discussion).
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr N H
4+
4PF6-
[Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 [Cr(tpy)(HLT11)][PF6]4
exp.: 6.4.3.8 (p. 133); str.: 3.9.2.5 (p. 90) exp.: 6.4.3.9 (p. 134); str.: 3.9.2.2 (p. 86)
N
N
N
N
N
N
Cr CN
3+
3PF6-
N
N
N
N
N
N
Cr
3+
3PF6-
O
[Cr(tpy)(LT7)][PF6]3 [Cr(tpy)(LT8)][PF6]3
exp.: 6.4.3.10 (p. 134); str.: 3.9.2.3 (p.
87)
exp.: 6.4.3.11 (p. 135); str.: 3.9.2.6 (p.
92)
N
N
N
N
N
N
Cr
3+
3PF6-
S
N
N
N
N
N
N
Cr
3+
3PF6-
[Cr(LT9)(tpy)][PF6]3 [Cr(tpy)(5,5′′-Me2tpy)][PF6]3
exp.: 6.4.3.12 (p. 135); str.: 3.9.2.4 (p.
89)
exp.: 6.4.3.13 (p. 135); str.: 3.9.2.1 (p.
86)
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
OMe
OMe
N
N
N
N
N
N
Cr
3+
3CF3SO3-
[Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3
exp.: 6.4.3.14 (p. 136); exp.: 6.4.3.15 (p. 136)
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Table 3.3: Synthesised bis(terpyridine)chromium(III) complexes, part III: heteroleptic com-
plexes II (exp. = link to the experimental part, str. = link to the structure discussion).
N
N
N
N
N
N
Cr
3+
3PF6-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
[Cr(4′-(4-tolyl)tpy)(LT4)][PF6]3 [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3
exp.: 6.4.3.16 (p. 137) exp.: 6.4.3.17 (p. 137)
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
N
N
N
N
N
N
Cr
3+
3CF3SO3-
[Cr(LT2)(LT5)][CF3SO3]3 [Cr(5,5′′-Me2tpy)(LT4)][CF3SO3]3
exp.: 6.4.3.18 (p. 138) exp.: 6.4.3.19 (p. 138)
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N COOH
COOH
[Cr(LT1)(LT4)][CF3SO3]3 [Cr(LT5)(LT10)][CF3SO3]3
exp.: 6.4.3.20 (p. 139) exp.: 6.4.3.22 (p. 140)
3.2 Lability of the bis(terpyridine)chromium(III) complexes
Chromium(III) (d3) is a text-book23 example of a kinetically inert metal ion with respect to
ligand exchange. We observed a sensitive lability in alkaline environment or in the presence of
F− ions.
3.2.1 Lability in alkaline environment
The original aim was to replace the singly charged anions (CF3SO−3 and PF
−
6 ) by threefold
charged PO3−4 . However we observed the decomposition of [Cr(tpy)2][CF3SO3]3 when Na3PO4
was added. The solution turned from yellow to greenish and a white precipitate formed. The
white precipitate was found to be free ligand by 1H NMR spectroscopy. Since a decomposition
of the complex in an alkaline environment was supposed, the following experiments were con-
ducted.
Figure 3.2 shows a titration of an aqueous solution of [Cr(tpy)(4′-(4-tolyl)-tpy)][PF6]3 with
aqueous NaOH, monitored by UV-VIS spectroscopy. The decomposition can be observed in
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the decay of the characteristic absorption with two maxima at 350 and 364 nm. The decrease
of the absorption intensity after adding 0.25 eq. NaOH is considerable. After the addition of
three equivalents of NaOH, conversion was essentially complete.
In contrast, the {Cr(tpy)2}3+ complexes are stable in neutral aqueous solution. Figure 3.3
shows a 2 month monitoring of [Cr(tpy)2][PF6]3 in a neutral aqueous solution (deionised water,
pH = 6.36). The minimal variances in the spectrum are caused by evaporation of solvent and
a minimal decomposition between day 35 and day 67.
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Figure 3.2: Absorption spectra of an aqueous solution of [Cr(tpy)(4′-(4-tolyl)-tpy)][PF6]3
(1.0·10−4 mol l−1) during a titration with aqueous NaOH (1.0·10−2 mol l−1).
This correlates with the behaviour described for [Cr(bpy)3][ClO4]3 in aqueous solutions (pH <
7).113 Further decomposition (according to equation 3.1) has also been reported.113,114
[Cr(bpy)3]
3+(aq.) + 2[OH]−(aq.) −→ Cr[(bpy)2(OH)2]+(aq.) + bpy (3.1)
An associative mechanism has been proposed for this base-catalysed aquation reaction involving
a seven coordinate intermediate [Cr(bpy)3(OH2)]3+, that is deprotonated under basic conditions
and forms [Cr(bpy)2(OH)2]+ and free bpy. The same process has also been described for pho-
toaquation reactions under basic conditions.47,125
For comparison, [Cr(bpy)3][PF6]3 was titrated with NaOH under the same conditions as used
for the {Cr(tpy)2}3+ complexes. The decomposition is minimal (figure 3.4) compared with the
corresponding {Cr(tpy)2}3+ complexes (figure 3.2).
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Figure 3.3: Absorption spectra of an aqueous solution of [Cr(tpy)2][PF6]3 (1.0·10−4 mol l−1)
over a period of 67 days. Blue: fresh, red: after 29 days, green: after 35 days and purple: after
67 days.
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Figure 3.4: Absorption spectra of an aqueous solution of [Cr(bpy)3][PF6]3 (1.0·10−4 mol l−1)
during a titration with aqueous NaOH (1.0·10−2 mol l−1).
3.2. LABILITY OF THE BIS(TERPYRIDINE)CHROMIUM(III) COMPLEXES 45
Since {Cr(tpy)2}3+ complexes containing a diphenylaniline tpy ligand (here LT5) show a broad
absorption with maxima at 512 and 670 nm, the decomposition of
[(4′-(4-tolyl)-tpy)(LT5)][CF3SO3]3 was observable by the naked eye when NaOH was added
(figure 3.5). After the addition of 4 equivalents of NaOH, decomposition was nearly complete
and was complete after adding 8 equivalents.
To determine the composition of the residues, 3.10 mg of [Cr(tpy)(4′-(4-tolyl)-tpy)][PF6]3 in
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Figure 3.5: Absorption spectra of an aqueous solution of [Cr(4′-(4-tolyl)-tpy)(LT5)][CF3SO3]3
(1.0·10−4 mol l−1) during a titration with aqueous NaOH (1.0·10−2 mol l−1). Inset : Picture of
the solutions with the particular equivalents of NaOH.
20 ml water was treated with an excess of NaOH (aqueous solution, 7.25 eq.) and stirred for 1 h
at room temperature. The pale green solution with a flaky white precipitate was evaporated to
dryness. Then CHCl3 was added and the suspension was sonicated for 20 min. After filtration,
the clear filtrate was evaporated and a 1H NMR spectrum of the CDCl3 soluble part of the
residue was measured. The 1H NMR is shown in figure 3.6a and shows that the CDCl3 soluble
material is a mixture of the two ligands of the former complex. In this experiment the ratio
1 : 0.9 (4′-(4-tolyl)-tpy : tpy), was determined from the integrals of the signals labelled with I
and II in figure 3.6a. In a corresponding experiment with [Cr(4′-(4-tolyl)-tpy)(LT5)][CF3SO3]3
(10 eq. NaOH, in water) the ratio of the two ligands was 1 : 1.
In an independent experiment [Cr(tpy)(4′-(4-tolyl)-tpy)][CF3SO3]3 (3.6 mg in 2.5 ml MeCN)
was treated with a large excess (48 eq.) of tetrabutylammonium hydroxide (nBu4NOH). The
mixture was stirred for 1 h at room temperature, the solvent was removed by evaporation and
the residue redissolved in CH2Cl2 with a drop of MeOH for the preparation of the MALDI-
MS sample. The main signal at m/z 425.6 fits well with the calculated isotopic pattern for
{[Cr(4′-(4-tolyl)-tpy)(OH)3]-H}+ (figure 3.7). This is a strong evidence that the chromium con-
taining residue is {Cr(tpy)(OH)3} when OH− was added to the solution. A further hint are the
three additional bands in the IR spectrum at 3216, 2958 and 2872 cm−1 after the addition of
NaOH. The O−H vibration126 pattern matches with that reported for chromium(III) hydroxide
(Cr(OH)3).127 However the wavenumbers (Cr(OH)3: 3410, 2954 and 2866 cm−1)127 are only
partly consistent.
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The results of the UV-VIS monitoring (figures 3.2 and 3.5) are consistent with the postulated
formation of {Cr(tpy)(OH)3}. When NaOH is added to [Cr(tpy)(4′-(4-tolyl)-tpy)][PF6]3, three
equivalents are needed to essentially complete the decomposition (figure 3.2). In the second
example the decomposition is essentially completed after the addition of 8 equivalents, but the
main part of the decomposition took place after adding the first 4 equivalents of NaOH. Com-
bined with the fact that the ratio of the free ligand is roughly 1:1, one can estimate a statistical
elimination independent of functional groups on the ligand (figure 3.5).
Figure 3.6: 1H NMR spectra in CDCl3 of: a) the chloroform-soluble part of the residue of
[Cr(tpy)(4′-(4-tolyl)-tpy)][CF3SO3]3 (see text); b) tpy, c) 4′-(4-tolyl)-tpy. Signal marked with
an asterisk arises from one of the 13C satellite peaks of residual CHCl3.
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Figure 3.7: Comparison of the calculated (dark grey) and measured (light grey) isotope pattern
for {[Cr(4′-(4-tolyl)-tpy)(OH)3]-H}+.
3.2.2 Fluoride lability
While carrying out ligand exchange experiments (see 3.3, p. 43) we realised that complexes
with a PF−6 anion decompose when heated in the microwave reactor, whereas those containing
CF3SO−3 seem to be stable respectively undertake a ligand exchange.
Therefore, the following experiments were executed: Solutions (3 mg compound in 1.5 ml
MeCN) of [Cr(LT3)2][PF6]3 (figure 3.8.A.I) and [Cr(LT3)2][CF3SO3]3 (figure 3.8.A.II) were
heated in the microwave reactor for 1 h at 150 ◦C and 8 bar. Figure 3.8.B shows that no change
is visible in vial II ([Cr(LT3)2][CF3SO3]3), whereas [Cr(LT3)2][PF6]3 (vial 1) changed colour to
pale purple.
It is obvious that a decomposition has occurred. To determine the composition of the residue,
additional experiments were performed. [Cr(tpy)2][PF6]3 (around 3 mg) in MeCN (1.5 ml) was
heated under the same conditions (microwave reactor, 1 h, 150 ◦C, 8 bar) as in the experiment
described above. The UV-VIS spectrum shows a weak absorption with a maximum at 550 nm
(figure 3.9: blue curve).
As a blank, a 0.1 M solution of NH4PF6 in MeCN was heated in the microwave reactor under
the same conditions as the complexes described before (1 h, 150 ◦C, 8 bar). 19F{1H} NMR
spectroscopy shows a complete decomposition of the PF−6 ion (figure 3.10). According to the
19F{1H} NMR spectrum, heating in the microwave reactor yielded four different compounds.
The two doublets around −85 ppm fit with the reported spectra128 for POF−4 , POF3 and
PO2F−2 . Since the published data are not measured in the same solvent, a precise assignment
is not possible. Otero et al.128 report further "the 19F spectra showed several single peaks
from −165 to −125 ppm." The additional signals that could not be assigned fit in this range.
Therefore a hydrolysis, as discussed in the literature,128 can be proposed as decomposition of
the PF−6 in the microwave reactor. The resulting F
− ions coordinate then to the Cr(III) ion
and replace one tpy ligand.
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Figure 3.8: Pictures of the samples before (A) and after (B) heating in the microwave reactor.
I: [Cr(LT3)2][CF3SO3]3 II: [Cr(LT3)2][PF6]3.
In a further experiment [Cr(tpy)2][PF6]3 (3.0 mg in 2.5 ml MeOH) was treated with an excess
(32 eq.) of tetrabutylammonium fluoride (nBu4NF). The mixture was stirred for 1 h and yielded
a pale purple solution. The UV-VIS spectrum shows a weak absorption with a maximum at
570 nm (figure 3.9: red curve).
These maxima and the shapes of the absorption bands agree with those reported for [Cr(tpy)F3]
(λmax = 581 nm in propan-2-ol and 556 nm in water).129 It could also be confirmed that the
pale purple colour does not arise from {Fe(tpy)2}2+ since the distinctive shape130 (figure 3.9:
green curve) of its absorption band is missing. That was considered since tpy is known as a
sensitive reagent to detect iron cations. Impurities of iron cations can derive for example from
the spatula.131 The subsequent addition of tetrabutylammonium fluoride and FeSO4 to a MeOH
solution of [Cr(tpy)2][PF6]3 showed (figure 3.12) clearly the different shape of the absorption.
The fact that {Fe(tpy)}2+ is formed confirmed the presence of free tpy ligand in the solution
after adding tetrabutylammonium fluoride.
In a similar experiment [Cr(tpy)2][PF6]3 (3.0 mg in 2.5 ml CHCl3) was treated with an ex-
cess (32 eq.) of tetrabutylammonium fluoride (nBu4NF). After stirring for 1 h the solvent
was evaporated and a MALDI-MS was measured (sample preparation with CH2Cl2, matrix:
4-nitroaniline). The MALDI-MS shows one pattern with the most intense peak at m/z 323
(figure 3.11). This corresponds to [Cr(tpy)F2]+ and, as shown in figure 3.11, the match be-
tween measured and calculated isotopic patterns is good. As reported above, a decomposition
of the {Cr(tpy)2}3+ complexes was observed when nBu4NF was added to a MeOH or CHCl3
solution, whereas no change was observed in the absorption spectrum when an aqueous solution
was treated with nBu4NF. We postulate the greater number of hydrogen bonds between F−
and water compared to F− in MeOH makes it act as a weaker nucleophile.
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Figure 3.9: Normalised UV-VIS spectrum. Blue: proposed [Cr(tpy)F3] in MeCN
([Cr(tpy)2][PF6]3 heated in the mw, λmax = 550 nm); red: proposed [Cr(tpy)F3] in MeOH (ad-
dition of nBu4NF to [Cr(tpy)2][PF6]3, λmax = 570 nm); green: control experiment [Fe(tpy)2]2+.
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Figure 3.10: 19F{1H} NMR spectra in d3-MeCN of: a) NH4PF6 before heating in the microwave
reactor; b) decomposition products of NH4PF6 after heating in the microwave reactor for 1 h
at 150 ◦C and 8 bar.
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Figure 3.11: Comparison of the calculated (dark grey) and measured (light grey) isotope pattern
for [Cr(tpy)F2]+.
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Figure 3.12: Absorption spectra of [Cr(tpy)2][PF6]3 in MeOH after it has been treated with
nBu4NF (solid line) and after additional adding of FeSO4 (dotted line).
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3.3 Ligand exchange
In two cases, crystal structures of homoleptic complexes were obtained from a bulk product that
was assumed to be heteroleptic (scheme 3.3). Therefore we had to consider a ligand exchange
between the heteroleptic complexes and the formation of homoleptic complexes. But we have
also a definitive evidence for the existence of heteroleptic {Cr(tpyA)(tpyB)}3+ complexes, the
X-ray structures (compare 3.9, p. 70).
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Scheme 3.3: Assumed heteroleptic structures in the bulk product (A1 and B1) and the ho-
moleptic structures (A2 and B2), which were confirmed by X-ray crystallography.
In example A (scheme 3.3) the bulk compound A1 was characterised by elemental analysis
(6.4.3.20, p. 139). This was not the case in example B, since this complex could not be obtained
pure. In both examples a sterically demanding ligand is exchanged for a less sterically demand-
ing one. However, single crystal structures of complexes containing one sterically demanding lig-
and were also obtained ([Cr(tpy)(5,5′′-Me2tpy)][PF6]3 and [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3.
The crystal structure of [Cr(tpy)(5,5′′-Me2tpy)][PF6]3 is discussed in 3.9.2.1 on page 86. The
data for [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3 are only preliminary, but the data confirmed the
main structural features of the cation (figure 3.13).
As a consequence of these observations a series of exchange experiments was conducted. To
easily monitor a ligand exchange, LT5 was added to [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, since
{Cr(tpy)2}3+ complexes with this diphenylaniline tpy (LT5) appear dark in contrast to the
yellow [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 (3.5.1, p. 52). Scheme 3.4 summarises the performed
ligand exchange experiments I to III. An obvious change in the absorption spectra, and also
visible to the naked eye, occurred only under harsh conditions (figure 3.14). Figure 3.15
shows that the pattern of the normalised UV-VIS spectrum for I is consistent with that for
[Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3. A close look at the UV-VIS spectrum (figure 3.14) of trial
II (refluxing for 7 h) also shows a slight increase of the absorption intensity at around 500 nm.
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Figure 3.13: The cation of [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3 with ellipsoids plotted at 50 %
probability level. Anions, H atoms and solvent molecules are omitted for clarity. (R1: 0.1572)
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Figure 3.14: UV-VIS spectra in MeCN of [Cr(5,5′′-Me2tpy)2][PF6]3 (black) and the ligand
exchange trials (compare scheme 3.4) I (red), II (green) and III (blue). The inset shows the
colour change of ligand exchange experiment I.
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III LT5, 1 eq. stirring at rt, 2 days MeCN no colour change
detectable
no exchange (B)
Scheme 3.4: Overview of the ligand exchange experiments I to III.
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Figure 3.15: UV-VIS spectra in MeCN of exchange trial I (solid line) (compare scheme 3.4)
compared with [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 (dotted line).
In a further ligand exchange experiment (IV, scheme 3.5) a reverse exchange was performed,
in which the heavier ligands 4′,-(4-tolyl)tpy and LT5 could potentially be exchanged by tpy.
The decrease in the absorption intensity between 440 and 840 nm indicates that some of the
4′-diphenylaniline tpy ligand has been replaced by tpy (figure 3.16).
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N
Cr
3+
3CF3SO3-
R1 R2
label additional ligand reaction conditions solvent observations
IV tpy, 5 eq. mw, 1 h, 150 ◦C, 10 bar MeCN dark red solution, change ob-
servable in UV-VIS spectrum
Scheme 3.5: Ligand exchange experiment IV. The products of the ligand exchange reaction
could not be determined in detail, therefore R1 and R2 stand for H, Me, 4′-(4-tolyl) and N,N -
diphenylaniline.
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Figure 3.16: UV-VIS spectra in MeCN of the exchange trial IV: before the microwave reaction
(additional ligand already added) (solid line) and after the reaction (dotted line).
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In an ancillary experiment, a possible ligand exchange in the {Cr(tpy)(CF3SO3)3}-moiety dur-
ing the last reaction step (adding of the second ligand, compare 3.1 p. 33) was tested. To a
MeCN solution of [Cr(LT4)(CF3SO3)3] (scheme 3.6, C) an excess of tpy (2.0 eq.) was added.
The reaction was done under reflux conditions (V) and by heating in the microwave reactor
(VI). After the reaction, the crude product was washed with CH2Cl2 and in this way free ligand
collected, since the chromium complexes are not soluble therein. The CH2Cl2 was evaporated
and a 1H NMR (in CDCl3) of the residue measured. The ratio of tpy to LT4 was determined
by 1H NMR spectroscopy. The ratios are 1.00 : 0.11 (V) and 1.00 : 0.17 (VI) respectively
(scheme 3.6). Therefore one can estimate that mainly the target complex
(tpy)(LT4)][CF3SO3]3 (D) was formed. But the presence of free LT4 in the reaction mix-
ture points to a ligand exchange and the formation of the homoleptic [Cr(tpy)2][CF3SO3]3 (E).
A ligand exchange in the last step of the reaction was therefore proved. These observations
agree with the observations done before for the complexes containing the sterically demanding
ligand LT4. Also the fact that the exchange rate is higher under harsher conditions (microwave
reactor) is consistent with previous observations.
F3CSO3
SO3CF3
N
N
N
Cr
SO3CF3
2 eq. tpy, MeCN
N
N
N
Cr
3+
3CF3SO3-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
N
N
vs.
C                                                                D                                      E
label reaction conditions ratio tpy : LT4∗ ratio tpy : LT4 [%]
V reflux, 7 h 1.00 : 0.11 90.1 : 9.9
VI mw, 1 h, 150 ◦C, 10 bar 1.00 : 0.17 85.5 : 14.5
∗: ratio of free ligands based on the integration in the 1H NMR spectra
Scheme 3.6: Ligand exchange experiments V and VI.
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3.4 Photophysics of the bis(terpyridine)chromium(III) complexes
Since the complexes containing one of the 4′-diphenylaniline tpy ligands LT5 or LT6 have quite
different photophysical properties, they are discussed separately in section 3.5 (p. 52).
3.4.1 Absorption spectra of the bis(terpyridine)chromium(III) complexes
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Figure 3.17: UV-VIS spectra measured in aqueous solution of [Cr(tpy)2][PF6]3 (black, 1·10−5
M), [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 (orange, 5·10−5 M), [Cr(tpy)(HLT11)][PF6]4 (yellow, 5·10−5
M) and [Cr(tpy)(5,5′′-Me2tpy)][PF6]3 (blue, 5·10−5 M).
The complexes which do not include a 4′-diphenylaniline tpy ligand absorb mainly in the UV-
range. They show two absorption bands at around 270 nm and 365 nm (figure 3.17). The
absorption in the visible range is weak (figure 3.17). [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 has a sub-
stantially more intense absorption between 300 and 500 nm, compared to the other complexes.
The data are comparable with those reported in the literature for [Cr(tpy)2][ClO4]3 in MeCN132
and aqueous HCl solution.109
3.4.2 Photoluminescence of the bis(terpyridine)chromium(III) complexes
In the literature little has been reported about the photoluminescence of {Cr(tpy)2}3+ com-
plexes. The reported emission maxima of the {Cr(tpy)2}3+ complexes lie betweeen 700 and
800 nm (table 3.4). However in our measurements we see bands at higher energies several
times more intense than those reported. The emission bands at higher energies appear at ex-
actly half of the wavelength of those at lower energies (figure 3.18). As figure 3.19 shows,
the emission around 350 nm was also observed when the complex was excited at lower ener-
gies. We supposed therefore that the emission bands at around 700 nm are the 1st harmonic
of the emissions at around 350 nm. As shown in figure 3.20, the excitation spectra for both
emissions are identical. The identical fluorescence lifetime (for [Cr(tpy)2][PF6]3, τ = 2.8 ns, in
MeCN) of both emissions is a further hint to substantiate the proposition that the emission
at higher energies is the first harmonic of those at lower energies. Sutin et al. reported that
the lifetime of [Cr(tpy)2]3+ is three orders of magnitude shorter compared with [Cr(bpy)3]3+
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complexes (v 0.05 µs for [Cr(tpy)2]3+ and 66 µs for [Cr(bpy)3]3+, both measured in 1 M
HCl).133 We observed a difference of even four orders of magnitude (2.8 ns for [Cr(tpy)2][PF6]3
(in MeCN, see above) and 58 µs for [Cr(bpy)3][PF6]3 (in water, see 2.3.2, p. 20)).
Maestri et al. explained the shorter fluorescence lifetime by the fact that the tpy ligand is
stiffer than the bpy ligand. They supposed that the mer -form of the cation {Cr(tpy)2}3+ has
to be highly distorted. This makes the metal ion more exposed to solvent approaches, which
can result in a direct vibrational coupling between the solvent molecules and the metal core.
This results in an increase of non radiative processes.109 In our crystal structures we found that
the chelate angles are between 77.39◦ and 79.41◦, the tpy are ligands only little distorted from
planarity and nearly orthogonal to each other (3.9 on page 70).
Table 3.4: Reported emission wavelengths for {Cr(tpy)2}3+
compound emission
[nm]
excitation
[nm]
solvent source
[Cr(tpy)2]3+ ∗ 775 - 1 M HCl Sutin et al.133
[Cr(4′-(4-tolyl)tpy)2][ClO4]3 773 340 water Nair et al.51
[Cr(P3)2][ClO4]3 707 340 water Nair et al.51
* = The anions are not defined in the paper.
P3 = 4′-(4-Bromophenyl)-2,2′:6′,2′′-terpyridine (6.2.1.3, p. 108)
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Figure 3.18: Photoluminescence spectrum of [Cr(tpy)2][PF6]3 in MeCN (1·10−5 M), excited at
280 nm. The first harmonic of the excitation is omitted and its position is marked with an
asterisk.
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Figure 3.19: Photoluminescence spectra of [Cr(tpy)2][PF6]3 in water (5·10−5 M), excited at 280
nm (black solid line), 335 nm (grey dashed line). The first harmonics of the excitations are
omitted and their positions are marked with asterisks.
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Figure 3.20: Excitation spectra of [Cr(tpy)2][PF6]3 in MeCN for different wavelengths. The
spectra are normalised. Since they are one above the other they were plotted in b) in a stacked
manner. The excitation spectra for emissions at 356 nm (black), 376 nm (orange), 679 nm
(grey), 706 nm (orange) and 748 nm (blue) are presented.
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3.4.2.1 Does the emission derive from a complex or from free ligand?
Figure 3.21 shows that the emission pattern depends upon the concentration of the solution.
Further it was found that the broad band of [Cr(tpy)2][PF6]3 (λmax = 390 nm) disappears after
the addition of FeSO4 (figure 3.22). The iron(II) cations act as a trap for free tpy, leading to
the formation of non-luminescent [Fe(tpy)2]2+. The observations described above and the fact
that the {Cr(tpy)2}3+ complexes are not kinetically inert (3.2, p. 38) lead to the assumption
that we observe mainly the emission of the free ligand. Therefore we compared the emission for
the complex with the reported data for tpy and 4′-(4-tolyl)tpy in the neutral and protonated
states.134,135
Figure 3.22 shows an emission spectrum of [Cr(tpy)2][PF6]3 in MeCN excited at 280 nm. This
spectrum shows three emission maxima at 340 nm, 356 nm and 390 nm and a shoulder at
412 nm. The broad band with the maximum at 390 nm and a shoulder at 412 nm can be as-
signed to tpy in its mono- and diprotonated forms. The band with the maxima at 340 nm and
365 nm belong to the emission of tpy in its neutral state (compare table 3.5). Upon addition
of one drop of FeSO4 (concentrated in MeOH) the broad band at 390 nm vanishes. Addition-
ally a band at 378 nm appears. The residual emission band can then be interpreted as the
ligand based emission of {Cr(tpy)2}3+ and/or {Cr(tpy)(X)3}, where {Cr(tpy)(X)3} stands for
a possible decomposition product (3.2, p. 38). Therefore the emission of free tpy, neutral or
protonated, has to be considered as several times more intense than a possible emission arriving
from the complex. The formation of [Fe(tpy)2]2+, and therefore a trapping of free ligand, was
confirmed by UV-VIS measurements. Figure 3.23 shows the characteristic absorption bands
for [Fe(tpy)2]2+ at 320 and 530 nm. The proposed decay of the {Cr(tpy)2}3+ complex and
protonation of the tpy ligand is shown in equations 3.2 to 3.4. Consideration of figure 3.21
leads to the conclusion that the position of the equilibrium depends on the concentration. For
more concentrated samples (1·10−4 and 5·10−5 M) the presence of H2tpy2+, Htpy+ and tpy can
be affirmed, whereas the less concentrated samples show only the emissions bands of tpy and
H2tpy2+.
{Cr(tpy)2}3+ + 3X− 
 {Cr(tpy)X3}+ tpy (3.2)
tpy +H+ 
 Htpy+ (3.3)
Htpy+ +H+ 
 H2tpy2+ (3.4)
where X− = F− or OH−
Figure 3.24 shows that the residue [Cr(tpy)(F)3] of a decomposition is photoluminescent. Since
the sample was prepared as described in section 3.2 (p. 38), Fe2+ was added to trap all free
ligand to enable the emission of the complex to be measured.
Since the emission derived from the free tpy ligand (neutral or protonated), is many times more
intense than that of the complex, small amounts of free ligand make it difficult or impossible
to observe the emission from the complex.
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Figure 3.21: Photoluminescence spectrum of [Cr(tpy)2][PF6]3 in MeCN solutions of different
concentrations, excited at 280 nm. Key: 1·10−4 M: blue, 5·10−5 M: red, 2.5·10−5 M: green,
1.25·10−5 M: purple, 1·10−5 M: orange.
Table 3.5: Emission wavelengths for tpy and 4′-(4-tolyl)tpy in the neutral and protonated states
in MeCN.
complex emission [nm] source
tpy 340 Yoshikawa et al.134
[tpyH][PF6] 412 (ex. 313 nm) Yoshikawa et al.134,135
[tpyH2][PF6][Cl] 395 (ex. 278 nm) Yoshikawa et al.135
4′-(4-tolyl)tpy 386 Yoshikawa et al.135
[4′-(4-tolyl)tpyH2][PF6][Cl] 436 (ex. 285 nm) Yoshikawa et al.135
↪→ no excitation wavelength reported for tpy and 4′-(4-tolyl)tpy
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Figure 3.22: Photoluminescence spectrum of [Cr(tpy)2][PF6]3 in MeCN (1·10−4 M), excited at
280 nm. Solid line: before adding FeSO4, dashed line: after adding 1 drop of a concentrated
solution of FeSO4 in MeOH.
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Figure 3.23: UV-VIS spectrum of [Cr(tpy)2][PF6]3 in MeCN (1·10−5 M), excited at 280 nm.
Key: solid line: before adding FeSO4, dashed line: after adding 1 eq. FeSO4.
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Figure 3.24: Photoluminescence spectrum of [Cr(tpy)(F)3] in MeCN (1·10−5 M). Adding FeSO4:
0 eq.: orange, 0.5 eq.: clear blue - dotted, 1.0 eq.: clear blue, 2.0 eq.: purple, 3.0 eq.: green, 4.0
eq.: red, 5.0 eq.: dark blue.
3.5 Complexes containing 4′-diphenylaniline terpyridine ligands
3.5.1 Absorption spectroscopy
All synthesised {Cr(tpy)2}3+ complexes containing one of the 4′-diphenylaniline tpy ligands
LT5 or LT6 (scheme 3.7) have a dark red colour. The broad absorption in the visible range
(figure 3.25) is assigned to the intra-molecular charge transfer in the 4′-diphenylaniline tpy
(scheme 3.7), where the tertiary amine acts as electron donor and the pyridyl nitrogens as
electron acceptors.136 In the free ligand this charge transfer is expressed as an intense band in
the near-UV (figure 3.26). If the ligand coordinates to a metal centre, the coordinated cation
serves to stabilize the photo-generated negatively charged tpy fragment. The charge transfer
band therefore shifts to lower energies. This effect causes a red shift in the absorption of the
complex compared to the free ligands.136139 This red shift was observed for complexes contain-
ing different transition metals (table 3.6).
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Scheme 3.7: Intra-molecular charge transfer in ligand LT5 (R = -H) and LT6 (R = -OMe).
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Figure 3.25: a) Absorption spectra in aqueous solution of [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3
(dashed line) and [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 (solid line). b) Picture of the 5·10−5 M
aqueous solution of [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3.
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Figure 3.26: Absorption spectra, normalised at 295 nm, of aqueous solutions of LT5 (solid line)
and tpy (dashed line).
Table 3.6: Absorption data of various transition metal complexes containing either LT5 or LT6.
complex solvent absorption max. source
[Ru(LT5)2][PF6]2 CH2Cl2 288, 356, 405, 532 Yan et al.140
[Ru(tpy)(LT5)][NO3]2 MeOH -, 414, 493 Berlinguette et al.141
[Ru(LT6)2]2+] MeCN 284, 310, 502 Balzani, Sauvage et al.142
[Os(LT6)2]2+] MeCN 280, 314, 504, 672 Balzani, Sauvage et al.142
[Ir(LT5)2][PF6]3 CH2Cl2 -, 492 Yellowless, Gareth
Williams et al.143
H2O -, 494
MeCN 253, 288, 321, 493
[Ir(LT6)(4′-(3,5-
tBu2phenyl)tpy)][PF6]3
MeCN 280, 322, 350, 509∗ Flamigni et al.144
[Zn(LT5)2][PF6]2 DMF 289, 358, 458∗ Cheng et al.145
[Zn(LT5)2][PF6]2 MeCN 284, 311 (sh), 325, 407 Constable, Housecroft et al.38
[Zn(LT6)2][PF6]2 MeCN 283, 313 (sh), 325, 420 Constable, Housecroft et al.38
[Cd(LT5)2][PF6]2 DMF 277, 359, 450∗ Chen et al.146
4′-(3,5-tBu2phenyl)tpy: 4'-(3,5-di-tert-butylphenyl)-2,2':6',2-terpyridine
]: The anions are not defined in the paper.
∗: Data measured from the reported graph
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3.5.1.1 Negative solvatochromic effect
The {Cr(tpy)2}3+ complexes containing one of the diphenylaniline tpy ligands (LT5 and LT6)
show a shift to higher energies in the absorption when dissolved in solvents of increasing
polarity. This negative solvatochromism147 was investigated in detail based on [Cr(4′-(4-
tolyl)tpy)(LT6)]3+ (figures 3.27, 3.28 and 3.29). In some solvents a shift to higher energies
in the absorption maxima (figure 3.30 a-d) over time is observed, for the investigations of the
solvatochromic effect, fresh solutions of these complexes were used (figure 3.31). Whereas the
observed shifting is slow in water, MeOH and DMSO, where no change was observable within
one hour, it is faster in DMF (figure 3.30d) and essentially completed after 4 h. The absorption
maxima shifts are:
in DMSO: from 519 nm (fresh) to 488 nm (after 4 days)
in MeOH: from 535 nm (fresh) to 509 nm (after 4 days)
in water: from 524 nm (fresh) to 452 nm (after 4 days)
in DMF: from 507 nm (fresh) to 483 nm (after 6 hours)
As the {Cr(tpy)2}3+ complexes are not kinetically stable (section 3.2, p. 38) it was assumed
that this is also the case here. The measurements of the fresh solutions in MeOH, DMSO and
DMF fit a trend line for a dependence of absorption maximum in the visible range on polarity/
dipole moment. The position of the absorption maximum in the visible range shows a corre-
lation with the polarity of the solvent. In figure 3.31 the correlations between the absorption
maximum and the dipole moment and the polarity index are shown. The only exception to the
relationship is water.
Sovatochromic effects were also reported for some of the complexes in the literature (table 3.6).
Flamigni et al. reported a significant negative solvatochromic effect (CH2Cl2 (λmax: 557 nm)
to DMSO (λmax: 449 nm)) for the heteroleptic [Ir(LT6)(4′-(3,5-tBu2phenyl)tpy)][PF6]3 com-
plex.144 Whereas Yellowless, Williams et al. reported a small effect for the homoleptic complex
[Ir(LT5)2][PF6]3 (table 3.6). They explained this observation with the fact that for the homolep-
tic complexes with D2d symmetry, there is no dipole moment in the ground state. Therefore
the increase of the polarity in the excited state will be small.143 This is not consistent with our
observations for the homoleptic [Cr(LT5)2][PF6]3 complex, where we observed a similar solva-
tochromic effect (CH2Cl2 (λmax: 559 nm) to EtOAc (λmax: 507 nm)) as in the heteroleptic
complexes.
Figure 3.27: Picture of samples containing [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 in different sol-
vents.
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Figure 3.28: UV-VIS spectra of [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 measured in different sol-
vents. EtOAc (dark blue, 514 nm, MeCN (green, 526 nm), acetone (red, 528 nm), EtOH
(purple, 551 nm), CH2Cl2 (light blue, 563 nm) and CHCl3 (orange, 574 nm). In brackets are
the absorption maxima in the visible range noted.
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Figure 3.29: Normalised absorption spectra of [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 measured in
different solvents. EtOAc (dark blue, 514 nm), MeCN (green, 526 nm), acetone (red, 528 nm),
EtOH (purple, 551 nm), CH2Cl2 (light blue, 563 nm), CHCl3 (orange, 574 nm) and CF3CH2OH
(green, dashed, 584 nm). In brackets are the absorption maxima in the visible range noted.
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Figure 3.30: UV-VIS spectra of 5·10−5 M solutions of [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 in
water (a), MeOH (b), DMSO (c) and DMF (d). In a - c, the black line is for a fresh sample
and the grey line is the measurement after 4 days. In d, the change of the absorption spectrum
within 6 hours is shown.
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Figure 3.31: Correlations between the absorption maxima of
[Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3 in the visible range and the dipole moment (a) and
the polarity index (b) of the particular solvent. The coefficient of determination for the linear
regressions are: 0.928 (for a) and 0.754 (for b). Water was excluded in both cases for the
calculation of the coefficient of determination. Source for the solvent properties: High Purity
Solvent Guide.148
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3.5.2 Photoluminescence measurements
As the emission maximum of an aqueous solution containing [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3
is significantly different from an MeCN solution of the same complex, a titration was performed.
To an MeCN solution of [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 water was added in small amounts
(figure 3.32). A decrease in intensity of the emission band at 473 nm, which was also observed
in pure MeCN, and an increasing of intensity of the emission band at around 415 nm was ob-
served. This corresponds to the emission wavelength which was observed in pure water. The
decrease in the emission intensity is fast at the beginning, and after the addition of around 5%
of water the decay slows down. But the decrease in the band at 473 nm is basically finished
before the intensity of the band at 415 nm starts increasing substantially. Whereas no changes
were observed in the UV-VIS spectra (figure 3.34).
The corresponding homoleptic complexes [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 (figure 3.33a) and
[Cr(LT5)2][CF3SO3]3 (figure 3.33b) always showed one of the two emissions observed in the het-
eroleptic complex ([Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3, figure 3.32). The intensity of the emis-
sion band at 470 nm decreases when water is added to a MeCN solution of [Cr(LT5)2][CF3SO3]3
and analogously for [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 the emission at around 420 nm increases
when water is added.
In a similar experiment water was added to a MeCN solution (1·10−5 M) of [Cr(tpy)2][PF6]3
(figure 3.36). An approximately linear increase in the emission intensity at 352 nm was ob-
served. Upon adding an aqueous FeSO4 solution (5·10−4 M), a comparable increase of the
emission intensity was observed until 0.5 eq. of the FeSO4 had been added. Then a remarkable
decrease of the intensity was observed (figure 3.36). A possible explanation is the formation of
an emitting {Cr(tpy)X3} and a subsequent trapping of the free ligand by the Fe2+ ions. After
the addition of 0.5 eq., all free ligand is trapped, therefore the Fe2+ ions start to decompose the
postulated {Cr(tpy)X3} complex. The consequence is a decreasing in the emission intensity.
The two free ligands 4′-(4-tolyl)tpy and LT5 express a quite different emission maximum when
excited at 280 nm (figure 3.35). The emission maxima for the free ligands are not consistent
with those observed for the complex [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3. When water was
added to a MeCN solution of the free ligand 4′-(4-tolyl)tpy no change in the intensity of the
emission was observed. However when the same was done with a MeCN solution of LT5 (free
ligand), an increasing of the band was observed (figure 3.37), as with the complex. The same
emission bands as reported above were also measured if the complexes were excited at 340 nm.
Excitation in the lower energy visible absorbing band resulted in no emission.
Similar effects were also observed with several solvent mixtures, and likewise with
[Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3. They are summarised in table 3.7.
Table 3.7: Overview of a series of measurements with [Cr(LT6)2][CF3SO3]3 where the compo-
sition of the solvent was changed.
solvent added solvent: shift λemmax [nm] excitation λ
ex [nm]
I MeCN CF3CH2OH 597 → 422 350
II CH2Cl2 CF3CH2OH 515 → quenched 350
III DMSO H2O 588 → 394 340
IV CHCl3 CF3CH2OH 505 → 429 360
V DMF CF3CH2OH 600 → 441 360
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Figure 3.32: Emission spectrum of [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 in MeCN adding water,
when excited at 280 nm. The numbers in the key correspond to the amount of water in percent.
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Figure 3.33: Emission spectra of [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 (a) and [Cr(LT5)2][CF3SO3]3
(b) in MeCN upon the addition of water, when excited at 280 nm. The numbers in the key
correspond to the amount of water in percent by volume.
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Figure 3.34: UV-VIS spectra of [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 in MeCN. The spectra
were recorded before (grey, solid line) and after (black, dashed line) the addition of 20 % water
by volume.
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Figure 3.35: Photoluminescence spectra of 4′-(4-tolyl)tpy (solid line) and LT5 (dashed line) in
MeCN, excited at 280 nm.
3.5. COMPLEXES CONTAINING 4′-DIPHENYLANILINE TERPYRIDINE LIGANDS 73
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
0.045
0.05
0 10 20 30 40 50
em
is
si
o
n
 in
te
n
si
ty
 [
a.
u
.]
added water [μl]
0.5 eq. 
FeSO4
added
Figure 3.36: Emission intensity at 352 nm of [Cr(tpy)2][PF6]3 (in MeCN, 1·10−5 M) plotted
against amount of water added; 25 µl correspond to 1 % water in MeCN. The grey triangles
represent pure water addition, and the black squares the addition of a 5·10−4 M aqueous solution
of FeSO4.
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Figure 3.37: Photoluminescence spectrum of LT5 in MeCN adding water, when excited at
280 nm. The numbers in the key correspond to the amount of water in percent by volume.
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As shown in table 3.7, the emission maxima depend on the solvent. In figure 3.38 the emis-
sion maxima in pure solvents are plotted against the dipole moment (a) and the polarity (b)
of the solvents. As already observed for the solvatochromic effect in the absorption spectra
(figure 3.31), an approximately linear correlation is observed with exception of the point for
water. The emission maxima for the free ligand (LT6) also depend on solvent. The emission
maxima were 565 nm in MeCN (λex = 350 nm) and 523 nm in CHCl3 (λex = 360 nm). The
emissions measured for the complex containing solution (λmaxem : 597 nm (MeCN) and 505 nm
(CHCl3)) are therefore not identical to those for the free ligand.
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Figure 3.38: Correlations between the emission maxima of [Cr(4′-(4-tolyl)tpy)(LT6)][CF3SO3]3
and the dipole moment (a) and the polarity index (b) of the particular solvent. The coefficient
of determination for the linear regressions are: 0.963 (for a) and 0.790 (for b). Water was
excluded in both cases for the calculation of the coefficient of determination. Source for the
solvent properties: High Purity Solvent Guide.148
76 CHAPTER 3. BIS(TERPYRIDINE)CHROMIUM(III) COMPLEXES
3.6 Electrochemical measurements
The electrochemical processes of some of the {Cr(tpy)2}3+ complexes were studied using cyclic
voltammetry techniques. Each complex showed three reversible redox processes (table 3.8, fig-
ures 3.39, 3.40 and 3.41). The fourth reversible reduction and two irreversible reductions men-
tioned in the literature52,118,149 were not observed for all complexes (figure 3.43). Wheras the
potentials for E3+/2+1/2 , E
2+/1+
1/2 and E
1+/0
1/2 are at comparable values to those of the {Cr[bpy]3}3+
complexes (2.4, p. 24), the E0/1−1/2 reduction occurs at a significantly more negative potential.
The difference between the potentials E1+/01/2 and E
0/1−
1/2 is around 1 V, between the three higher
reduction potentials only around 0.5 V. The influence of the substitution on tpy is negligi-
ble. The results are consistent with those in the literature for [Cr(tpy)2][ClO4]3 51,52,118,132 and
[Cr(4′-(4-tolyl)tpy)2][ClO4]3.51
Table 3.8: Cyclic voltammetric data for {Cr(tpy)2}3+ complexes. Measured in MeCN with
[nBu4N][PF6] as supporting electrolyte and a scan rate of 0.1 V s−1. Referenced to Fc/Fc+.
reductions [V] oxidation [V]
compound E3+/2+1/2 E
2+/1+
1/2 E
1+/0
1/2 E
0/1−
1/2 E
3+/4+
1/2
[Cr(tpy)2][PF6]3 -0.533 -0.953 -1.469 -2.388 -
[Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 -0.581 -0.949 -1.278 -
[Cr(LT5)2][CF3SO3]3 -0.601 -0.955 -1.431 -2.341 0.683
[Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 -0.544 -0.946 -1.463 -2.367 -
[Cr(tpy)(5,5′′-Me2tpy)][PF6]3 -0.537 -0.957 -1.457 -2.338 -
[Cr(tpy)(HLT11)][PF6]4 -0.400 -0.855 -1.338 -
[Cr(4′-(4-tolyl)tpy)(LT4)][PF6]3 -0.599 -1.095 -1.583 -
[Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 -0.587 -0.955 -1.276 -2.343 0.660
[Cr(tpy)(LT6)][CF3SO3]3 -0.601 -0.938 -1.254 ∗
[Cr(LT5)(LT10)][CF3SO3]3 -0.507 -0.880 -1.393 0.547
∗: This complex exhibits two oxidation potentials at 0.382 and 0.933 V
One exception is the protonated complex [Cr(tpy)(HLT11)][PF6]4 (figure 3.44) which shows
broad peaks in the cyclic voltammogram. In the square wave measurement, always two serried
signals were observed. We explained that with slightly different reduction potentials for the two
different ligands, as was reported for similar {Cr[bpy]3}3+ complexes (2.4, p. 24).
Recent results from Wieghardt et al.52 indicate that all redox processes are ligand based and
chromium remains in the 3+ oxidation state (table 3.9). The study is based on X-ray, magnetic
susecptibility and X-band EPR results for the complex [Cr(tpy)2][PF6]3 in its four oxidation
states. This stands in contrast to the common explanation in several publications51,118,121,122,132
that the first reduction forms the low-spin Cr(II) complex. We have not confirmed whether this
formulation will also hold for the complexes with substituted tpy ligands.
The complexes containing N,N -diphenylaniline tpy ligands also show reversible oxidation pro-
cesses (table 3.8, figures 3.40, 3.41 and 3.42). These processes are also ligand based and corre-
spond to the data obtained for the free ligands. The oxidation potentials for the free ligands
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were 0.917 V for LT5 and 0.402 and 0.984 for LT6 (measured in MeCN with respect to Fc/Fc+
and [nBu4N][PF6] as supporting electrolyte at a scan rate of 0.1 V s−1.)
Table 3.9: The composition of {Cr(tpy)2}n (n = 3+, 2+, 1+ and 0) according to Wieghardt et
al..52
3+ 2+ 1+ 0
[CrIII(tpy0)2][PF6]3 [CrIII(tpy•)(tpy0)][PF6]2 [CrIII(tpy•)2][PF6] [CrIII(tpy•)(tpy••)]
S = 3/2 S =1 S = 1/2 S = 0
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Figure 3.39: Cyclic voltammograms for [Cr(tpy)2][PF6]3 (solid line) and [Cr(tpy)(5,5′′-
Me2tpy)][PF6]3 (dotted line). Measured in MeCN solution with respect to Fc/Fc+ and
[nBu4N][PF6] as supporting electrolyte at a scan rate of 0.1 V s−1.
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Figure 3.40: Cyclic voltammogram for [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3. With respect to
Fc/Fc+, measured in MeCN solution with [nBu4N][PF6] as supporting electrolyte and a scan
rate of 0.1 V s−1.
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Figure 3.41: Cyclic voltammogram for [Cr(LT5)2][CF3SO3]3. Measured in MeCN with respect
to Fc/Fc+ and [nBu4N][PF6] as supporting electrolyte at a scan rate of 0.1 V s−1.
3.6. ELECTROCHEMICAL MEASUREMENTS 79
-6.00E-06
-1.00E-06
4.00E-06
9.00E-06
1.40E-05
-0.6 -0.1 0.4 0.9 1.4
cu
rr
en
t 
[A
]
potentail [V]
Figure 3.42: Cyclic voltammogram of the oxidation processes for [Cr(tpy)(LT6)][CF3SO3]3.
Measured in MeCN with respect to Fc/Fc+ and [nBu4N][PF6] as supporting electrolyte at a
scan rate of 0.1 V s−1.
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Figure 3.43: Cyclic voltammogram of the four reversible reduction processes for
[Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3. Measured in MeCN with respect to Fc/Fc+ and
[nBu4N][PF6] as supporting electrolyte at a scan rate of 0.1 V s−1.
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Figure 3.44: Cyclic voltammogram (solid line) and square wave (dashed line) of the reduc-
tion processes for [Cr(tpy)(HLT11)][PF6]4. Measured in MeCN with respect to Fc/Fc+ and
[nBu4N][PF6] as supporting electrolyte at a scan rate of 0.1 V s−1.
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3.7 EPR measurements
Since chromium(III) compounds (d3) are paramagnetic (S = 3/2), electron paramagnetic res-
onance (EPR) spectroscopy provides an additional analytical method. This work was car-
ried out in collaboration with Prof. Dr. Cornelia Palivan (Department of Chemistry, Uni-
versity of Basel). Figure 3.45 shows the EPR measurements of the pure powder samples of
[Cr(tpy)2][PF6]3 and [Cr(tpy)(5,5′′-Me2tpy)][PF6]3. The obtained signals are broad, but com-
parable with the spectrum reported in the literature for [Cr(tpy)2][PF6]3.150
0 1000 2000 3000 4000 5000 6000
magnetic field [G]
Figure 3.45: EPR spectra (at 295 K and 10 mW microwave power, conversion time 61.12 ms), of
powder samples of [Cr(tpy)2][PF6]3 (black solid line), [Cr(tpy)(5,5′′-Me2tpy)][PF6]3 (grey solid
line) and [Co(tpy)2][PF6]3 (black dashed line).
With the objective of obtaining a fine splitting of the spectra, magnetically diluted samples
were made. Therefore the corresponding cobalt(III) complexes (diamagnetic, and hence EPR
silent) were synthesised (4.1, p. 95). In a first attempt, the homoleptic [Co(tpy)2]3+ com-
plex was used to dilute both heteroleptic and homoleptic {Cr(tpy)2}3+ complex samples. The
magnetically diluted samples were prepared by dissolving the chromium(III) and cobalt(III)
complexes in the same solvent, followed by 5 minutes stirring and then slow evaporation. The
EPR spectrum of the powder mixture was then measured.150 Figure 3.46 shows the EPR spec-
trum for the magnetically diluted samples of [Cr(tpy)2][PF6]3 and [Cr(tpy)(5,5′′-Me2tpy)][PF6]3.
[Co(tpy)2][PF6]3 was doped with 2 % of {Cr(tpy)2}3+. Although the signals are better resolved,
attempts to simulate the spectra were not possible. An assumed problem was that the mix-
tures were not homogeneous; the different solubilities of the two complexes ({Cr(tpy)2}3+ and
[Co(tpy)2]3+) could be the reason for this. Therefore several attempts with different solvents
(MeCN, (CH3)2CO, DMF and water) and different percentages of the chromium(III) complex
were made but were unsuccessful.
82 CHAPTER 3. BIS(TERPYRIDINE)CHROMIUM(III) COMPLEXES
0 1000 2000 3000 4000 5000
magnetic field [G]
Figure 3.46: EPR spectra (at 295 K and 10 mW microwave power, conversion time 61.12 ms)
of magnetically diluted powder samples of 2 % [Cr(tpy)2][PF6]3 in [Co(tpy)2][PF6]3 (black line)
and 2 % [Cr(tpy)(5,5′′-Me2tpy)][PF6]3 in [Co(tpy)2][PF6]3 (grey line).
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3.8 DSC trials with bis(terpyridine)chromium(III) complexes
To the best of our knowledge no examples of chromium(III) complexes as dyes in DSCs (dye-
sensitised solar cells) were known to date. However, Waltz and Lilie already mentioned in 1983
the possible potential of {Cr(bpy)3}3+ for solar energy conversion.61 Damrauer and Shores
investigated the photophysical properties of the heteroleptic [Cr(bpy)2(4-dmc)][BF4]3 (4-dmc
= dimethyl [2,2′-bipyridine]-4,4′-dicarboxylate) as a potential sensitiser in DSC devices. They
evaluated the strongly oxidizing excited state found for the reported complex combined with
the long lifetime of the excited state as promising premises for an application in DSCs, whereby
no DSC results were reported.62
Chromium compounds are used as a dopant in TiO2.151,152 Further Taghavinia et. al recently
reported a Cr-Pt counter electrode, as an alternative to the platinum coated ITO (indium
tin oxide) or FTO (fluorine doped tin oxide) counter electrode. The Cr-Pt counter electrode
consists of a chromium coating (cube-like morphology) as a rough coating which provides high
surface for electro-deposited platinum.153
3.8.1 Dye-sensitzed solar cell trials
The broad absorption of [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 (figure 3.25, p. 53) and a HOMO
- LUMO gap of 1.2 eV (from electrochemistry in MeCN (3.6, p. 59) and 1.5 eV (from ab-
sorption measurements in MeCN) made the complexes with diphenylaniline terpyridine ligands
strong candidates for DSC applications. Since the dye has to be closely adsorbed on the sur-
face of the semiconductor for a workable and efficient DSC,68,154 a complex with an anchoring
ligand had to be synthesised. Since carboxylic acid is the standard anchoring group for sensi-
tisers68 4-([2,2′:6′,2′′-terpyridin]-4′-yl)phthalic acid (LT10) was chosen as anchoring ligand and
[Cr(LT5)(LT10)][CF3SO3]3 synthesised (figure 3.47 and 6.4.3.22, p. 140).
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Figure 3.47: Structure of [Cr(LT5)(LT10)][CF3SO3]3.
3.8.2 DSC fabrication and characterisation
The DSCs were prepared using an adapted method of Grätzel et al..155 As photoanode com-
mercial Test Cell Titania Electrodes from Solaronix were used. The electrodes were first rinsed
with EtOH, then sintered for 30 min at 450 ◦C and cooled to around 80 ◦C. Then the electrodes
were immersed into a dye solution (for details compare: table 3.10). The electrodes were then
rinsed with the solvent in which they had been dipped and EtOH. Also a reference cell was pre-
pared applying the procedure described above and using commercial N719156 from Solaronix.
Commercial Test Cell Platinum Electrodes from Solaronix were used as counter electrodes, after
heating them for 30 min at 450 ◦C. The two electrodes were assembled using a thermoplastic
hot-melt sealing foil (Test Cell Gaskets from Solaronix ) by pressing them together while heat-
ing. Two different electrolytes based on I2/I−3 and Co
2+/Co3+ were used (for the compositions
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compare table 3.11). The electrolytes were filled into the cells by vacuum backfilling. The hole
on the counter electrode was then sealed using the thermoplastic hot-melt sealing foil (Test
Cell Sealings from Solaronix ) and a cover glass (Test Cell Caps from Solaronix ). The cells were
masked and measured using a SolarSim 150 (1000 W m−2 = 1 sun). The power of the simulated
light was calibrated using a reference Si cell.
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Figure 3.48: Standard dye N719.156
3.8.3 DSC trials
The parameters of the DSC assembling trials are summarised in table 3.10 and the results listed
in table 3.11.
With [Cr(LT5)(LT10)][CF3SO3]3 and I2/I−3 as electrolyte two sets of two cells each were re-
alised. The electrodes of DSCs-A were dipped for one night in the dye solution, whereas the
electrodes for DSCs-B were immersed for 5 days (table 3.10). After the dipping and washing of
the anode the TiO2 layer was coloured dark red, indicating that some of the dye was absorbed
on the TiO2. However only a very low short circuit current (e.g.: well performing copper(I)
complexes: >1, and N719 >12)39 and open circuit voltage (e.g.: well performing copper(I) com-
plexes: >500, and N719 ∼750)39 was observed. Also no improvement could be achieved after
two and six days respectively. Unfortunately, a precipitation of the electrolyte was observed, in
some cells after 1 h.
In an alternative approach (DSC-C) the anode was first dipped in a DMSO solution of the
anchoring ligand (LT10) overnight. After washing with DMSO and EtOH, the electrode was
immersed for 5 days in a MeCN solution of [Cr(LT5)(CF3SO3)3]. The idea in this approach
was that the anchoring ligand adsorbs first on the TiO2 and coordinates in the second step to
[Cr(LT5)(CF3SO3)3] and forms [Cr(LT5)(LT10)][CF3SO3]3 (scheme 3.8). The pale red coloured
TiO2 layer indicated that some complex was adsorbed on the TiO2 surface. But the efficiencies
were as low as for DSC-A and DSC-B.
In a further trial the homoleptic [Cr(LT5)2][CF3SO3]3 without anchoring ligand was used as
dye. Since the TiO2 layer was coloured after the dipping an adsorption of the complex occurred.
In this approach the efficiencies are even worse.
As a blank measurement (DSC-blank) a cell without a dye, only filled with electrolyte, was
measured. For this cell even higher efficiencies were received than for the cells with dye. The
standard cell (standard-N719) with the standard dye N719 showed as proof of principle that
the cells work.
As mentioned above, a precipitation was observed after a short time in the I2/I−3 electrolyte, in
the cells containing chromium complexes. In all chromium complex containing cells mentioned
above a precipitation in the electrolyte was observed, whereas no precipitation was observed in
the cells of the DSC-blank and standard N719 attempts within a week.
But also the two trials with Co2+/Co3+ as alternative electrolyte (DSC-E and DSC-F) were
not successful.
3.8. DSC TRIALS WITH BIS(TERPYRIDINE)CHROMIUM(III) COMPLEXES 85
The complex with the anchoring ligand ([Cr(LT5)(LT10)][CF3SO3]3) adsorbed on the TiO2 but
no current was generated and the efficiency was therefore very low. Also the other attempts
showed very low currents and efficiencies. Since we found that {Cr(tpy)2}3+ complexes are ki-
netically not inert and are labile in the presence of base and F−, a decomposition of the complex
is a possible reason for the failure of the cells. A further problem could be the precipitation in
the electrolyte.
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Scheme 3.8: Preparation of the anodes for trial DSC-C: In the first step the free anchoring ligand
(LT10) is adsorbed on the TiO2 surface (A). In the second step, the complex [Cr(LT5)(LT10)]3+
is formed directly on the TiO2 layer (B).
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Table 3.10: Conditions for the preparation of DSC-A to DSC-F and standard-N719.
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Table 3.11: Measured characteristic parameters for DSC-A to DSC-F, DSC-blank and standard-
N719.
attempt electrolyte JSC
[mA/cm2]
VOC
[mV]
ff [%] η [%]
DSC-A cell 1 fresh I2/I−3 0.07 229 55.5 0.009
DSC-A cell 2 fresh I2/I−3 0.10 247 56.8 0.013
DSC-A cell 1 2 days old I2/I−3 0.08 241 54.7 0.011
DSC-A cell 2 2 days old I2/I−3 0.10 224 55.3 0.013
DSC-A cell 2 6 days old I2/I−3 0.09 246 56.0 0.012
DSC-B cell 1 fresh I2/I−3 0.10 242 53.5 0.012
DSC-B cell 2 fresh I2/I−3 0.10 233 54.5 0.012
DSC-B cell 1 2 days old I2/I−3 0.12 262 51.4 0.016
DSC-B cell 2 2 days old I2/I−3 0.10 238 55.4 0.013
DSC-C cell 1 fresh I2/I−3 0.15 222 53.3 0.019
DSC-C cell 2 fresh I2/I−3 0.16 330 50.8 0.028
DSC-C cell 1 2 days old I2/I−3 0.10 154 53.7 0.008
DSC-D fresh I2/I−3 0.05 150 50.2 0.004
DSC-blank fresh I2/I−3 0.31 415 49.2 0.064
DSC-blank 2 days old I2/I−3 0.29 394 43.4 0.050
standard-N719 fresh I2/I−3 16.31 627 72.9 7.45
standard-N719 2 days old I2/I−3 16.38 640 73.5 7.704
DSC-E fresh Co2+/Co3+ 0.04 135 34.9 0.002
DSC-F fresh Co2+/Co3+ 0.06 90 31.4 0.002
composition of the electrolytes:
I2/I−3 : LiI (0.1 mol·l−1), I2 (0.05 mol·l−1), 1-methylbenzimidazole (0.5 mol·l−1)
and 1-butyl-3-methylimidazolinium iodide (0.6 mol·l−1) in methoxypro-
pionitrile
Co2+/Co3+: [Co(bpy)3][PF6]2 (0.2 mol·l−1), [Co(bpy)3][PF6]3 (0.05 mol·l−1), LiClO4
(0.1 mol·l−1) and 4-tert-butylpyridine (0.2 mol·l−1) in MeCN
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3.9 X-ray structures
In November 2013, the Cambridge Structural Database157 (Conquest v. 1.16, CSD v. 5.35158)
contained only four complexes containing {Cr(tpy)2} units. And only in one example has
chromium the oxidation state 3+: [Cr(tpy)2][ClO4]3·H2O.159,160 Further are reported struc-
tures of: [Cr(tpy)2][PF6]2·MeCN,52 [Cr(tpy)2][PF6]52 and [Cr(tpy)2].52
Single crystals were obtained using three different approaches: slow diffusion of Et2O into an
MeCN solution of the complex, slow diffusion of hexane into an acetone solution of the complex
or slow evaporation of a MeOH solution of the complex. For details compare tables 3.12, 3.13,
3.16 and 3.17. Single crystals of two homoleptic complexes were obtained from solutions of
heteroleptic complexes ([Cr(5,5′′-Me2tpy)2][CF3O3S]3 and [Cr(LT1)2][CF3SO3]3). This is con-
sistent with the lability of the complexes and the observed ligand exchange (3.2, p. 38, and
3.3, p. 43). Although the interactions among the cations and the anions and solvent molecules
are dominant, several cations show also interactions between the cations. Therefore, pi-pi and
CH...pi complete the CH...N and CH...F interactions in the packing.
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3.9.1 Homoleptic complexes
Table 3.12: Crystallographic data of homoleptic {Cr(tpy)2}3+ complexes, part I
compound [Cr(tpy)2][PF6]3 [Cr(4′-(4-tolyl)tpy)2]
[CF3SO3]3
[Cr(LT3)2][PF6]3
formula moiety 2(C30H22CrN6),
6(F6P), 5(C2H3N)
C44H34CrN6,
3(CF3O3S),
2(C2H3N)
C50H34CrN6,
3(F6P), 0.2(C2H3N)
formula weight [g mol−1] 2112.1 1228.12 1222.16
crystal colour and habit yellow, plate yellow, needle orange, block
crystal system orthorhombic monoclinic triclinic
space group Pbca C2/c P1
22.0190(11) 14.5535(8) 11.4677(5)
a, b, c [Å] 32.5520(17) 17.1633(11) 14.9613(6)
47.334(3) 21.9247(14) 15.2475(6)
90 90 100.0920(10)
α, β, γ [◦] 90 108.308(4) 108.6350(10)
90 90 92.1140(10)
U [Å3] 33927(3) 5199.3(6) 2428.41(17)
Dc [Mg m−3] 1.654 1.569 1.671
Z 16 4 2
µ(Cu-Kα) [mm−1] 4.390 3.802 3.920
T [K] 123(2) 123(2) 123
refln. collected 161369 17034 25679
unique refln. 30417 4644 8765
refln. for refinement 19918 3700 8274
parameters 2406 404 861
threshold I>2.0σ I>2.0σ I>2.0σ
R1 (R1 all data) 0.0782 (0.1232) 0.0383 (0.0539) 0.0580 (0.0596)
wR2 (wR2 all data) 0.1973 (0.2219) 0.0906 (0.0984) 0.0683 (0.0689)
goodness of fit 1.056 1.019 1.0213
crystal growing diffusion
MeCN/Et2O
MeOH slow evapora-
tion
diffusion
MeCN/Et2O
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Table 3.13: Crystallographic data of homoleptic {Cr(tpy)2}3+ complexes, part II
compound [Cr(5,5′′-Me2tpy)2]
[CF3SO3]3
[Cr(HLT11)(LT11)]
[PF6]4
[Cr(LT1)2][CF3SO3]3
formula moiety C34H30CrN6,
3(CF3O3S), H2O
C40H29CrN8, 4(F6P) C120H113Cr2F18N19O18.50S6
formula weight [g mol−1] 1039.9 1253.56 2755.65
crystal colour and habit orange, needle yellow, block red, block
crystal system monoclinic triclinic triclinic
space group P 21/n P1 P1
9.5697(12) 10.2844(14) 11.5505(5)
a ,b, c [Å] 18.148(2) 19.644(3) 14.0824(6)
23.573(3) 24.538(3) 20.7389(8)
90 76.099(9) 106.9770(10)
α, β, γ [◦] 92.963(9) 80.775(8) 97.252(2)
90 78.789(8) 94.309(2)
U [Å3] 4088.5(9) 4686.7(11) 3178.2(2)
Dc [Mg m−3] 1.689 1.571 1.440
Z 4 4 1
µ(M-Kα) [mm−1] 4.708 (M=Cu) 0.458 (M=Mo) 3.183 (M=Cu)
T [K] 123(2) 123(2) 123(2)
refln. collected 22707 59218 48955
unique refln. 7137 18272 11290
refln. for refinement 3598 9196 10982
parameters 605 1393 985
threshold I>2.0σ I>2.0σ I>2.0σ
R1 (r1 all data) 0.0660 (0.1579) 0.0880 (0.1827) 0.0378 (0.0387)
wR2 (wR2 all data) 0.1268 (0.1608) 0.2486 (0.3175) 0.1073 (0.1089)
goodness of fit 0.96 1.061 1.032
crystal growing diffusion
MeCN/Et2O
diffusion
MeCN/Et2O
diffusion
MeCN/Et2O
notes obtained from
heteroleptic bulk
complex [Cr(5,5′′-
Me2tpy)(LT4)]
[CF3SO3]3
received from het-
eroleptic bulk com-
plex [Cr(LT1)(LT4)]
[CF3SO3]3
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The two complexes 2{[Cr(tpy)2][PF6]3}·5MeCN and [Cr(5,5′′-Me2tpy)2][CF3SO3]3·H2O, both
with a non-extended tpy core show no interactions between the cations. The crystal packing is
dominated by CH...F, CH...N and CH...O interactions between the cations and the anions and
the solvent molecules respectively.
3.9.1.1 Structure of 2{[Cr(tpy)2][PF6]3}·5MeCN
2{[Cr(tpy)2][PF6]3}·5MeCN crystallises in the orthorhombic space group Pbca with four inde-
pendent cations (figure 3.49) in the asymmetric unit (Z′=4). The deviations in the metrical
parameters of the four cations are small (compare table 3.14). The two tpy domains are ar-
ranged nearly orthogonal; the angle between the least squares planes lies between 84.5◦ and
89.5◦ (compare table 3.14).
Figure 3.49: Structure of one of the four independent [Cr(tpy)2]3+ cations with ellipsoids plotted
at 50 % probability level. H atoms, counter ions and solvent molecules are omitted for clarity.
Bond lengths and angles for all four cations are reported in table 3.14.
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Table 3.14: Metrical parameters for the four independent cations of 2{[Cr(tpy)2][PF6]3}·5MeCN
cation a: cation b: cation c: cation d:
bond [Å] bond [Å] bond [Å] bond [Å]
Cr1AN1A 2.054(3) Cr1BN1B 2.055(3) Cr1CN1C 2.099(4) Cr1DN1D 2.039(4)
Cr1AN2A 1.985(3) Cr1BN2B 1.976(3) Cr1CN2C 2.003(4) Cr1DN2D 1.981(4)
Cr1AN3A 2.058(4) Cr1BN3B 2.057(3) Cr1CN3C 2.035(4) Cr1DN3D 2.049(4)
Cr1AN4A 2.042(3) Cr1BN4B 2.062(3) Cr1CN4C 2.063(4) Cr1DN4D 2.053(4)
Cr1AN5A 1.987(3) Cr1BN5B 1.989(3) Cr1CN5C 1.983(3) Cr1DN5D 1.978(4)
Cr1AN6A 2.062(4) Cr1BN6B 2.042(3) Cr1CN6C 2.049(3) Cr1DN6D 2.057(4)
angle [◦] angle [◦] angle [◦] angle [◦]
N2A-Cr1A-N1A 78.78(14) N2B-Cr1B-N1B 79.01(13) N2C-Cr1C-N1C 77.39(15) N2D-Cr1D-N1D 78.80(15)
N2A-Cr1A-N3A 78.34(14) N2B-Cr1B-N3B 79.29(14) N2C-Cr1C-N3C 79.59(17) N2D-Cr1D-N3D 79.41(15)
N1A-Cr1A-N3A 157.06(14) N1B-Cr1B-N3B 158.24(13) N3C-Cr1C N1C 156.93(16) N1D-Cr1D-N3D 157.98(16)
N5A-Cr1A-N4A 79.00(14) N5B-Cr1B-N4B 79.12(13) N5C-Cr1C-N4C 78.37(14) N5D-Cr1D-N4D 78.43(15)
N5A-Cr1A-N6A 78.22(15) N5B-Cr1B-N6B 78.97(14) N5C-Cr1C-N6C 78.92(14) N5D-Cr1D-N6D 79.38(15)
N4A-Cr1A-N6A 157.17(14) N6B-Cr1B-N4B 157.98(13) N6C-Cr1C-N4C 157.19(14) N4D-Cr1D-N6D 157.76(15)
angle [◦] between tpy domains:
cation a: 84.77 cation b: 89.57 cation c: 89.15 cation d: 87.3
Figure 3.50: Packing of 2{[Cr(tpy)2][PF6]3}·5MeCN. The four independent cations are shown
in blue (A), green (B), yellow (C) and red (D), the anions (PF−6 ) in light grey and the solvent
molecules (MeCN) in light blue. H atoms were omitted for clarity.
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3.9.1.2 Structure of [Cr(5,5′′-Me2tpy)2)][CF3SO3]3·H2O
[Cr(5,5′′-Me2tpy)2)][CF3SO3]3·H2O crystallises in the monoclinic P21/n space group. The two
tpy domains are arranged nearly orthogonal (angle between least squares planes = 89.2◦) and
the metrical parameters (compare caption to figure 3.51) are comparable with this reported
for 2{[Cr(tpy)2][PF6]3}·5MeCN. The accommodation of three [CF3SO3]− anions and one water
molecule per complex cation prevents the formation of inter-cation tpy embraces,161,162 and
therefore the principal packing interactions involve CH...F and CH...O contacts (figure 3.52).
Figure 3.51: Structure of the cation in [Cr(5,5′′-Me2tpy)2][CF3SO3]3 with ellipsoids plotted at
50 % probability level. H atoms, counter ions and solvent molecules are omitted for clarity.
Selected bond lengths [Å]: Cr1-N1 = 2.083(5), Cr1-N2 = 1.983(5), Cr1-N3 = 2.056(5), Cr1-
N4 = 2.062(5), Cr1-N5 = 1.988(5), Cr1-N6 = 2.065(5); and bond angles [◦]: N1-Cr1-N2 =
78.7(2), N3-Cr1-N2 = 78.2(2), N1-Cr1-N3 = 156.92(19), N4-Cr1-N5 = 78.22(19), N6-Cr1-N5 =
78.04(19), N4-Cr1-N6 = 155.94(19).
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Figure 3.52: Packing for [Cr(5,5′′-Me2tpy)2][CF3SO3]3·H2O. Colour code: cation (red), counter
anion (blue) and water (green).
The further homoleptic complexes include tpy-ligands which are substituted at the 4′-position
with at least one aromatic ring. This rings are twisted compared with the tpy domain in order
to minimise the repulsions between the ortho-hydrogen atoms and to optimise pi-pi-interactions
between the cations. The torsion angles are between 17.4◦ and 39.7◦ (compare table 3.15).
In these examples interactions among the cations can be assigned, based on the structural
information.119 But the principal packing interactions are CH...F, CH...O and CH...N contacts
with the counter anions and solvent molecules accommodated in the packing.
Table 3.15: Torsion angles between the tpy domain and the aromatic ring at the 4′-position.
[Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN tpy(N1-N3)-tolyl(C16) 17.4◦
[Cr(LT3)2][PF6]3·0.2MeCN tpy(N1-N3)-naph(C16) 39.7◦
tpy(N4-N6)-naph(C41) 21.4◦
[Cr(HLT11)(LT11)][PF6]4 tpy(N1A-N3A)-py(N4A) 28.9◦
tpy(N5A-N7A)-py(N8A) 37.3◦
tpy(N1B-N3B)-py(N4B) 23.0◦
tpy(N5B-N7B)-py(N8B) 34.6◦
[Cr(LT1)2][CF3SO3]3 tpy(N1-N3)-phen(C16) 17.6◦
tpy(N4-N6)-phen(C41) 18.6◦
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3.9.1.3 Structure of 5{[Cr(LT3)2][PF6]3}·MeCN
5{[Cr(LT5)2][PF6]3}·MeCN crystallises in the triclinic space group P1. Figure 3.53 shows an
ORTEP representation of the cation [Cr(LT3)2]3+. It is noticeable that the two naphthalene
units are twisted differently with respect to the tpy domains (21.4◦ respectively 39.7◦). This
complex shows also two different pi-pi-interactions among two complexes involving the naphthyl
groups (figure 3.54).119 The naphthyls containing C16 overlap with the plane of the rings being
coparallel by symmetry (centre of inversion) with a distance of the least squares planes of 3.53 Å.
The naphthyl groups are offset with each other (figure 3.55). The second interaction involves
the 2nd ligand on the complex. The naphthyl group containing C41 interacts with the pyridine-
ring containing N6. This pi-pi interaction has to be less strong, since the angle between the two
least square planes is 21.1◦. The distance between the two calculated ring centroids is 3.84 Å
and the shortest distance between a least square plane (pyridine containing N6) and a centroid
(naphthyl containing C41) is 3.26 Å. As a consequence of these two different interactions, the
cations are packed in chains where the orientation of each link changes in an alternating manner
(figure 3.56). These chains do not interact directly with one another (figure 3.57).
Figure 3.53: Structure of the cation in [Cr(LT3)2][PF6]3 with ellipsoids plotted at 50 % proba-
bility level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected bond
lengths [Å]: Cr1-N1 = 2.058(2), Cr1-N2 = 1.967(2), Cr1-N3 = 2.061(2), Cr1-N4 = 2.055(2),
Cr1-N5 = 1.971(2), Cr1-N6 = 2.047(2); and bond angles [◦]: N1-Cr1-N2 = 78.68(8), N3-Cr1-N2
= 78.95(8), N1-Cr1-N3 = 157.59(9), N4-Cr1-N5 = 79.07(8), N6-Cr1-N5 = 78.46(8), N4-Cr1-N6
= 157.53(9).
Figure 3.54: Face-to-face interaction contacts in [Cr(LT3)2][PF6]3. The interactions between
the naphthyls containing C16 are highlighted in blue, the interactions between the naphthyl
group containing C41 and the ring containing N6 in red.
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Figure 3.55: Face-to-face interaction contacts in [Cr(LT3)2][PF6]3. Superposition of the stick
and the spacefill presentation shows the stacked face-to-face interaction. The distance between
the least square planes is 3.53 Å and the planes are parallel (angle = 0◦) to each other.
Figure 3.56: Illustration of a chain formed by the [Cr(LT3)2)]3+-cations. Counter ions, H atoms
and solvent molecules are omitted for clarity. The ligands containing C16 are presented in blue,
those containing C41 in red.
Figure 3.57: View along the independent chains formed by the [Cr(LT3)2)]3+-cations. Counter
ions, H atoms and solvent molecules are omitted for clarity. The ligands containing C16 are
presented in blue, those containing C41 in red.
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3.9.1.4 Structure of [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN
Figure 3.58: Structure of the cation in [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN with ellipsoids
plotted at 50 % probability level. H atoms, counter ions and solvent molecules are omitted for
clarity. Selected bond lengths [Å]: Cr1-N1 = 2.062(2), Cr1-N2 = 1.9717(18), Cr1-N3 = 2.055(2);
and bond angles [◦]: N1-Cr1-N2 = 78.79(8), N3-Cr1-N2 = 78.59(8), N1-Cr1-N3 = 157.27(7).
[Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN crystallises in the monoclinic C2/c space group
(figure 3.58). The metrical parameters of the two ligands in this complex are identical, be-
cause a 2-fold axis goes through the metal centre. Between two cations, pi-pi plane to plane
and CH...pi interactions can be observed. The face-to-face interaction between the pyridine-ring
containg N3 and the phenyl-ring containing C16 can be classified as moderate since the two
least squares planes are not parallel. The angle betweeen the planes is 17.4◦. The distance be-
tween the calculated centroids (of the rings containing N3 and C16) is 3.71 Å and the shortest
distance between a centroid and a plane 3.40 Å (centroid of the ring containing C16 and plane
of the ring containing N3). Additional CH...pi interactions C20H...C1 and C20H...C2 (2.79 Å
respectively 2.82 Å) between the pyridine-ring containing N1 and the phenyl-ring increase the
cation-cation-interactions (figure 3.59).119
Figure 3.59: Interaction contacts in [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN. The face to face
interaction (blue space-filling) and the CH...pi interactions (red) are shown separately. H atoms,
counter ions and solvent molecules are omitted for clarity.
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Figure 3.60: Chain-shaped packing of [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN. The cations were
coloured alternatingly to improve the clearness. H atoms, counter ions and solvent molecules
are omitted for clarity.
3.9.1.5 Structure of [Cr(LT1)2][CF3SO3]3
Figure 3.61: The structure ot the cation in [Cr(LT1)2][CF3SO3]3 with ellipsoids plotted at 50 %
probability level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected
bond lengths [Å]: Cr1-N1 = 2.0580(16), Cr1-N2 = 1.9815(15), Cr1-N3 = 2.0622(15), Cr1-N4
= 2.0691(16), Cr1-N5 = 1.9836(15), Cr1-N6 = 2.0555(15); and bond angles [◦]: N1-Cr1-N2 =
78.32(6), N3-Cr1-N2 = 78.30(6), N1-Cr1-N3 = 156.59(6), N4-Cr1-N5 = 78.19(6), N6-Cr1-N5 =
78.29(6), N4-Cr1-N6 = 156.37(6).
[Cr(LT1)2][CF3SO3]3 crystallises in the triclinic P1 space group (figure 3.61). These cations
interact in a similar way as those in [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN. But since the two
ligands are crystallographically independent, the complex is not symmetric and therefore two
slightly different interactions are present (compare figure 3.62). Based on the geometrical data
the interactions have to be categorised as weaker compared to those in the previously men-
tioned complex. The angles between the least squares planes are 20.3◦ (rings containing N6
and C41) and 20.5◦ (rings containing N3 and C16). The distances between the centroids are
3.85 Å (rings containing N6 and C41) and 4.12 Å (rings containing N3 and C16). 4.12 Å is
really too long for a significant pi-stacking interaction. And the minimal distances between a
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Figure 3.62: [Cr(LT1)2][CF3SO3]3: Face-to-face stacking between the cations, between the rings
containing N3 and C16 (red) and N6 and C41 (blue).
plane and a centroid are 3.50 Å (rings containing N3 and C16) and 3.57 Å (rings containing N6
and C41).119 This has the consequence that the orientation of the complex in the chain-shaped
packing changes alternatingly, like in [Cr(LT3)2)][PF6]3·0.2MeCN. The solvent molecules and
anions in this structure are badly disordered and could not be modelled in a satisfactory way.
3.9.1.6 Structure of [Cr(HLT11)(LT11)][PF6]4
The preliminary data show that the unit cell of [Cr(HLT11)(LT11)][PF6]4 contains two inde-
pendent cations (figure 3.63). The cations are displayed as ball and stick since the anisotropic
refinement was not possible for all atoms. The distance between the cations is too big to in-
teract by pi-pi or CH...pi interactions.119 A possible reason for this observation is the presence
of one additional PF−6 anion in the packing, since one of the non-coordinating pyridine rings
is protonated. In contrast to the complexes reported above there are no solvent molecules in
the lattice (figure 3.65). The angle between the two tpy domains is 75.4◦ (cation A) and 77.7◦
(cation B) respectively. This is a bigger deviation from the orthogonal position, compared with
the other reported complexes. The non-coordinating pyridine rings containing N4A and N4B
are protonated. In contrast the other non-coordinating pyridine rings containing N8A and N8B
are not protonated. There is an interaction between adjacent cations through N-H...N hydrogen
bonds between the protonated and not protonated units. As a consequence, the cations form
chains (figure 3.64) with alternating cations A and B as building blocks.
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Figure 3.63: Two independent cations in [Cr(HLT11)(LT11)][PF6]4 plotted as ball and stick.
H atoms and counter ions are omitted for clarity. Selected bond lengths [Å]: Cr1A-N1A =
2.042(7), Cr1A-N2A = 1.984(6), Cr1A-N3A = 2.053(7), Cr1A-N5A = 2.055(7), Cr1A-N6A =
1.986(6), Cr1A-N7A = 2.056(7); Cr1B-N1B = 2.035(7), Cr1B-N2B = 1.986(6), Cr1B-N3B =
2.058(7), Cr1B-N5B = 2.064(7), Cr1B-N6B = 1.969(6), Cr1B-N7B = 2.073(7); and bond angles
[◦]: N1A-Cr1A-N2A = 77.9(2), N3A-Cr1A-N2A = 78.8(2), N1A-Cr1A-N3A = 156.6(3), N5A-
Cr1A-N6A = 78.8(3), N7A-Cr1A-N6A = 78.6(3), N5A-Cr1A-N7A = 157.3(2), N1B-Cr1B-N2B
= 78.1(3), N3B-Cr1B-N2B = 78.6(3), N1B-Cr1B-N3B = 156.7(3), N5B-Cr1B-N6B = 79.1(3),
N7B-Cr1B-N6B = 77.9(3), N5B-Cr1B-N7B = 156.9(3).
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Figure 3.64: Nitrogen-hydrogen connections between protonated and non-protonated pyridine
rings build a linear hydrogen-bonded polymer. The [Cr(HLT11)(LT11)]4+ cations A (red) and
B (blue) alternate as building blocks of the chain. Bond distances [Å]: N4A-H...N4B: 1.80 and
N4B-H...N8A: 1.79.
Figure 3.65: Packing for [Cr(HLT11)(LT11)][PF6]4. Colour code: cation A (red), cation B
(blue) and anion PF−6 (green).
Figure 3.66: Light microscope picture of a [Cr(HLT11)(LT11)][PF6]4 plate.
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3.9.2 Heteroleptic complexes
Although several crystal growth trials were accomplished with all the synthesised heteroleptic
bis(terpyridine)chromium(III) complexes, measurable crystals were only obtained for cations
with one unsubstituted tpy.
Table 3.16: Crystallographic data for heteroleptic {Cr(tpy)2}3+ complexes, part I
compound [Cr(tpy)(4′-(4-
tolyl)tpy)][PF6]3
[Cr(tpy)(HLT11)]
[PF6]3[CF3SO3]
[Cr(tpy)(5,5′′-
Me2tpy)][PF6]3
formula moiety C37H28CrN6,
3(F6P), 3(C2H3N)
C35H26CrN7,
3(F6P), CF3O3S
C32H26CrN6,
3(F6P), 3(C2H3N)
formula weight 1166.71 1180.62 1104.66
crystal colour and habit orange, block orange, plate orange, block
[g mol−1]
crystal system monoclinic monoclinic orthorhombic
space group Cc C2/c Pbca
14.8008(10) 13.0909(10) 12.6552(9)
a, b, c [◦A] 16.1020(10) 27.138(2), 19.1818(13)
21.0282(14) 12.3651(10) 36.810(3)
90 90 90
α, β, γ [◦] 106.033(5) 94.194(2) 90
90 90 90
U [Å3] 4816.56 4381.0(6) 8935.61
Dc [Mg m−3] 1.609 1.790 1.642
Z 4 4 8
µ(M-Kα) [mm−1] 0.451 (M=Mo) 0.556 (M=Mo) 4.199 (M=Cu)
T [K] 123 123(2) 123(2)
refln. collected 53498 41505 117869
unique refln. 17525 6362 8050
refln. for refinement 12289 4933 7612
parameters 668 471 627
threshold I>3.0σ I>2.0σ I>2.0σ
R1 (r1 all data) 0.0384 (0.0509) 0.0694 (0.0857) 0.0339 (0.0356)
wR2 (wR2 all data) 0.0389 (0.0621) 0.1883 (0.2065) 0.0908 (0.0921)
goodness of fit 1.0984 1.033 1.053
crystal growing diffusion acetone/
hexane
diffusion
MeCN/Et2O
diffusion
MeCN/Et2O
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Table 3.17: Crystallographic data for heteroleptic Cr(tpy)2 complexes, part II
compound [Cr(tpy)(LT7)][PF6]3 [Cr(tpy)(LT8)][PF6]3 [Cr(tpy)(LT9)][PF6]3
formula moiety C37H25CrN7,
3(F6P), 3(C3H6O)
C34H24CrF18N6OP3 C37H28CrN6S,
3(F6P), 2(C2H3N)
formula weight 1228.78 1019.5 1157.72
[g mol−1]
crystal colour and habit orange, block orange, plates orange, needle
crystal system monoclinic triclinic triclinic
space group P21/c P1 P1
9.4797(5) 12.715(2) 12.3948(7)
a, b, c [Å] 27.4574(15) 18.720(4) 12.5942(8)
19.5291(10) 20.255(4) 17.4369(10)
90 96.984(6) 73.761(3)
α, β, γ [◦] 96.296(3) 100.216(6) 76.298(3)
90 104.519(9) 63.737(3)
U [Å3] 5052.5(5) 4522.8(16) 2323.3(2)
Dc [Mg m−3] 1.615 1.497 1.655
Z 4 4 2
Mu(M-Kα) [mm−1] 0.438 (M=Mo) 0.468 (M=Mo) 4.474 (M=Cu)
T [K] 123(2) 123(2) 123
refln. collected 98720 42394 27428
unique refln. 12182 16318 8169
refln. for refinement 10177 9460 7237
parameters 709 1287 652
threshold I>2.0σ I>2.0σ I>0.0σ
R1 (r1 all data) 0.0389 (0.0513) 0.0876 (0.1588) 0.0592 (0.0618)
wR2 (wR2 all data) 0.1379 (0.1161) 0.2325 (0.3050) 0.0641 (0.0706)
goodness of fit 1.075 1.072 1.0891
crystal growing diffusion
MeCN/Et2O
diffusion
MeCN/Et2O
diffusion
MeCN/Et2O
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3.9.2.1 [Cr(tpy)(5,5′′-Me2tpy)][PF6]3·3MeCN
[Cr(tpy)(5,5′′-Me2tpy)][PF6]3·3MeCN crystallises in the orthorhombic space group Pbca
(figure 3.67). The two tpy domains are arranged in an angle of 85.8◦ (angle of the least squares
planes). The three anions (PF−6 ) and three solvent molecules (MeCN) are ordered and their
accommodation in the lattice prevents inter-cation embraces. Therefore the prinicipal packing
interactions are CH...F and CH...N contacts between the cation and the anions and the solvent
molecules respectively.
Figure 3.67: The cation in [Cr(tpy)(5,5′′-Me2tpy)][PF6]3 with ellipsoids plotted at 50 % prob-
ability level. Counter ions, H atoms and solvent molecules are omitted for clarity. Selected
bond lengths [Å]: Cr1-N1 = 2.0655(15), Cr1-N2 = 1.9887(15), Cr1-N3 = 2.0648(15), Cr1-N4
= 2.0715(15), Cr1-N5 = 1.9836(15), Cr1-N6 = 2.0579(15); and bond angles [◦]: N1-Cr1-N2 =
78.53(6), N2-Cr1-N3 = 78.45(6), N1-Cr1-N3 = 156.24(6), N4-Cr1-N5 = 78.49(6), N6-Cr1-N5 =
78.65(6), N4-Cr1-N6 = 157.14(6).
3.9.2.2 [Cr(tpy)(HLT11)][PF6]3[CF3SO3]
[Cr(tpy)(HLT11)][PF6]3[CF3SO3] crystallises in the monoclinic space group C2/c (figure 3.68).
The non-coordinating pyridine is protonated as seen in the homoleptic complex
[(HLT11)(LT11)][PF6]4 (page 81). An additional analogy to this homoleptic complex is that
the lattice is solvent free. The two tpy domains are nearly perfectly arranged orthogonally (an-
gle between the least squares planes: 89.2◦). As in the structure described above there are no
direct contacts between the cations. The principal packing interactions are CH...F interactions
with the anions. The presence of three PF−6 and one CF3SO
−
3 anion shows that there was no
complete anion exchange. The pyridyl of ligand LT11 is disorderd. The twist angle between
the tpy domain and the pyridyl-ring is 30.6◦ (I) and 31.5◦ (II) respectively, but in the opposite
direction (angles between the least squares planes, compare figure 3.69). The occupancies of
the two disordered positions are 53% (I) and 47% (II).
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Figure 3.68: The cation in [Cr(tpy)(HLT11)][PF6]3[CF3SO3] with ellipsoids plotted at 50 %
probability level. Counter anions are omitted for clarity. Selected bond lengths [Å]: Cr1-N1
= 2.0644(18), Cr1-N2 = 1.988(2), Cr1-N4 = 2.0571(17), Cr1-N5 = 1.983(2); and bond angles
[◦]: N1-Cr1-N2 = 78.39(5), N1-Cr1-N1 = 156.77(10), N4-Cr1-N5 = 78.73(5), N4-Cr1-N4 =
157.45(10). The pyridine-ring containing N3 is disorderdered: red (I) and blue (II).
Figure 3.69: The two tpy domains are arranged in an angle of 89.2◦. The pyridine-ring is twisted
compared with the tpy domain: red (I): 30.56◦ and blue (II): 31.5◦
3.9.2.3 Structure of [Cr(tpy)(LT7)][PF6]3·3Me2CO
[Cr(tpy)(LT7)][PF6]3·3Me2CO crystallises in the monoclinic space group P21/c (figure 3.70).
The two tpy domains are arranged at an angle of 89.8◦. The phenyl-ring (containing C16) is
twisted through 26.3◦ with respect to the tpy domain. The phenyl-rings containing C16 of ad-
jacent cations stand perfectly parallel to each other with a distance of 3.74 Å (distance between
the least squares planes and the centroids). The rings are co-parallel because of symmetry;
an inversion center is located in the middle between the two phenyl-rings. Beside these face-
to-face pi-pi-interactions, CH...N interactions between C26H and N7 (2.66 Å) plus C38H and
N7 (2.60 Å) are present.119 The consequence is that each pair of cations is inter-connected by
face-to-face and two CH...N (C38H...N7) interactions. Further, each pair is connected to four
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pairs via CH...N (C26H...N7) connections (figure 3.71).
Figure 3.70: [Cr(LT7)(tpy)][PF6]3·3C3H6O with ellipsoids plotted at 50 % probability level. H
atoms, counter ions and solvent molecules are omitted for clarity. Selected bond lengths [Å]:
Cr1-N1 = 2.0627(16), Cr1-N2 = 1.9843(16), Cr1-N3 = 2.0557(16), Cr1-N4 = 2.0504(16), Cr1-
N5 = 1.9850(16), Cr1-N6 = 2.0584(16); and bond angles [◦]: N1-Cr1-N2 = 78.40(6), N3-Cr1-N2
= 78.64(6), N1-Cr1-N3 = 157.03(6), N4-Cr1-N5 = 79.03(7), N6-Cr1-N5 = 78.32(6), N4-Cr1-N6
= 157.34(7).
Figure 3.71: [Cr(LT7)(tpy)][PF6]3·3Me2CO packing with face-to-face pi-pi interactions between
the phenyl-rings (spacefill) and CH...N interactions (thin red lines). Colour code: red: cation,
blue: counter anion PF−6 and green: acetone.
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3.9.2.4 [Cr(tpy)(LT9)][PF6]3·2MeCN
[Cr(tpy)(LT9)][PF6]3·2MeCN crystallises in the triclinic space group P1 (figure 3.72). The two
tpy domains are arranged in an angle of 88.0◦. The phenyl-ring containing C31 is twisted
through 18.6◦ with respect to the tpy domain. The interactions between the cations are similar
to those reported for [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3·2MeCN. A moderate pi-pi interaction is
present between the pyridyl-ring (containing N6) and the phenyl-ring (containing C31). The
angle between the least squares planes is 14.9◦ and the shortest distance between a centroid
and a least squares plane is 3.49 Å (centroid of the phenyl-ring and least squares plane of the
pyridyl-ring). The distance between the two centroids is 3.71 Å (figure 3.73).119
Figure 3.72: The cation in [Cr(tpy)(LT9)][PF6]3·2MeCN with ellipsoids plotted at 50 % proba-
bility level. H atoms, counter ions and solvent molecules are omitted for clarity. Selected bond
lengths [Å]: Cr1-N1 = 2.052(3), Cr1-N2 = 2.001(2), Cr1-N3 = 2.074(3), Cr1-N4 = 2.071(3),
Cr1-N5 = 1.981(2), Cr1-N6 = 2.064(3); and bond angles [◦]: N1-Cr1-N2 = 78.41(11), N3-Cr1-
N2 = 77.99(11), N1-Cr1-N3 = 156.40(11), N4-Cr1-N5 = 78.01(10), N6-Cr1-N5 = 78.35(10),
N4-Cr1-N6 = 156.31(10), C34-S1-C37 = 103.9(2).
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Figure 3.73: Face-to-face contacts in [Cr(tpy)(LT9)][PF6]3·2MeCN: pi-pi packing between the
pyridyl-ring containing N6 and the phenyl-ring containing C31. Counter anions, solvent
molecules and H atoms are omitted for clarity.
3.9.2.5 [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3·3MeCN
[Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3·3MeCN crystallises in the monoclinic space group Cc
(figure 3.74). The tpy domains are arranged in an angle of 88.9◦. The phenyl-ring is twisted
with respect to the tpy domain by 23.4◦. The contacts between two cations can either be clas-
sified as face-to-face or edge-to-face but the tolyl-ring of one cation is accommodated within
the cleft (85.2◦) formed by two pyridine-rings (containing N1 and N4) of the other cation. The
closest CH...pi interactions are 3.40 to 3.50 Å (figure 3.75).119
3.9. X-RAY STRUCTURES 109
Figure 3.74: The cation in [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 with ellipsoids plotted at 50 % prob-
ability level. Counter ions, H atoms and solvent molecules are omitted for clarity. Selected bond
lengths [Å]: Cr1-N1 = 2.054(2), Cr1-N2 = 1.986(2), Cr1-N3 = 2.061(2), Cr1-N4 = 2.064(2),
Cr1-N5 = 1.979(2), Cr1-N6 = 2.052(2); and bond angles [◦]: N1-Cr1-N2 = 78.83(9), N2-Cr1-N3
= 78.73(9), N1-Cr1-N3 = 157.56(9), N4-Cr1-N5 = 77.90(9), N6-Cr1-N5 = 78.67(9), N4-Cr1-N6
= 156.44(9).
Figure 3.75: Short contacts in [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3·MeCN. Tolyl unit (green) in the
cleft formed by the two pyridine rings containing N1 and N4 (blue). CH...pi interactions are
highlighted in red.
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3.9.2.6 Structure of [Cr(tpy)(LT8)][PF6]3
[Cr(tpy)(LT8)][PF6]3 crystallises in the triclinic space group P1. The structure determination is
only preliminary. The asymmetric unit contains two different cations A and B (figure 3.76). The
two tpy domains are arranged in an angle of 85.6◦ (cation A) and 89.6◦ (cation B) respectively.
The furan-rings are twisted compared with the corresponding tpy domains by: 7.1◦ (cation A)
and 15.2◦ (cation B). The interactions between two equivalent cations are similar to those
described in [Cr(LT9)(tpy)][PF6]3·2MeCN. The angles between the least squares planes are quite
different in the two face-to-face interactions: 3.5◦ (rings containing N3A and O1A) and 16.05◦
(rings containing N1B and O1B). The shortest distance between a centroid and a plane are
3.32 Å (cation A) and 3.66 Å (cation B). Additionally to these interactions, a weak pi-pi contact
can be found between the two cation pairs, namely between the rings containing O1B and N1A.
The angle between the least squares planes is 9.8◦ and the shortest distance between a plane
and a centroid is 3.57 Å.
Figure 3.76: The two independent cations in [Cr(tpy)(LT8)][PF6]3 with ellipsoids plotted at
50 % probability level. H atoms, counter ions and solvent molecules are omitted for clarity.
Selected bond lengths [Å]: Cr1A-N1A = 2.060(6), Cr1A-N2A = 1.988(6), Cr1A-N3A = 2.067(6),
Cr1A-N4A = 2.077(6), Cr1A-N5A = 1.986(6), Cr1A-N6A = 2.059(6); Cr1B-N1B = 2.067(6),
Cr1B-N2B = 1.974(6), Cr1B-N3B = 2.069(6), Cr1B-N4B = 2.056(6), Cr1B-N5B = 1.987(6),
Cr1B-N6B = 2.077(6); and bond angles [◦]: N1A-Cr1A-N2A = 78.3(2), N3A-Cr1A-N2A =
78.6(2), N1A-Cr1A-N3A = 156.8(2), N4A-Cr1A-N5A = 77.9(2), N6A-Cr1A-N5A = 78.8(2),
N4A-Cr1A-N4A = 156.8(2), N1B-Cr1B-N2B = 78.6(2), N3B-Cr1B-N2B = 78.3(2), N1B-Cr1B-
N3B = 156.9(2), N4B-Cr1B-N5B = 78.7(2), N6B-Cr1B-N5B = 78.2(2), N4B-Cr1B-N6B =
156.9(2).
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Figure 3.77: Interactions between cations in [Cr(tpy)(LT8)][PF6]3. The plane-to-plane inter-
actions between the rings containing N3A and O1A (red) and N1B and O1B (blue) can be
classified as good. However the interactions between N1A and O1B (green - blue) are weak.
Counter anions, solvent molecules and H atoms omitted for clarity.
Figure 3.78: [Cr(LT8)(tpy)][PF6]3: The cations A (red) and B (blue) form layers. Additional
colour codes: PF−6 counter anions (green) and solvent molecules (acetone, orange).

Chapter 4
Bis(terpyridine)cobalt(III) complexes
4.1 Synthesis of the bis(terpyridine)cobalt(III) complexes
For the powder EPR measurements diamagnetic analogues of the {Cr(tpy)2}3+ complexes were
necessary to prepare magnetically diluted samples (3.7, p. 63). Therefore three different ho-
moleptic {Co(tpy)2}3+ were synthesised (scheme 4.1).
The complexes with {Co(tpy)2}3+ cores have been synthesised according to an established
protocol (scheme 4.1) in our group.162 In the first step the {Co(tpy)2}2+ complex is synthe-
sised. Co(OAc)2·4H2O and two equivalents of the tpy ligand are stirred for 20 min at room
temperature in a CHCl3/ MeOH mixture (9:1). The {Co(tpy)2}2+ intermediate was oxidised
in a saturated aqueous bromine solution overnight at room temperature, to receive the target
{Co(tpy)2}3+ complex.
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Scheme 4.1: Synthesis pathway to {Co(tpy)2}3+ complexes and overview of the synthesised
complexes (exp. = link to the experimental)
Chapter 5
Terpyridine ligand synthesis
5.1 Synthesis of the tpy ligands
2,2′:6′,2′′-Terpyridine (tpy) and derivatives thereof were all synthesised using different ring-
assembly methodologies.34
5.1.1 2,2′:6′,2′′-Terpyridine (tpy)
The unsubstituted 2,2′:6′,2′′-terpyridine (tpy) was synthesised by a two step synthesis reported
by Jameson et al.164 In the first step the enaminone P1 (scheme 5.1) is prepared by the reaction
of 2-acetylpyridine and N,N -dimethylformamide dimethyl acetal. In the second step, the potas-
sium enolate of 2-acetylpyridine reacts with enaminone P1, with subsequent loss of dimethyl
amine. Closure of the resulting, not isolated, intermediate
(Z)-1,5-di(pyridin-2-yl)pent-2-ene-1,5-dione (P1]) with ammonium acetate gives
2,2′:6′,2′′-terpyridine (tpy). The overall yield is very low, and was in our case 3.1 %.
N
N
O
O
N
O
N
O
N(CH3)2
N
N N
O
O
N+
P1
tpy
P1#
N
O
, t-BuOK
NH4OAc, 
AcOH
Scheme 5.1: Synthesis route for 2,2′:6′,2′′-terpyridine (tpy)
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5.1.1.1 5,5′′-Dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy)
5,5′′-Dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy) was synthesised in a two step reaction ac-
cording to the protocol of Sasaki et al..165 In the first step of this Kröhnke reaction166 the
pyridinium salt (P2, scheme 5.2) was synthesised by heating 2,6-diacetylpyridine and elemen-
tal iodine in pyridine.165,167 In the second step methacrolein in formamide forms the (not
isolated) intermediate P2].168 The closure of the two rings with ammonium acetate gives
5,5′′-dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy). The overall yield is moderate, and was in
our synthesis 55.2 %.
P2
5,5''-Me2tpy
N
O O
N
O O
NN
O
I2, pyridine
I- I-
N
NN N
O O
OO
P2#
Py+Py+
NH4OAc
NH4OAc
Scheme 5.2: 5,5′′-dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy)
5.1.1.2 2,2′:6′,2′′-Terpyridines (tpy) substituted at the 4′-position
2,2′:6′,2′′-Terpyridines (tpy) which are substituted at the 4′-position were synthesised according
to the protocol of Wang et al.169 In an one-pot synthesis, aryl aldehyde (A, scheme 5.3) and
two equivalents 2-acetylpyridine molecules (B) react under basic conditions with ammonia as
the nitrogen source to give a 4′-substituted terpyridine (C). The enolate (I) of 2-acetylpyridine
(B) can be generated by potassium hydroxide. The intermediate II is formed via an aldol con-
densation170 of the aryl aldehyde A and the first equivalent of the enolate I. In the subsequent
Michael -addition the diketone III is formed.170 In the final ring closing step with aqueous am-
monia, the target product was obtained in moderate yields.
The synthesised ligands 4′-(4-tolyl)tpy, LT1 − LT3 and P3 (table in scheme 5.3) were known in
the literature.169,171,172 To the best of our knowledge, ligand LT4 was not reported before. Also
no examples of the reaction starting with 2-acetylpyridine substituted at the 6,6′′-positions are
published. The yields of these reactions lie between 24.9 and 52.6 % (table in scheme 5.3). The
lowest yield is for the synthesis of the sterically more hindered tpy which is substituted at the
6,6′′-positions (LT4).
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label: R1: R2: yield: literature:
4`-(4-tolyl)tpy H 52.6% Tang et al.171
LT1 H 37.8% Constable et al.173
LT2 H 27.7 % Wang et al.169
LT3 H 33.8 % McMillin et al.139
P3 Br H 42.2 % Wang et al.169
LT4 Me 24.9 % not reported
Scheme 5.3: Synthesis of 2,2′:6′,2′′-terpyridines (tpy) substituted in the 4′-position.
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5.1.1.3 Synthesis of 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -diphenylaniline (LT5)
N
NN
Br
NH
N
NN
N
+
P3 LT5
Sodium tert-butoxide, 
Bis(dibenzylideneacetone)palladium,
Tri-t-butylphosphine
toluene
Scheme 5.4: Synthesis of 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -diphenylaniline (LT5).
Ligand LT5 was first reported by Goodall et al.172 An improved synthetic strategy was pre-
viously reported by our group.38 In a palladium catalysed Buchwald-Hartwig-coupling174,175
4′-(4-bromophenyl)-2,2′:6′,2′′-terpyridine (P3) reacts with diphenylamine. The overall yield of
this two step synthesis is moderate (29.6 %).
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5.1.2 Further terpyridine ligands
The following ligands (figure 5.1) were available in the laboratory and used for the synthesis of
{Cr(tpy)2}3+. They were synthesised by current or former members of our group or students
in the lab course (inorganic chemistry lab course, 4th semester, at the University of Basel).
4-([2,2′:6′,2′′-Terpyridin]-4′-yl)-N,N -bis(4-methoxyphenyl)aniline (LT6)
↪→ Synthesised by Nik Hostettler.38
4-([2,2′:6′,2′′-Terpyridin]-4′-yl)benzonitrile (LT7)
↪→ Synthesised by Frank Schaeper.
4′-(Furan-2-yl)-2,2′:6′,2′′-terpyridine (LT8)
↪→ Synthesised by Frank Schaeper.176
4′-(4-(Methylthio)phenyl)-2,2′:6′,2′′-terpyridine (LT9)
↪→ Synthesised by Federica Reinders177
4-([2,2′:6′,2′′-Terpyridin]-4′-yl)phthalic acid (LT10)
↪→ Synthesised by Ralf Schmitt.38
4′-(Pyridin-4-yl)-2,2′:6′,2′′-terpyridine (LT11)
↪→ Synthesised by students in the lab course, using the protocol of Wang et al.169
N
N
N
N
O O
N
N
N
N
N
N
N
N
N
N
S
O
N
N
N
OH
O
O OH
N
N
N
N
LT6                                           LT7                                         LT8
LT9                                          LT10                                        LT11
Figure 5.1: Ligands LT6 to LT11 were available in the lab.
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5.2 X-ray structure
5.2.1 Structure of 2{[H2LT4][CF3SO3]2}·Et2O
The ligand LT4 crystallised in the double protonated form (figure 5.2). The torsion angle be-
tween the pyridine rings containing N1 and N2 is 10.6◦ and between the pyridine ring containing
N2 and the phenyl ring (containing C10) is 27.4◦. A two fold axis goes through the molecule
(axis N2 - C10 - C14). The protons on C14 (50:50) and the CF3-moiety of the anion (60:40) are
disordered. The anions pack close to the protonated pyridine rings (figure 5.3). The shortest
N-H...O distance is 2.09 Å. The ligands form layers controlled by pi-pi plane to plane interactions
between the pyridine rings containing N1. The space between two rows is forced by the toluene
moieties and the tubes so formed are occupied by the solvent molecules.
Table 5.1: Crystallographic data of 2{[H2LT4][CF3SO3]2}·Et2O
formula moiety 2(C24H23N3), µ(Cu-Kα) [mm−1] 2.227
4(CF3O3S), C4H10O T [K] 123
formula weight 1377.35 refln. collected 24747
crystal colour and habit green, block unique refln. 2932
crystal system monoclinic refln. for refinement 2856
space group C 2/c parameters 260
11.4673(5) threshold I>2.0σ
a, b, c [Å] 31.9948(13) R1 (R1 all data) 0.0489 (0.0489)
8.8068(4) wR2 (wR2 all data) 0.1417 (0.1421)
90.00 goodness of fit 1.107
α, β, γ [◦] 93.523(2) crystal growing: diffusion
MeCN/Et2O
90.00
U [Å3] 3225.1(2)
Dc [Mg m−3] 1.418
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Figure 5.2: 2{[H2LT4][CF3SO3]2}·Et2O with ellipsoids plotted at 50 % probability level.
Counter ions and solvent molecules are omitted for clarity. Only one of the disordered po-
sitions of the protons on C14 is shown.
Figure 5.3: Position of the two anions ([CF3SO3]−) near to the protonated pyridine rings of
[H2LT4]2+. Only the main form of the disordered anions is shown. The solvent molecule is
omitted for clarity.
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Figure 5.4: Packing of 2{[H2LT4][CF3SO3]2}·Et2O. The pyridine rings containing N1 are high-
lighted in the spacefill style. Colour code: red: cation, blue: anion and green solvent molecule.
Chapter 6
Experimental
6.1 General experimental
If not mentioned otherwise, all starting chemicals were commercially available. They were of
reagent grade, and used without further purification. The used solvents were purchased as dry
solvents (crown cap), in reagent grade or were distilled.
nuclear magnetic resonance (NMR): 1H, 13C{1H} and 19F NMR were recorded on a Bruker
AM250 (250 MHz), Bruker DRX400 (400 MHz) or a Bruker DRX500 (500 MHz) spectrometers,
respectively on Bruker AvanceIII-250 (250 MHz), AvanceIII-400 (400 MHz) and AvanceIII-500
spectrometers (500 MHz). For the assignment of the 1H and 13C{1H} spectra, COSY, DEPT-
135, HMBC and HMQC experiments were conducted on the Bruker AvanceIII-500 (500 MHz).
For 1H and 13C{1H} NMR measurements, the chemical shifts δ are relative and internally refer-
enced to the residual peak of the solvent (acetonitrile: 1H: 1.940, 13C: 118.690 and chloroform:
1H: 7.240, 13C: 77.230)i. All measurements were run at room temperature (295 K (500MHz),
300 K (250 and 400MHz)).
All reported triplets (t) are from the origin not triplets but not resolved doublet of doublets
with a very similar coupling constant.
infrared spectroscopy (IR): Infrared spectra were recorded on a Shimadzu FTIR-8400S
(with Golden Gate ATR) or on a Perkin Elmer Spectrum Two spectrophotometer (with Uni-
versal ATR two) spectrophotometer. Solid samples were measured using the attenuated total
reflection (ATR) technique.
electrospray ionisation mass spectrometry (ESI-MS): Mass spectra were measured (in
methanol) on a Bruker Esquire 3000plus by Dr. G. Schneider or R. Schmitt.
matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS): mass
spectra were measured, with 4-nitroaniline as matrix, on a Bruker Daltonics microflex by S.
Müller.
UV-VIS spectroscopy: UV-VIS spectroscopy measurements were done on an Agilent Tech-
nologies UV-Visible 8453 spectrophotometer or on a Varian Cary 5000 spectrophotometer. The
measurements were done in HPLC-grade solvents.
isource: MestReNova, there referenced as Budavari et al.178
123
124 CHAPTER 6. EXPERIMENTAL
photoluminescence: The photoluminescence measurements were performed on a Shimadzu
RF-5301PC spectrofluorophotometer.
photoluminescence lifetime: The lifetime of the photoluminescence was measured with an
Edinburgh Instruments mini-τ -apparatus, equipped with an EPL-405 picosecond pulsed diode
laser (λex = 404.2 nm, pulse width = 78.2 ps, Edinburgh Instruments) with the appropriate
wavelength filter, or with a compact fluorescence lifetime spectrometer C11367-11 from Hama-
matsu.
elemental analysis (EA): The elemental analyses were measured by S. Mittelheisser on an
Elementar Vario Micro Cube instrument, or byW. Kirsch with a Leco CHN-900 microanalyser.
electrochemistry: Electrochemical measurements were made on a CH Instruments 900B
potentiostat. The samples were dissolved in HPLC grade MeCN (10−4 to 10−5 mol dm−3)
containing 0.1 mol dm−3 [nBu4N][PF6] as supporting electrolyte. The following electrodes were
applied: working (glassy carbon), counter (platinum wire) and pseudo reference (silver wire).
Ferrocene was used as internal reference added at the end of the experiments.
X-ray diffraction: Data were collected on a Bruker-Nonius APEX2 diffractometer with data
reduction, solution and refinement using the programs APEX2,179 SIR92180 and CRYSTALS181
or SHELXL97 or SHELX-13.182 Visualisation and structural analyses were performed with the
software CCDC Mercury (versions 3.0 and 3.3).158,183
sun simulator: The properties of the DSCs were measured with a SolarSim150 (100 W m−2
= 1 sun).
microwave reaction: Microwave reactions were carried out in a Biotage Initiator 8 reactor.
electron paramagnetic resonance (EPR): EPR measurements were performed by Dr. M.
Spulber or Dr. R. Mayap Talom on a Bruker CW EPR Elexsys-500 spectrometer equipped
with a variable temperature unit. The spectra were recorded at 295 K and 100 K with the
following parameters: microwave power 10 mW, conversion time 61.12 ms, number of scans up
to 60, resolution 2048 points, modulation amplitude in the range of 5 G, sweep width 6000 G.
6.2. SYNTHESIS OF TERPYRIDINE LIGANDS 125
6.2 Synthesis of terpyridine ligands
6.2.1 Synthesis of precursors for terpyridine ligands
6.2.1.1 3-(Dimethylamino)-1-(pyridin-2-yl)prop-2-en-1-one (P1)
N
O
N
2-Acetylpyridine (17.2 ml, 153 mmol) and N,N -dimethylformamide dimethyl acetal (25.0 ml,
187 mmol) were dissolved in toluene (100 ml) and heated to reflux. Methanol was removed with
a Dean-Stark apparatus. The colour changed to dark red. After 8 h 45 min the reaction was
stopped, and allowed to cool to room temperature. The precipitate was separated by filtration
and the filtrate stored at 4 ◦C. Additional precipitate was filtered and the solution refluxed
for an additional 8 h. The solution was again stored overnight at room temperature and the
separation of the product was carried out as described above. Finally the volume of the solvent
was reduced, then cyclohexane was added and again stored at 4 ◦C overnight. The precipitate
was separated by filtration. All solid precipitate of the yellow product were combined (14.3 g,
81.2 mmol, 53.1 %).
1H NMR (250 MHz, 298 K, chloroform-d) δ/ppm = 8.63 (1 H, ddd, J = 4.8, 1.8, 0.9 Hz), 8.14
(1 H, dt, J = 7.9, 1.1 Hz), 7.91 (1 H, d, J = 12.7 Hz), 7.79 (1 H, td, J = 7.7, 1.8 Hz), 7.35 (1
H, ddd, J = 7.5, 4.8, 1.3 Hz), 6.45 (1 H, d, J = 12.7 Hz), 3.08 (6 H, d, J = 45.1 Hz). 1H NMR
spectroscopic data agree with literature data.164
6.2.1.2 1,1′-(Pyridine-2,6-diylbis(2-oxoethane-2,1-diyl))bis(pyridin-1-ium) iodide (P2)
N
O
I
N
O
N
I
This reaction was executed under a nitrogen atmosphere. 2,6-Diacetylpyridine (2.00 g, 12.3
mmol) and iodine (6.38 g, 25.1 mmol) were separately dissolved in dry pyridine (9 ml each).
The iodine solution was then added to the 2,6-diacetylpyridine solution and heated at 100 ◦C
for 6 h. After a short time, the precipitate inhibited the stirring, therefore additional pyridine (5
ml) was added to the reaction mixture. After cooling to room temperature, the crude product
was filtered. Recrystallisation from 95 % ethanol gave the beige product (5.12 g, 8.93 mmol,
72.9 %).
1H NMR (250 MHz, 298 K, acetonitrile-d3) δ/ppm = 9.16  8.86 (4 H, m), 8.67 (2 H, tt, J
= 7.9, 1.4 Hz), 8.47  8.24 (3 H, m), 8.25  8.04 (4 H, m), 6.98 (4 H, dd, J = 2.9, 1.2 Hz). 1H
NMR spectroscopic data agree with literature data.184
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6.2.1.3 4′-(4-Bromophenyl)-2,2′:6′,2′′-terpyridine (P3)
N
N
N
Br
2-Acetylpyridine (4.49 ml, 40.0 mmol) and solid potassium hydroxide (2.24 g, 40.0 mmol) were
dissolved in a water/ ethanol mixture (1:1, 100 ml). After stirring at room temperature for 10
min 1-(5-bromopyridin-2-yl)ethan-1-one (3.70 g, 20.0 mmol) was added and allowed to stir for
1 h at room temperature. The colour changed from pale yellow to pale red. Solid potassium
hydroxide (3.08 g, 54.9 mmol) was added and the colour turned red. Then aqueous NH3 (2 ml,
conc. 32%) was added and the reaction mixture was heated at reflux for 5 h. The pale yellow
precipitate was filtered and washed with cold ethanol. The crude product was recrystallised
from ethanol to yield a white powder (3.27 g, 8.22 mmol, 42.2 %).
Although the 1H NMR spectrum showed some minor impurities, the product was used as the
precursor for the synthesis of LT5.
1H NMR (250 MHz, 298 K, chloroform-d) δ/ppm = 8.73 (2 H, ddd, J = 4.8, 1.8, 0.9 Hz), 8.71
(2 H, s), 8.68 (2 H, dt, J = 8.0, 1.1 Hz), 7.89 (2 H, ddd, J = 8.0, 7.5, 1.8 Hz), 7.82  7.73 (2
H, m), 7.68  7.61 (2 H, m), 7.37 (2 H, ddd, J = 7.2, 4.6, 1.1 Hz). 1H NMR spectroscopic data
agree with literature data.185
6.2.2 Terpyridine ligands
6.2.2.1 2,2′:6′,2′′-Terpyridine (tpy)
N
N
N
This reaction was executed under a nitrogen atmosphere. 2-Acetylpyridine (9.84 g, 81.2 mmol)
and potassium tert-butoxide (18.2 g, 162 mmol) were suspended in anhydrous THF (500 ml).
After stirring for 2 h at room temperature P1 (14.3 g, 81.2 mmol) was added and a colour
change occurred from yellow to dark red. The reaction mixture was stirred overnight at room
temperature. Then ammonium acetate (18.2 g, 162 mmol) was added successively followed
by acetic acid (250 ml). The colour changed to black and after 15 min the reaction mixture
was completely dissolved. The THF and as much as possible of the acetic acid were removed
on the rotary evaporator, leaving a black, oily residue. The residue was suspended in water
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(500 ml) and solid sodium carbonate was added until effervescing stopped. The mixture was
extracted three times with dichloromethane (200 ml). The combined organic phases were dried
over magnesium sulfate, filtered and evaporated to a black oil. The crude product was purified
with a silica column (long and wide) using toluene as eluent. The combined fractions were
recrystallised from hot hexane to remove some insoluble red residue. Tpy was isolated as a
white powder (1.13 g, 4.83 mmol, 5.94 %).
1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.71 (2 H, ddd, J = 4.8, 1.8, 0.9 Hz), 8.63
(2 H, dt, J = 8.0, 1.1 Hz), 8.46 (2 H, d, J = 7.8 Hz), 7.97 (1 H, t, J = 7.8 Hz), 7.86 (2 H, ddd,
J = 8.0, 7.5, 1.8 Hz), 7.34 (2 H, ddd, J = 7.5, 4.8, 1.2 Hz). 1H NMR spectroscopic data agree
with literature data.164
6.2.2.2 5,5′′-Dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy)
N
N
N
To a solution P2 (5.10 g, 8.90 mmol) in formamide (60 ml), ammonium acetate (10.3 g, 133
mmol) and methacrolein (2.06 ml, 2.00 mmol) were added. Heating at 100 ◦C overnight yielded
after short time in a precipitate. After cooling to room temperature, the precipitate was filtered,
washed with water and dried. 5,5′′-Me2tpy was isolated as a white powder (1.76 g, 6.73 mmol,
75.7 %).
1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.57  8.47 (4 H, m), 8.38 (2 H, d, J =
7.8 Hz), 7.92 (1 H, t, J = 7.8 Hz), 7.71  7.60 (2 H, m), 2.42 (6 H, d, J = 0.7 Hz). 1H NMR
spectroscopic data agree with the literature data.165
6.2.2.3 4′-(4-Tolyl)-2,2′:6′,2′′-terpyridine (4′-(4-tolyl)tpy)
N
N
N
2-Acetylpyridine (4.50 ml, 40.1 mmol) and 4-methylbenzaldehyde (2.38 ml, 20.1 mmol) were
dissolved in ethanol (100 ml). Solid potassium hydroxide (3.08 g, 54.9 mmol) was added and
the colour turned red. After all potassium hydroxide was dissolved, aqueous NH3 (60 ml, conc.
32%) was added and stirred overnight at 35◦C. The formed pale yellow precipitate was filtered
and washed with cold ethanol. The crude product was recrystallised from ethanol to yield white
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needles (3.41 g, 10.6 mmol, 52.6 %).
1H NMR (250 MHz, 298 K, chloroform-d) δ/ppm = 8.79  8.68 (4 H, m), 8.67 (2 H, dt, J =
8.0, 1.1 Hz), 7.94  7.77 (4 H, m), 7.30 - 7.33 (4 H, m), 2.43 (3 H, s). 1H NMR spectroscopic
data agree with the literature data.171
6.2.2.4 4′-(4-(tert-Butyl)phenyl)-2,2′:6′,2′′-terpyridine (LT1)
N
N
N
2-Acetylpyridine (2.24 ml, 20.0 mmol) and 4-tert-butylbenzaldehyde (1.94 ml, 10.0 mmol) were
dissolved in ethanol (50 ml). Solid potassium hydroxide (1.12 g, 20.0 mmol) was added and the
colour turned red. After all the potassium hydroxide had dissolved, aqueous NH3 (1 ml, conc.
32%) was added and the mixture was stirred overnight at room temperature. The pale yellow
precipitate was filtered and washed with cold ethanol. The crude product was recrystallised
from ethanol with some drops of chloroform to yield a white powder (1.38 g, 3.78 mmol, 37.8%).
1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.76  8.71 (4 H, m), 8.67 (2 H, dt, J =
8.1, 1.1 Hz), 7.92  7.83 (4 H, m), 7.56  7.49 (2 H, m), 7.35 (2 H, ddd, J = 7.5, 4.8, 1.2 Hz),
1.38 (9 H, s). 1H NMR spectroscopic data agree with literature data.173
6.2.2.5 4′-([1,1′-Biphenyl]-4-yl)-2,2′:6′,2′′-terpyridine (LT2)
N
N
N
The compound was prepared by the same method as LT1. 2-Acetylpyridine (2.24 ml, 20.0
mmol) and [1,1′-biphenyl]-4-carbaldehyde (1.82 g, 10.0 mmol) were dissolved in ethanol (50
ml). Then solid potassium hydroxide (1.12 g, 20.0 mmol) and aqueous NH3 (30 ml, conc. 32%)
were added. The target product was isolated as a white powder (1.07 g, 2.77 mmol, 27.7%).
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1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.80 (2 H, s), 8.75 (2 H, ddd, J = 4.8,
1.9, 0.9 Hz), 8.69 (2 H, dt, J = 7.9, 1.1 Hz), 8.07  7.97 (2 H, m), 7.89 (2 H, td, J = 7.7, 1.8
Hz), 7.78  7.72 (2 H, m), 7.71  7.65 (2 H, m), 7.53  7.45 (2 H, m), 7.42  7.33 (3 H, m). 1H
NMR spectroscopic data agree with literature data.186
6.2.2.6 4′-(Naphthalen-2-yl)-2,2′:6′,2′′-terpyridine (LT3)
N
N
N
The compound was prepared by the same method as LT1. 2-Acetylpyridine (2.24 ml, 20.0
mmol) and 2-naphthaldehyde (1.36 ml, 10.0 mmol) were dissolved in ethanol (50 ml). Then
solid potassium hydroxide (1.12 g, 20.0 mmol) and aqueous NH3 (1 ml, conc. 32%) were added.
The target product was isolated as a white needles (1.22 g, 3.38 mmol, 33.8%).
1H NMR (250 MHz, 298 K, chloroform-d) δ/ppm = 8.94  8.84 (2 H, m), 8.75 - 8.77 (2 H,
m), 8.69 - 8.73 (2 H, m), 8.42 (1 H, s), 8.12  7.82 (6 H, m), 7.62  7.49 (2 H, m), 7.38 (2 H,
ddd, J = 7.5, 4.8, 1.3 Hz). 1H NMR spectroscopic data agree with literature data.139
6.2.2.7 6,6′′-Dimethyl-4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (LT4)
3
4
56
N
2
N
2
3
4
N
14
3 2
A
BC
The compound was prepared by the same method as LT1. 1-(6-Methylpyridin-2-yl)ethan-1-
one (1.57 ml, 12.0 mmol) and 4-methylbenzaldehyde (0.710 ml, 6.00 mmol) were dissolved in
ethanol (30 ml). Then solid potassium hydroxide (673 mg, 12.0 mmol) and aqueous NH3 (1 ml,
conc. 32%) were added. The crude product was redissolved in CH2Cl2 and washed three times
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with water, dried over MgSO4 and evaporated to dryness. The residue was recrystallised from
ethanol with some drops of chloroform. The target product was isolated as a white powder (526
mg, 1.50 mmol, 24.9%).
1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.71 (s, 2H, B3), 8.44 (d, J = 7.8 Hz, 2H,
A3), 7.91  7.78 (m, 2H, C2), 7.75 (t, J = 7.7 Hz, 2H, A4), 7.35 - 7.32 (m, 2H, C3), 7.20 (d,
J = 7.6 Hz, 2H, A5), 2.67 (s, 6H, AMe), 2.44 (s, 3H, CMe). 13C{1H} NMR (101 MHz, 298
K, chloroform-d) δ/ppm = 158.0 (A6), 156.3 (A2/B2), 156.0 (A2/B2), 150.2 (B4), 139.0 (C4),
137.1 (A4), 136.1 (C1), 129.7 (C3), 127.3 (C2), 123.4 (A5), 118.8 (B3), 118.5 (A3), 24.9 (AMe),
21.4 (CMe). IR: (solid, ν/cm−1) 539 (s), 564 (m), 586 (w), 630 (m), 639 (m), 651 (m), 662 (s),
719 (w), 739 (m), 747 (s), 750 (s), 759 (m), 764 (m), 799 (s), 822 (m), 896 (m), 991 (w), 1019
(w), 1038 (w), 1064 (w), 1086 (w), 1115 (w), 1125 (w), 1156 (w), 1187 (w), 1212 (w), 1258 (w),
1269 (w), 1387 (m), 1391 (m), 1412 (m), 1464 (m), 1516 (m), 1540 (m), 1569 (s), 1572 (s), 1580
(m), 1605 (w), 1613 (w), 2921 (w), 3989 (m). EA: Found C 81.84, H 6.02, N 11.96; C24H21N3
requires C 82.02, H 6.06, N 12.27.
6.2.2.8 4-([2,2′:6′,2′′-Terpyridin]-4′-yl)-N,N -diphenylaniline (LT5)
N
N
N
N
This reaction was executed under a nitrogen atmosphere. P3 (3.27 g, 8.42 mmol) and dipheny-
lamine (1.43 g, 8.42 mmol) were suspended in toluene (60 ml). After adding sodium tert-
butoxide (1.05 g, 10.9 mmol) the colour changed to orange. Bis(dibenzylideneacetone)palladium
(96.9 mg, 0.168 mmol) and tri-tert-butylphosphine (13.8 mg, 0.168 mmol) were suspended sep-
arately in toluene (4 ml) and added to the reaction mixture with a syringe. The solution turned
purple and was heated at 100 ◦C for 16 h. The reaction mixture was filtered hot through celite.
The solution was evaporated to dryness and washed with ethanol. The crude product was then
recrystallised twice from ethanol and some drops of chloroform. The target product was isolated
as a brown powder (2.79 g, 5.86 mmol, 69.6%).
1H NMR (400 MHz, 298 K, chloroform-d) δ/ppm = 8.74  8.69 (m, 4H), 8.67 (dt, J = 8.0,
1.1 Hz, 2H), 7.88 (ddd, J = 8.0, 7.5, 1.8 Hz, 2H), 7.82  7.76 (m, 2H), 7.37  7.27 (m, 6H), 7.19
 7.13 (m, 6H), 7.11  7.04 (m, 2H). 1H NMR spectroscopic data agree with literature data.186
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6.3 Synthesis of tris(diimine)chromium(III) complexes
All bipyridine ligands were available commercially and used without further purification.
6.3.1 Synthesis of the {Cr(NN)2Cl2}Cl- type precursors
6.3.1.1 [Cr(bpy)2Cl2]Cl
Cr
N
N
N
N Cl
+
Cl-
Cl
Anhydrous CrCl3 (3.00 g, 18.9 mmol) and bpy (9.40 g, 60.2 mmol) were suspended in EtOH
(100 ml). The reaction mixture was heated to reflux, and then traces of zinc powder were added.
After a short time, the mixture turned black. The reaction was heated at reflux for 2.5 h, then
the reaction mixture was cooled in an ice bath, yielding a green precipitate. The precipitate
was recrystallised from water and filtered hot. [Cr(bpy)2Cl2]Cl was isolated as a pale brown
solid (2.99 g, 9.52 mmol, 50.3 %).
IR: (solid, ν/cm−1) 648 (w), 654 (m), 669 (m), 730 (s), 741 (w), 765 (s), 770 (s), 804 (s), 821
(s), 852 (w), 904 (w), 1015 (w), 1033 (m), 1113 (w), 1175 (w), 1242 (w), 1280 (w), 1321 (w),
1430 (w), 1446 (m), 1472 (w), 1504 (w), 1568 (w), 1606 (m), 3119 (w).
6.3.1.2 [Cr(phen)2Cl2]Cl
Cr
Cl
+
Cl-
Cl
N
N
N
N
Anhydrous CrCl3 (3.00 g, 18.9 mmol) and phen (10.3 g, 56.8 mmol) were suspended in EtOH
(100 ml). The reaction mixture was heated to reflux, and then zinc powder (18.6 mg, 0.284
mmol) was added. After a short time, the mixture turned black. The reaction was heated at
reflux for 30 min, then the reaction mixture was cooled to 0 ◦C, yielding a green precipitate.
The precipitate was recrystallised from water and filtered hot. [Cr(phen)2Cl2]Cl was isolated
as a greyish solid (8.36 g, 16.1 mmol, 85.0 %).
IR: (solid, ν/cm−1)513 (s), 654 (w), 717 (s), 740 (m), 784 (w), 830 (w), 851 (s), 876 (m), 913
(w), 1107 (w), 1151 (w), 1211 (w), 1308 (w), 1341 (w), 1425 (m), 1519 (m), 1581 (w), 1606 (w),
1630 (w), 3044 (w), 3351 (w).
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6.3.1.3 [Cr(5,5′-Me2bpy)2Cl2]Cl
Cr
N
N
N
N Cl
+
Cl-
Cl
Anhydrous CrCl3 (516 mg, 3.26 mmol) and 5,5′-Me2bpy (1.50 g, 8.14 mmol) were suspended
in EtOH (15 ml). The reaction mixture was heated to reflux, and then zinc powder (3.19
mg, 0.0488 mmol) was added. After a short time, the mixture turned black. The reaction
was heated at reflux for 45 min, then the reaction mixture was cooled to room temperature,
yielding a green precipitate. The precipitate was recrystallised from water and filtered hot.
[Cr(5,5′-Me2bpy)2Cl2]Cl was isolated as a bark green solid (526 mg, 1.33 mmol, 40.9 %).
MS: (ESI, m/z): 490.1 [M-Cl]+ (calc. 490.08). IR: (solid, ν/cm−1) 651 (m), 662 (s), 670 (m),
727 (s), 768 (w), 826 (m), 852 (s), 857 (w), 918 (w), 927 (w), 999 (m), 1003 (w), 1040 (m), 1056
(s), 1060 (w), 1144 (m), 1146 (w), 1155 (w), 1232 (m), 1251 (m), 1295 (w), 1320 (m), 1390 (m),
1447 (w), 1474 (m), 1504 (m), 1578 (m), 1599 (w), 1610 (w), 2953 (w), 3013 (w). EA: Found
C 53.96, H 4.44, N 10.38; C24H24Cl3CrN4·0.5H2O requires C 53.80, H 4.70, N 10.46.
6.3.1.4 [Cr(4,4′-Me2bpy)2Cl2]Cl
Cr
N
N
N
N Cl
+
Cl-
Cl
Anhydrous CrCl3 (573 mg, 3.62 mmol) and 4,4′-Me2bpy (2.00 g, 10.9 mmol) were suspended
in EtOH (20 ml). The reaction mixture was heated to reflux, and then zinc powder (3.55
mg, 0.0543 mmol) was added. After a short time, the mixture turned black. The reaction
was heated at reflux for 20 min, then the reaction mixture was cooled at room temperature,
yielding a green precipitate. The precipitate was recrystallised from water and filtered hot.
[Cr(4,4′-Me2bpy)2Cl2]Cl was isolated as a greyish solid (415 mg, 0.788 mmol, 21.8 %).
MS: (ESI, m/z): 490.2 [M-Cl]+ (calc. 490.08). IR: (solid, ν/cm−1) 562 (m), 828 (s), 903 (m),
926 (m), 1028 (s), 1239 (s), 1243 (m), 1279 (m), 1308 (m), 1377 (w), 1411 (m), 1412 (m), 1484
(m), 1486 (m), 1553 (m), 1615 (s), 3005 (w), 3398 (w). EA: Found C 52.46, H 4.96, N 10.53;
C24H24Cl3CrN4·H2O requires C 52.91, H 4.70, N 10.46.
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6.3.2 Synthesis of the {Cr(NN)2(CF3SO3)2}(CF3SO3)- type precursors
6.3.2.1 [Cr(bpy)2(CF3SO3)2][CF3SO3]
Cr
N
N
N
N O3SCF3
+
CF3SO3-
O3SCF3
[Cr(bpy)2Cl2]Cl (1.00 g, 2.13 mmol) was dissolved in CF3SO3H (5.0 ml, 56 mmol) and the dark
red solution was stirred overnight at room temperature. The reaction was then cooled to 0
◦C and Et2O (90 ml) was added, yielding an orange precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(bpy)2(CF3SO3)2][CF3SO3]
was isolated as a pale orange solid (1.66 g, 2.05 mmol, 96.2 %).
IR: (solid, ν/cm−1) 621 (s), 633 (s), 727 (s), 768 (s), 772 (m), 971 (m), 998 (s), 1013 (s), 1030
(s), 1074 (w), 1151 (m), 1159 (s), 1177 (m), 1192 (m), 1198 (m), 1234 (m), 1261 (m), 1274 (m),
1343 (s), 1448 (m), 1474 (m), 1503 (w), 1570 (w), 1605 (m), 1700 (w).
6.3.2.2 [Cr(phen)2(CF3SO3)2][CF3SO3]
Cr
O3SCF3
+
CF3SO3-
O3SCF3
N
N
N
N
[Cr(phen)2Cl2]Cl (1.50 g, 2.89 mmol) was dissolved in CF3SO3H (7.0 ml, 79 mmol) and the
dark red solution was stirred overnight at room temperature. The reaction was then cooled to
0 ◦C and Et2O (90 ml) was added, yielding a dark red precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(phen)2(CF3SO3)2][CF3SO3]
was isolated as a pale purple solid (1.98 g, 2.83 mmol, 97.9 %).
IR: (solid, ν/cm−1) 632 (s), 720 (s), 741 (m), 848 (s), 877 (m), 1026 (s), 1109 (s), 1145 (s),
1221 (s), 1241 (s), 1285 (s), 1415 (w), 1428 (m), 1497 (w), 1522 (m), 1585 (w), 1609 (w), 1636
(w), 3066 (w), 3101 (w), 3294 (w).
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6.3.2.3 [Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3]
Cr
N
N
N
N O3SCF3
+
CF3SO3-
O3SCF3
[Cr(5,5′-Me2bpy)2Cl2]Cl (112 mg, 0.213 mmol) was dissolved in CF3SO3H (0.5 ml, 6 mmol) and
the dark red solution was stirred overnight at room temperature. The reaction was then cooled
to 0 ◦C and Et2O (50 ml) was added, yielding an orange precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3]
was isolated as an orange solid (121 mg, 0.172 mmol, 80.6 %).
IR: (solid, ν/cm−1) 631 (s), 667 (w), 725 (m), 759 (m), 833 (m), 839 (m), 852 (m), 1021 (s),
1059 (m), 1161 (s), 1200 (m), 1230 (m), 1287 (m), 1311 (m), 1393 (w), 1475 (m), 1605 (w),
2852 (w), 3045 (w), 3363 (w). EA: Found C 35.22, H 3.62, N 6.33; C27H24CrF9N4O9S3·2H2O
requires C 35.88, H 3.12, N 6.20.
6.3.2.4 [Cr(4,4′-Me2bpy)2(CF3SO3)2][CF3SO3]
Cr
N
N
N
N O3SCF3
+
CF3SO3-
O3SCF3
[Cr(4,4′-Me2bpy)2Cl2]Cl (350 mg, 0.664 mmol) was dissolved in CF3SO3H (1.5 ml, 17 mmol) and
the dark red solution was stirred overnight at room temperature. The reaction was then cooled
to 0 ◦C and Et2O (100 ml) was added, yielding a dark red precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(4,4′-Me2bpy)2(CF3SO3)2][CF3SO3]
was isolated as an orange solid (391 mg, 0.551 mmol, 82.9 %).
IR: (solid, ν/cm−1) 512 (s), 567 (s), 628 (s), 729 (w), 759 (m), 821 (m), 827 (m), 926 (w),
1020 (s), 1153 (s), 1170 (s), 1203 (s), 1234 (m), 1294 (s), 1416 (w), 1445 (w), 1486 (w),
1500 (w), 1553 (w), 1616 (m), 1625 (m), 2964 (w). EA: Found C 35.98, H 3.27, N 6.47;
C27H24CrF9N4O9S3·1.5H2O requires C 36.25, H 3.04, N 6.26.
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6.3.3 Synthesis of the {Cr(NN)3} complexes
6.3.3.1 [Cr(bpy)3][PF6]3
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(bpy)2Cl2]Cl (188 mg, 0.399 mmol) was dissolved in CF3SO3H (1.4 ml, 16 mmol) and the
dark red solution was stirred at room temperature overnight. The reaction was then cooled to
0 ◦C and Et2O (20 ml) was added, yielding a dark red precipitate of [Cr(bpy)2(CF3SO3)2][CF3SO3].
This was separated by filtration onto a Schlenk frit, was washed with Et2O and dried under
a flow of N2. The flask attached to the Schlenk frit was replaced by a two necked round-
bottom flask containing solid bpy (68.7 mg, 0.440 mmol). MeCN (25 ml) was used to dissolve
[Cr(bpy)2(CF3SO3)2][CF3SO3] and transfer it to the reaction flask. The reaction mixture was
heated at reflux for 4 h and the colour changed to yellow-orange. Solvent was evaporated, the
residue redissolved in MeOH (3 ml) and the mixture was sonicated for 20 min. The solution
was then filtered and the filtrate poured into a MeOH solution of excess NH4PF6. The yellow
precipitate formed was separated by filtration, and was washed with Et2O. [Cr(bpy)3][PF6]3
was isolated as a pale yellow powder (233 mg, 0.244 mmol, 61.0 %).
IR: (solid, ν / cm−1) 648 (w), 654 (m), 669 (m), 731 (s), 742 (w), 766 (s), 771 (s), 804 (s), 822
(s), 852 (w), 905 (w), 1015 (w), 1034 (m), 1114 (w), 1176 (w), 1242 (w), 1281 (w), 1321 (w),
1430 (w), 1447 (m), 1473 (w), 1504 (w), 1568 (w), 1607 (m), 3120 (w). UV-VIS I: (MeCN, 1.0
× 10−5 mol dm−3) λ / nm 235 sh ( / dm3 mol−1 cm−1 41300), 244 sh (34400), 265 (18000),
277 (16400), 306 sh (23700), 313 (25500), 345 (8900), 363 (5400). UV-VIS II:(H2O, 1.0 ×
10−5 mol dm−3) λ / nm 234 sh ( / dm3 mol−1 cm−1 27750), 276 (10750), 310 (19250), 344
sh (5350), 358 sh (3550), 420 (350). EA: Found C 37.65, H 2.68, N 8.81; C30H24CrF18N6P3
requires C 37.71, H 2.53, N 8.80.
6.3.3.2 [Cr(bpy)2(phen)][PF6]3
Cr
N
N
N
N
N
N
3+
3PF6-
[Cr(bpy)2(CF3SO3)2][CF3SO3] (50.0 mg, 0.0616 mmol) and phen (27.3 mg, 0.173 mmol) were
suspended in CH2Cl2 (5 ml). The reaction mixture was heated at reflux (10 h) and a yellow
precipitate formed. This was separated by filtration, dissolved in H2O (20 ml) and precipitated
with an excess of NH4PF6. The yellow precipitate that formed was separated by filtration,
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and was washed with Et2O. [Cr(bpy)2(phen)][PF6]3 was isolated as a yellow powder. The bulk
sample could not be obtained pure, but an X-ray structure could be determined (2.5.2, p. 29).
6.3.3.3 [Cr(bpy)2(5,5
′-Me2bpy)][PF6]3
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(bpy)2(CF3SO3)2][CF3SO3] (200 mg, 0.246 mmol) and 5,5′-Me2bpy (47.8 mg, 0.259 mmol)
were dissolved in MeCN (15 ml). The reaction mixture was heated at reflux for 6 h and the
colour changed to yellow-orange. Solvent was evaporated, the residue redissolved in water (4
ml) and the mixture was sonicated for 20 min. The solution was then filtered and the filtrate
poured into an aqueous solution of excess NH4PF6. The yellow precipitate that formed was
separated by filtration, and was washed with Et2O. [Cr(bpy)3][PF6]3 was isolated as a yellow
powder (191 mg, 0.194 mmol, 79.1 %).
IR: (solid, ν/cm−1) 554 (m), 752 (m), 800 (s), 928 (w), 1033 (m), 1224 (w), 1251 (w), 1280 (w),
1311 (w), 1417 (w), 1484 (w), 1499 (w), 1555 (w), 1616 (m), 3098 (w), 3658 (w). UV-VIS:
(H2O, 1.0 × 10−5 mol dm−3) λ / nm 237 sh ( / dm3 mol−1 cm−1 32400), 313 (20750), 324
sh (13700), 358 sh (4400). EA: Found C 38.83, H 2.90, N 8.50; C32H28CrF18N6P3 requires C
39.08, H 2.87, N 8.55.
6.3.3.4 [Cr(bpy)2(4,4
′-Me2bpy)][PF6]3
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(bpy)2(CF3SO3)2][CF3SO3] (169 mg, 0.208 mmol) and 4,4′-Me2bpy (40.4 mg, 0.219 mmol)
were dissolved in MeCN (12 ml). The reaction mixture was heated at reflux for 5 h 45 min and
the colour changed to yellow. Solvent was evaporated, the residue redissolved in water (3 ml)
and the mixture was sonicated for 20 min. The solution was then filtered and the filtrate poured
into an aqueous solution of excess NH4PF6. The yellow precipitate that formed was separated
by filtration, and was washed with Et2O. [Cr(bpy)3][PF6]3 was isolated as a yellow powder (139
mg, 0.141 mmol, 57.5 %). IR: (solid, ν/cm−1) 652 (w), 668 (w), 730 (m), 740 (m), 764 (m), 817
(s), 1033 (m), 1111 (w), 1169 (w), 1241 (w), 1321 (w), 1447 (m), 1473 (m), 1501 (m), 1598 (w),
1606 (m), 3098 (w). EA: Found C 37.86, H 2.90, N 8.48; C32H28CrF18N6P3·1.5H2O requires C
6.3. SYNTHESIS OF TRIS(DIIMINE)CHROMIUM(III) COMPLEXES 137
38.03, H 3.09, N 8.32.
6.3.3.5 [Cr(phen)3][PF6]3
Cr
N
N
N
N
N
N
3+
3PF6-
[Cr(phen)2(CF3SO3)2][CF3SO3] (280 mg, 0.400 mmol) and phen (144 mg, 0.800 mmol) was
suspended in CH2Cl2 (12 ml). The reaction mixture was heated at 110 ◦C and 10 bar in the
microwave reactor (1 h 30 min) and a yellow precipitate formed. This was separated by filtration
and washed with CH2Cl2. Then the intermediate was dissolved in H2O (20 ml), filtered and
precipitated with an excess of NH4PF6. The yellow precipitate that formed was separated by
filtration, and was washed with H2O and Et2O. The precipitate was recrystallised from water.
[Cr(phen)3][PF6]3 was isolated as a yellow powder (0.116 mg, 0.113 mmol, 28.3 %).
IR: (solid, ν/cm−1) 554 (s), 656 (m), 713 (m), 717 (m), 822 (s), 880 (m), 1112 (w), 1155 (w),
1227 (w), 1312 (w), 1416 (w), 1429 (m), 1524 (m), 1584 (w), 1609 (w), 1636 (w), 3110 (w), 3570
(w). UV-VIS: (MeCN, 1.0 × 10−5 mol dm−3) λ / nm 211 sh ( / dm3 mol−1 cm−1 82700),
222 sh (76900), 268 (57500), 283 sh (35850), 352 (3300), 322 (10800). EA: Found C 41.58, H
2.31, N 7.96; C36H24CrF18N6P3·0.5H2O requires C 41.72, H 2.43, N 8.11.
6.3.3.6 [Cr(phen)2(5,5
′-Me2bpy)][PF6]3
Cr
N
N
N
N
N
N
3+
3PF6-
[Cr(phen)2(CF3SO3)2][CF3SO3] (280 mg, 0.400 mmol) and 5,5′-Me2bpy (88.4 mg, 0.480 mmol)
were suspended in CH2Cl2 (12 ml). The reaction mixture was heated at 110 ◦C and 10 bar in
the microwave reactor (1 h) and a yellow precipitate formed. This was separated by filtration,
dissolved in H2O (20 ml) and precipitated with an excess of NH4PF6. The yellow precipitate
that formed was separated by filtration, and was washed with Et2O. The precipitate was re-
crystallised from water and filtered hot. The precipitate was then dissolved in a small amount
of acetone, filtered and overlaid with Et2O. [Cr(phen)2(5,5′-Me2bpy)][PF6]3 was isolated as a
yellow powder (65.4 mg, 0.0634 mmol, 19.5 %).
IR: (solid, ν/cm−1) 554 (m), 658 (w), 702 (m), 716 (m), 725 (m), 742 (m), 754 (m), 769 (m),
777 (m), 780 (m), 827 (s), 879 (m), 1063 (m), 1113 (m), 1156 (m), 1227 (w), 1246 (w), 1319
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(w), 1432 (m), 1478 (m), 1523 (m), 1584 (w), 1605 (w), 1634 (w), 3099 (w). UV-VIS: (H2O,
1.0 × 10−5 mol dm−3) λ / nm 226 sh ( / dm3 mol−1 cm−1 55650), 268 (41400), 284 sh (25350),
326 sh (12200), 362 sh (4000). EA: Found C 41.77, H 2.64, N 8.13; C36H28CrF18N6P3 requires
C 41.92, H 2.74, N 8.15.
6.3.3.7 [Cr(phen)2(4,4
′-Me2bpy)][PF6]3
Cr
N
N
N
N
N
N
3+
3PF6-
[Cr(phen)2(CF3SO3)2][CF3SO3] (405 mg, 0.471 mmol) and 4,4′-Me2bpy (117 mg, 0.637 mmol)
were dissolved in MeCN (30 ml). The reaction mixture was heated at reflux for 5 h 15 min and
the colour changed to yellow. Solvent was evaporated, the residue redissolved in MeOH (4 ml)
and the mixture was sonicated for 20 min. The solution was then filtered and the filtrate poured
into a MeOH solution of excess NH4PF6. The beige precipitate that formed was separated by
filtration, and was washed with Et2O. [Cr(phen)2(4,4′-Me2bpy)][PF6]3 was isolated as a beige
powder (314 mg, 0.305 mmol, 64.7 %).
IR: (solid, ν/cm−1) 554 (s), 635 (m), 719 (m), 741 (m), 823 (s), 879 (w), 1032 (m), 1113 (w),
1153 (w), 1225 (w), 1255 (m), 1285 (w), 1429 (m), 1522 (m), 1616 (w), 3108 (w). UV-VIS:
(H2O, 1.0 × 10−5 mol dm−3) λ / nm 226 sh ( / dm3 mol−1 cm−1 70800), 273 (48450), 304 sh
(19050), 360 sh (3370). EA: Found C 41.37, H 2.90, N 7.99; C36H28CrF18N6P3·0.5H2O requires
C 41.55, V 2.81, N 8.07.
6.3.3.8 [Cr(5,5′-Me2bpy)3][PF6]3
Cr
N
N
N
N N
N
3+
3PF6-
[Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3] (189 mg, 0.219 mmol) and 5,5′-Me2bpy (51.7 mg, 0.281
mmol) were dissolved in MeCN (15 ml). The reaction mixture was heated at reflux for 4h 20
min and the colour changed to yellow. Solvent was evaporated, the residue redissolved in MeOH
(6 ml) and the mixture was sonicated for 20 min. The solution was then filtered and an excess
of NH4PF6 was added. The yellow precipitate that formed was separated by filtration, and was
washed with Et2O. [Cr(5,5′-Me2bpy)3][PF6]3 was isolated as a yellow powder (193 mg, 0.186
mmol, 85.4 %).
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IR: (solid, ν/cm−1) 666 (m), 722 (m), 759 (w), 816 (s), 827 (s), 1060 (m), 1169 (w), 1237 (w),
1246 (w), 1319 (w), 1386 (w), 1448 (w), 1476 (m), 1510 (w), 1607 (w), 1700 (w), 2366 (w).
UV-VIS: (H2O, 1.0 × 10−5 mol dm−3) λ / nm 245 ( / dm3 mol−1 cm−1 46350), 293 (22750),
325 sh (26650), 377 sh (4550). EA: Found C 41.49, H 3.37, N 8.13; C36H36CrF18N6P3 requires
C 41.59, H 3.49, N 8.08.
6.3.3.9 [Cr(5,5′-Me2bpy)2(phen)][PF6]3
Cr
N
N
N
N
3+
3PF6-
N
N
[Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3] (159 mg, 0.183 mmol) and phen (42.6 mg, 0.237 mmol)
were dissolved in MeCN (12 ml). The reaction mixture was heated at reflux for 3 h and the
colour changed to yellow. Solvent was evaporated, the residue redissolved in water (5 ml) and
the mixture was sonicated for 20 min. The solution was then filtered and an excess of NH4PF6
was added. The yellow precipitate that formed was separated by filtration, and was washed
with Et2O. [Cr(5,5′-Me2bpy)3][PF6]3 was isolated as a yellow powder (118 mg, 0.114 mmol,
62.2 %).
IR: (solid, ν/cm−1) 555 (s), 620 (m), 638 (m), 659 (m), 667 (m), 717 (s), 726 (s), 742 (m), 814
(s), 879 (w), 1031 (w), 1060 (w), 1113 (w), 1147 (m), 1163 (m), 1238 (m), 1288 (w), 1318 (w),
1386 (w), 1417 (w), 1431 (w), 1447 (w), 1453 (w), 1457 (w), 1477 (m), 1509 (w), 1524 (w), 1547
(w), 1585 (w), 1609 (w), 3101 (w). EA: Found C 42.02, H 3.28, m 8.06; C36H32CrF18N6P3
requires C 41.75, H 3.11, N 8.12.
6.3.3.10 [Cr(5,5′-Me2bpy)2(4,4′-Me2bpy)][PF6]3
Cr
N
N
N
N
3+
3PF6-
N
N
[Cr(5,5′-Me2bpy)2(CF3SO3)2][CF3SO3] (80.0 mg, 0.0922 mmol) and 4,4′-Me2bpy (21.9 mg,
0.119 mmol) were dissolved in MeCN (12 ml). The reaction mixture was heated at reflux
for 7 h and the colour changed to yellow. Solvent was evaporated, the residue redissolved in
water (3 ml) and the mixture was sonicated for 30 min. The solution was then filtered and an
excess of NH4PF6 was added. The yellow precipitate that formed was separated by filtration,
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and was washed with Et2O. [Cr(5,5′-Me2bpy)2(4,4′-Me2bpy)][PF6]3 was isolated as a yellow
powder (55.8 mg, 0.0537 mmol, 58.2 %).
IR: (solid, ν/cm−1) 557 (s), 668 (m), 701 (w), 723 (m), 726 (m), 820 (s), 1035 (w), 1060 (w),
1161 (w), 1237 (w), 1286 (w), 1319 (w), 1394 (w), 1437 (w), 1476 (m), 1505 (w), 1615 (w), 3075
(w). EA: found C 41.17, H 3.63, N 7.91; C36H36CrF18N6P3·0.5H2O requires C 41.23, H 3.56,
N 8.01.
6.3.3.11 [Cr(4,4′-Me2bpy)2(bpy)][PF6]3
Cr
N
N
N
N
3+
3PF6-
N
N
[Cr(4,4′-Me2bpy)2(CF3SO3)2][CF3SO3] (46.4 mg, 0.0535 mmol) and bpy (10.4 mg, 0.0667 mmol)
were dissolved in MeCN (5 ml). The reaction mixture was heated at reflux (9 h) and the colour
changed to yellow. Solvent was evaporated, the residue redissolved in water (1 ml) and the
mixture was sonicated for 30 min. The solution was then filtered and an excess of NH4PF6 was
added. The yellow precipitate that formed was separated by filtration, and was washed with
Et2O. [Cr(4,4′-Me2bpy)2(bpy)][PF6]3 was isolated as a yellow-orange powder (10.7 mg, 0.0106
mmol, 19.8 %).
EA: Found C 39.72, H 3.30, N 8.25; C34H32CrF18N6P3·0.5H2O requires C 40.01, H 3.26, N
8.23.
6.3.3.12 [Cr(4,4′-Me2bpy)2(5,5′-Me2bpy)][PF6]3
Cr
N
N
N
N
3+
3PF6-
N
N
[Cr(4,4′-Me2bpy)2(CF3SO3)2][CF3SO3] (81.0 mg, 0.093 mmol) and 4,4′-Me2bpy (22.1 mg, 0.120
mmol) were dissolved in MeCN (12 ml). The reaction mixture was heated at reflux for 6 h 20
min and the colour changed to yellow. Solvent was evaporated, the residue redissolved into
water (2 ml) and the mixture was sonicated for 20 min. The solution was then filtered and the
filtrate poured in an aqueous solution of excess NH4PF6. The yellow precipitate that formed
was separated by filtration, and was washed with Et2O. [Cr(4,4′-Me2bpy)2(5,5′-Me2bpy)][PF6]3
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was isolated as a yellow-orange powder (72.4 mg, 0.0696 mmol, 74.6 %).
IR: (solid, ν/cm−1) 554 (s), 740 (m), 818 (s), 928 (w), 1032 (m), 1164 (w), 1248 (w), 1282 (w),
1415 (w), 1478 (w), 1556 (w), 1616 (m), 1738 (w), 3082 (w), 3648 (w). EA: Found C 41.15, H
3.65, N 8.00; C36H36CrF18N6P3·0.5H2O requires C 41.23, H 3.56, N 8.01.
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6.4 Synthesis of bis(terpyridine)chromium(III) complexes
6.4.1 Synthesis of the precursors of type: {Cr(tpy)Cl3}
All reactions were performed under inert conditions (N2). For the reaction steps dry solvents
(crown cap) form Sigma Aldrich were used. Anhydrous CrCl3 was obtained from Acros Organics
and used as received.
6.4.1.1 [Cr(tpy)Cl3]
N
N
N
Cl
Cl
Cl
Cr
Anhydrous CrCl3 (185 mg, 1.15 mmol) and tpy (350 mg, 1.50 mmol) were suspended in EtOH
(10 ml). The reaction mixture was heated to reflux, and then granulated zinc (21.0 mg, 0.320
mmol) was added. After a short time, the mixture turned black and a green precipitate was
formed. The reaction was heated at reflux for 6.5 h, then the reaction mixture was filtered,
leaving excess zinc behind in the reaction flask. The green precipitate collected on the filter-frit
was washed with EtOH. [Cr(tpy)Cl3] (415 mg, 1.06 mmol, 91.7 %) was used in the next step
without further purification.
IR: (solid, ν/cm−1) 453 (m), 489 (w), 513 (w), 558 (m), 654 (s), 675 (w), 734 (m), 783 (vs),
827 (w), 889 (w), 905 (w), 926 (w), 980 (w), 1025 (s), 1040 (m), 1050 (m), 1069 (w), 1099 (w),
1137 (w), 1158 (m), 1171 (w), 1186 (w), 1242 (m), 1291 (w), 1302 (w), 1317 (m), 1402 (w),
1446 (s), 1475 (s), 1500 (w), 1572 (w), 1600 (w), 3064 (w). EA: Found C 46.01, H 3.00, N
11.00; C15H11Cl3CrN3 requires C 46.00, H 2.83, N 10.73.
6.4.1.2 [Cr(4′-(4-tolyl)tpy)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (761 mg, 4.76 mmol) and 4′-(4-tolyl)tpy (2.00 g, 6.18 mmol) suspended in EtOH (60
ml). Granulated zinc (68.2 mg, 1.05 mmol) was added and heated at reflux for 4 h 15 min.
[Cr(4′-(4-tolyl)tpy)Cl3] was used in the next step without further purification.
IR: (solid, ν/cm−1) 501 (s), 519 (m), 612 (w), 650 (w), 661 (s), 690 (s), 695 (s), 719 (w), 728
(s), 751 (s), 790 (s), 827 (w), 834 (s), 890 (m), 899 (w), 1017 (w), 1026 (s), 1034 (w), 1066 (w),
1078 (w), 1099 (w), 1186 (w), 1205 (m), 1244 (s), 1262 (w), 1271 (w), 1289 (w), 1338 (m), 1367
(w), 1411 (m), 1436 (w), 1446 (w), 1467 (m), 1489 (m), 1520 (m), 1547 (w), 1568 (m), 1576
6.4. SYNTHESIS OF BIS(TERPYRIDINE)CHROMIUM(III) COMPLEXES 143
(s), 1582 (s), 1603 (m), 3059 (w), 3061 (w), 3998 (w). EA: Found C 54.96, H 3.86, N 8.58;
C22H17Cl3CrN3 requires C 54.85, H 3.56, N 8.72.
6.4.1.3 [Cr(LT1)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (168 mg, 1.05 mmol) and 4′-(4-(tert-butyl)phenyl)-2,2′:6′,2′′-terpyridine (LT1) (500 mg,
1.37 mmol) suspended in EtOH (15 ml). Granulated zinc (15.1 mg, 0.231 mmol) was added and
heated at reflux for 6 h. [Cr(LT1)Cl3] was used in the next step without further purification.
IR: (solid, ν/cm−1) 545 (m), 651 (w), 660 (m), 684 (w), 718 (w), 731 (m), 758 (m), 797 (s),
829 (w), 895 (w), 981 (w), 1012 (w), 1025 (s), 1043 (w), 1066 (w), 1099 (w), 1120 (w), 1165
(w), 1206 (w), 1213 (w), 1248 (w), 1277 (w), 1303 (w), 1363 (w), 1406 (m), 1432 (w), 1464 (w),
1475 (m), 1549 (w), 1601 (s), 2870 (w), 2908 (w), 2964 (w), 3069 (w). EA: Found C 57.04, H
4.68, N 8.05; C25H23Cl3CrN3 requires C 57.32, H 4.43, N 8.02.
6.4.1.4 [Cr(LT2)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (188 mg, 1.18 mmol) and 4′-([1,1′-biphenyl]-4-yl)-2,2′:6′,2′′-terpyridine (LT2) (590 mg,
1.53 mmol) suspended in EtOH (15 ml). Granulated zinc (16.9 mg, 0.259 mmol) was added
and heated at reflux for 5 h 15 min. [Cr(LT2)Cl3] was used in the next step without further
purification.
IR: (solid, ν/cm−1) 509 (s), 625 (w), 659 (w), 689 (m), 730 (m), 741 (w), 766 (m), 792 (s), 825
(w), 841 (w), 846 (w), 887 (w), 898 (w), 971 (w), 1004 (w), 1026 (m), 1036 (w), 1051 (w), 1067
(w), 1095 (w), 1163 (w), 1209 (w), 1243 (w), 1302 (w), 1366 (w), 1402 (w), 1424 (w), 1448 (w),
1471 (w), 1491 (w), 1542 (w), 1565 (w), 1598 (m), 1613 (w), 3060 (w), 3569 (w), 3991 (m).
EA: Found C 58.87, H 3.83, N 7.74; C27H19Cl3CrN3·0.5H2O requires C 58.66, H 3.65, N 7.60.
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6.4.1.5 [Cr(LT3)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (188 mg, 1.18 mmol) and 4′-(naphthalen-2-yl)-2,2′:6′,2′′-terpyridine (LT3) (550 mg, 1.53
mmol) suspended in EtOH (15 ml). Granulated zinc (16.9 mg, 0.259 mmol) was added and
heated at reflux for 6 h. [Cr(LT3)Cl3] was used in the next step without further purification.
IR: (solid, ν/cm−1) 500 (s), 502 (s), 506 (s), 577 (m), 607 (m), 651 (m), 659 (s), 666 (w), 690
(s), 721 (w), 728 (s), 751 (s), 763 (m), 772 (m), 775 (m), 787 (s), 817 (s), 865 (s), 883 (m), 891
(m), 904 (w), 947 (w), 956 (w), 969 (w), 1005 (w), 1026 (s), 1034 (m), 1043 (w), 1051 (w), 1066
(w), 1093 (w), 1104 (w), 1161 (w), 1168 (w), 1203 (w), 1223 (w), 1249 (m), 1290 (w), 1302 (w),
1347 (w), 1362 (w), 1381 (w), 1418 (m), 1442 (m), 1456 (w), 1475 (s), 1548 (m), 1565 (m), 1601
(s), 3062 (w), 3383 (w), 3995 (m). EA: Found C 55.54, H 3.63, N 7.78; C25H17Cl3CrN3·1.5H2O
requires C 55.12, H 3.70, N 7.71.
6.4.1.6 [Cr(5,5′′-Me2tpy)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (72.3 mg, 0.452 mmol) and 5,5′′-dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy) (130 mg,
0.497 mmol) suspended in EtOH (9 ml). Granulated zinc (6.50 mg, 99.5 µmol) was added
and heated at reflux for 6 h. [Cr(5,5′′-Me2tpy)Cl3] was used in the next step without further
purification.
EA: Found C 48.02, H 3.80, N 10.00; C17H15Cl3CrN3·0.5H2O requires C 47.63, H 3.76, N 9.80.
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6.4.1.7 [Cr(LT4)Cl3]
N
N
N
Cl
Cl
Cl
Cr
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (124 mg, 0.854 mmol) and 6,6′′-dimethyl-4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (LT4) (300
mg, 0.776 mmol) suspended in EtOH (12.5 ml). Granulated zinc (11.2 mg, 0.171 mmol) was
added and heated at reflux for 7 h 45 min. [Cr(LT4)Cl3] was used in the next step without
further purification.
IR: (solid, ν/cm−1) 584 (m), 632 (m), 658 (s), 674 (w), 711 (w), 744 (m), 751 (m), 767 (m),
797 (s), 811 (s), 892 (m), 904 (w), 943 (w), 959 (w), 991 (w), 1002 (w), 1010 (m), 1018 (m),
1036 (m), 1048 (w), 1119 (w), 1128 (w), 1163 (w), 1175 (m), 1191 (w), 1229 (w), 1243 (w),
1373 (w), 1406 (w), 1419 (w), 1428 (m), 1443 (m), 1447 (m), 1454 (m), 1483 (m), 1518 (w),
1549 (m), 1554 (m), 1569 (m), 1606 (s), 3078 (w), 3994 (m). EA: Found C 56.21, H 4.26, N
8.31; C24H21Cl3CrN3 requires C 56.54, H 4.15, N 8.24.
6.4.1.8 [Cr(LT5)Cl3]
N
N
N
Cl
Cl
Cl
CrN
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (188 mg, 1.18 mmol) and 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -diphenylaniline (LT5) (731
mg, 1.53 mmol) suspended in EtOH (15 ml). Granulated zinc (16.9 mg, 0.259 mmol) was
added and heated at reflux for 6 h. [Cr(LT5)Cl3] was used in the next step without further
purification.
IR: (solid, ν/cm−1) 501 (s), 519 (m), 612 (w), 650 (w), 661 (s), 690 (s), 695 (s), 719 (w), 728
(s), 751 (s), 790 (s), 827 (w), 834 (s), 890 (m), 899 (w), 1017 (w), 1026 (s), 1034 (w), 1066 (w),
1078 (w), 1099 (w), 1186 (w), 1205 (m), 1244 (s), 1262 (w), 1271 (w), 1289 (w), 1338 (m), 1367
(w), 1411 (m), 1436 (w), 1446 (w), 1467 (m), 1489 (m), 1520 (m), 1547 (w), 1568 (m), 1576
(s), 1582 (s), 1603 (m), 3059 (w), 3061 (w), 3998 (w). EA: Found C 62.57, H 4.07, N 9.07;
C33H24Cl3CrN4 requires C 62.43, H 3.81, N 8.82.
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6.4.1.9 [Cr(LT11)Cl3]
N
N
N
Cl
Cl
Cl
CrN
The compound was prepared by the same method as [Cr(tpy)Cl3], starting with anhydrous
CrCl3 (185 mg, 1.15 mmol) and 4′-(pyridin-4-yl)-2,2′:6′,2′′-terpyridine (LT11) (430 mg, 1.39
mmol) suspended in EtOH (10 ml). Granulated zinc (7.60 mg, 0.116 mmol) was added and
heated at reflux for 6 h 15 min. [Cr(LT11)Cl3] was used in the next step without further
purification.
EA: Found C 51.28, H 3.29, N 11.71; C20H14Cl3CrN3 requires C 51.28, H 3.29, N 11.71.
6.4.2 Synthesis of the precursors of the type {Cr(tpy)(CF3SO3)3}
6.4.2.1 [Cr(tpy)(CF3SO3)3]
N
N
N
F3CSO3
O3SCF3
O3SCF3
Cr
[Cr(tpy)Cl3] (27.5 mg, 0.0700 mmol) was dissolved in CF3SO3H (0.3 ml, 2.80 mmol) and the
dark red solution was stirred overnight at room temperature. The reaction was then cooled to
0 ◦C and Et2O (20 ml) was added, yielding a dark red precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(tpy)(CF3SO3)3] was isolated
as a dark red solid (28.0 mg, 0.038 mmol, 54.2 %).
IR: (solid, ν/cm−1) 515 (s), 534 (m), 571 (m), 604 (s), 622 (vs), 661 (m), 682 (w), 734 (m),
766 (m), 777 (s), 829 (w), 905 (m), 989 (vs), 1031 (s), 1054 (w), 1096 (w), 1104 (w), 1157
(vs), 1171 (vs), 1196 (vs), 1236 (s), 1230 (w), 1309 (w), 1325 (m), 1345 (s), 1408 (w), 1450
(w), 1484 (w), 1508 (w), 1574 (w), 1605 (w), 3093 (w). EA: Found C 29.62, H 1.77, N 5.74;
C18H11CrF9N3O9S3 requires C 29.52, H 1.51, N 5.74.
6.4.2.2 [Cr(5,5′′-Me2tpy)(CF3SO3)3]
N
N
N
F3CSO3
O3SCF3
O3SCF3
Cr
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[Cr(5,5′′-Me2tpy)Cl3] (100 mg, 0.238 mmol) was dissolved in CF3SO3H (0.8 ml, 9.53 mmol) and
the dark red solution was stirred overnight at room temperature. The reaction was then cooled
to 0 ◦C and Et2O (20 ml) was added, yielding a dark red precipitate. The solid was separated
by filtration, washed with Et2O and dried under an air stream. [Cr(5,5′′-Me2tpy)(CF3SO3)3]
was isolated as a dark red solid and used for further reactions without characterisation.
6.4.2.3 [Cr(LT4)(CF3SO3)3]
N
N
N
O3SCF3
O3SCF3
O3SCF3
Cr
[Cr(LT4)Cl3] (250 mg, 0.490 mmol) was dissolved in CF3SO3H (1.7 ml, 16.6 mmol) and the
dark red solution was stirred overnight at room temperature. The reaction was then cooled to
0 ◦C and Et2O (40 ml) was added, yielding a dark red precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(LT4)(CF3SO3)3] was isolated
as a dark red solid and used for further reactions without characterisation.
6.4.2.4 [Cr(LT5)(CF3SO3)3]
N
N
N
O3SCF3
O3SCF3
O3SCF3
CrN
[Cr(LT5)Cl3] (75.0 mg, 0.118 mmol) was dissolved in CF3SO3H (0.4 ml, 4.4 mmol) and the
dark red solution was stirred overnight at room temperature. The reaction was then cooled to
0 ◦C and Et2O (20 ml) was added, yielding a dark red precipitate. The solid was separated by
filtration, washed with Et2O and dried under an air stream. [Cr(LT5)(CF3SO3)3] was isolated
as a dark red solid (72.8 mg, 0.0746 mmol, 67.8 %).
EA: Found C 43.96, H 2.71, N 6.03; C36H24CrF9N4O9S3·0.5H2O requires C 43.91, H 2.56, N
5.74.
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6.4.3 Synthesis of the bis(terpyridine)chromium(III) complexes
6.4.3.1 [Cr(tpy)2][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
[Cr(tpy)Cl3] (200 mg, 0.511 mmol) was dissolved in CF3SO3H (1.8 ml, 20.4 mmol) and the dark
red solution was stirred at room temperature overnight. The reaction was then cooled to 0 ◦C
and Et2O (20 ml) was added, yielding a dark red precipitate of [Cr(tpy)(CF3SO3)3]. This was
separated by filtration onto a Schlenk frit, was washed with Et2O and dried under a flow of
N2. The flask attached to the Schlenk frit was replaced by a two necked round-bottomed flask
containing solid 2,2′:6′,2′′-terpyridine (tpy) (131 mg, 0.562 mmol). MeCN (10 ml) was used to
dissolve [Cr(tpy)(CF3SO3)3] and transfer it to the reaction flask. The reaction mixture was
heated at reflux (3.75 h) and the colour changed to yellow-orange. Solvent was evaporated, the
residue redissolved in MeOH (2 ml) and the mixture was sonicated for 20 min. The solution
was then filtered and the filtrate poured into an MeOH solution of excess NH4PF6. The yellow
precipitate that formed was separated by filtration, and was washed with hexane and Et2O.
[Cr(tpy)2][PF6]3 was isolated as a yellow powder (278 mg, 0.292 mmol, 57.0 %).
IR: (solid, ν/cm−1) 552 (s), 555 (vs), 660 (m), 772 (s), 779 (m), 802 (m), 824 (vs), 1028 (m),
1099 (w), 1247 (w), 1325 (m), 1448 (m), 1480 (m), 1506 (w), 1560 (w), 1603 (m). MS:MALDI-
TOF m/z 809.3 [MPF6]+ (calc. 808.1). UV-VIS: (H2O, 1.0 × 10−5 mol dm−3) λ / nm 265 (ε
/ dm3 mol−1 cm−1 29400), 282 sh (21700), 324 (14400), 334 (14900), 347 (15300), 363 (16700).
EA: Found C 38.18, H 2.58, N 8.86; C30H22CrF18N6P3 requires C 37.79, H 2.33, N 8.81.
6.4.3.2 [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(4′-(4-
tolyl)tpy)Cl3] (164 mg, 0.341 mmol) and CF3SO3H (1.2 ml, 14 mmol) in the first step, and then
4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (4′-(4-tolyl)tpy) (121 mg, 0.375 mmol) and a reaction time of
6 h 20 min in the second step. The target product precipitated during the reaction. This was
filtered and recrystallised from hot MeCN. [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3 was isolated as an
orange solid (302 mg, 0.263 mmol, 77.0 %).
IR: (solid, ν/cm−1) 500 (s), 505 (s), 517 (s), 529 (m), 572 (m), 613 (m), 625 (s), 634 (s), 662
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(w), 693 (w), 727 (w), 778 (m), 788 (m), 823 (m), 949 (w), 996 (m), 1027 (s), 1097 (w), 1116
(m), 1138 (m), 1158 (s), 1210 (m), 1222 (m), 1249 (s), 1363 (w), 1406 (w), 1435 (w), 1478
(w), 1533 (w), 1539 (w), 1601 (s), 1618 (w), 3066 (w). EA: Found C 49.34, H 3.40, N 8.70;
C47H34CrF9N6O9S3·H2O requires C 49.36, H 3.27, N 8.63.
6.4.3.3 [Cr(4′-(4-tolyl)tpy)2][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
The compound was prepared by the same method as [Cr(4′-(4-tolyl)tpy)2][CF3SO3)3]3, starting
with [Cr(4′-(4-tolyl)tpy)Cl3] (193 mg, 0.400 mmol) and CF3SO3H (1.4 ml, 16 mmol) in the first
step, and then 4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (4′-(4-tolyl)tpy) (142 mg, 0.440 mmol) and a
reaction time of 6 h in the second step. In this reaction a counter ion exchange was conducted.
The crude product was dissolved in MeOH, filtered and poured into a MeOH solution of excess
NH4PF6. The resulting precipitate was filtered and washed with cold MeOH. The bulk product
could not be obtained pure, but an X-ray structure could be determined (3.9.1.4, p. 79).
6.4.3.4 [Cr(LT3)2)][PF6]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(LT3)Cl3]
(100 mg, 0.195 mmol) and CF3SO3H (0.70 ml, 7.8 mmol) in the first step, and then 4′-
(naphthalen-2-yl)-2,2′:6′,2′′-terpyridine (LT3) (77.3 mg, 0.215 mmol) and a reaction time of
7 h in the second step. The counterion [Cr(4′-(4-tolyl)tpy)2][PF6]3 was isolated as an orange
solid (302 mg, 0.263 mmol, 77.0%). The bulk product could not be obtained pure, but an X-ray
structure could be determined (3.9.1.3, p. 77).
150 CHAPTER 6. EXPERIMENTAL
6.4.3.5 [Cr(5,5′′-Me2tpy)2)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
A microwave vial was charged with [Cr(5,5′′-Me2tpy)(CF3SO3)3] (26.5 mg, 34.8 µmol), 5,5′′-
dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy) (10 mg, 38.3 µmol) and MeCN (4 ml). The re-
action was heated in the microwave reactor at 150 ◦C and 11 bar for 2 h. Then the solvent
was evaporated and the residue redissolved in MeOH. The solution was filtered into a MeOH
solution with excess of NH4PF6. The solution was stored overnight at 4 ◦C, resulting in a yellow
precipitate (16.0 mg, 15.8 µmol, 45.5 %).
EA: Found C 39.02, H 3.50, N 8.45; C34H30CrF18N6·2H2O requires C 39.05, H 3.28, N 8.03.
6.4.3.6 [Cr(LT5)2][CF3SO3)3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N N
A mixture of [Cr(LT5)(CF3SO3)3] (50.0 mg, 51.2 µmol) and 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-
N,N -diphenylaniline (LT5) (26.9 mg, 56.4 µmol) in MeCN (2 ml) was heated at reflux for 7 h.
The crude product was recrystallised from EtOH to yield a dark red precipitate (18.2 mg, 12.5
µmol, 24.4 %).
IR: (solid, ν/cm−1) 503 (s), 570 (m), 635 (s), 661 (m), 691 (m), 717 (m), 749 (m), 786 (m),
829 (m), 1026 (s), 1068 (m), 1094 (m), 1120 (m), 1142 (s), 1198 (s), 1222 (s), 1240 (s), 1332
(m), 1366 (m), 1418 (m), 1439 (m), 1476 (s), 1520 (m), 1568 (s), 1575 (s), 1605 (m), 3075 (w),
3497 (w). EA: Found C 56.24, H 3.64, N 7.83; C69H51CrF9N8S3O9· 1H2O requires C 56.24, H
3.63, N 7.61.
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6.4.3.7 [Cr(HLT11)(LT11)][PF6]4
N
N
N
N
N
N
Cr
4+
4PF6-
NN H
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(LT11)Cl3]
(200 mg, 0.427 mmol) and CF3SO3H (1.5 ml, 17 mmol) in the first step, and then 4′-(pyridin-4-
yl)-2,2′:6′,2′′-terpyridine (LT11) (146 mg, 0.469 mmol) and a reaction time of 4 h in the second
step. To remove some remaining zinc powder from the first step the solution was filtered trough
a paper filter and celite respectively. The X-ray structure confirmed that a protonated complex
was isolated. The bulk product could not be obtained pure, but a X-ray structure could be
determined (3.9.1.6, p. 81).
6.4.3.8 [Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(165 mg, 0.421 mmol) and CF3SO3H (1.5 ml, 16.9 mmol) in the first step, and then 4′-(4-
tolyl)tpy (150 mg, 0.463 mmol) and a reaction time of 4 h 40 min in the second step. [Cr(tpy)(4′-
(4-tolyl)tpy)][PF6]3 was isolated as an orange solid (304 mg, 0.291 mmol, 69.1 %).
IR: (solid, ν/cm−1) 602 (w), 660 (m), 725 (m), 741 (w), 772 (s), 789 (w), 818 (vs), 828 (vs),
1028 (m), 1038 (w), 1047 (w), 1098 (w), 1171 (w), 1249 (w), 1327 (w), 1437 (w), 1447 (w),
1482 (m), 1549 (w), 1571 (w), 1605 (m), 1700 (s). UV-VIS: (H2O, 1.0 × 10−5 mol dm−3) λ /
nm 267 (ε / dm3 mol−1 cm−1 25700), 284 (23100), 347 (24150), 363 sh (20900). EA: Found C
42.00, H 2.55, N 8.04; C37H28CrF18N6P3·MeOH requires C 42.43, H 3.00, N 7.81.
152 CHAPTER 6. EXPERIMENTAL
6.4.3.9 [Cr(tpy)(HLT11)][PF6]4
N
N
N
N
N
N
Cr N H
4+
4PF6-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(157 mg, 0.400 mmol) and CF3SO3H (1.4 ml, 16 mmol) in the first step, and then 4′-(pyridin-
4-yl)-2,2′:6′,2′′-terpyridine (LT11) (137 mg, 0.440 mmol) and a reaction time of 5 h 30 min
in the second step. The X-ray structure and the elemental analysis results indicate that the
protonated complex was isolated. [Cr(tpy)(HLT11)][PF6]4 was isolated as a yellow powder (413
mg, 0.359 mmol, 89.6 %).
IR: (solid, ν/cm−1) 503 (s), 554 (s), 619 (w), 639 (m), 661 (s), 676 (w), 728 (s), 731 (s), 772
(s), 821 (s), 1028 (s), 1101 (w), 1170 (w), 1247 (s), 1284 (w), 1329 (w), 1413 (w), 1433 (w),
1451 (w), 1482 (s), 1509 (w), 1543 (w), 1564 (w), 1573 (w), 1599 (s), 1609 (s), 1623 (w), 3109
(w), 3320 (w), 3583 (w), 3657 (w). EA: Found C 35.17, H 2.43, N 8.60; C35H26CrF24N7P4·H2O
requires C 35.22, H 2.28, N 8.22.
6.4.3.10 [Cr(tpy)(LT7)][PF6]4
N
N
N
N
N
N
Cr CN
3+
3PF6-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(202 mg, 0.516 mmol) and CF3SO3H (1.8 ml, 21 mmol) in the first step, and then 4′-(4-
isocyanophenyl)-2,2′:6′,2′′-terpyridine (LT7) (190 mg, 0.567 mmol) and a reaction time of 4 h
30 min in the second step. The bulk product could not be obtained pure, but an X-ray structure
could be determined (3.9.2.3, p. 87).
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6.4.3.11 [Cr(tpy)(LT8)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
O
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(202 mg, 0.516 mmol) and CF3SO3H (1.8 ml, 21 mmol) in the first step, and then 4′-(furan-2-
yl)-2,2′:6′,2′′-terpyridine (LT8) (170 mg, 0.567 mmol) and a reaction time of 7 h 15 min in the
second step. The bulk product could not be obtained pure, but an X-ray structure could be
determined (3.9.2.6, p. 92).
6.4.3.12 [Cr(tpy)(LT9)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
S
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(132 mg, 0.336 mmol) and CF3SO3H (1.2 ml, 13.4 mmol) in the first step, and then 4′-
(methylthio)-2,2′:6′,2′′-terpyridine (LT9) (131 mg, 0.0.369 mmol) and a reaction time of 5 h
in the second step. The bulk product could not be obtained pure, but an X-ray structure could
be determined (3.9.2.4, p. 89).
6.4.3.13 [Cr(tpy)(5,5′′-Me2tpy)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(tpy)Cl3]
(95.4 mg, 0.244 mmol) and CF3SO3H (0.8 ml, 9.74 mmol) in the first step, and then 5,5′′-Me2tpy
(70.0 mg, 0.268 mmol) and a reaction time of 4 h 45 min in the second step. [Cr(tpy)(5,5′′-Me2tpy)][PF6]2
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was isolated as an orange solid (215 mg, 0.219 mmol, 89.8 %).
IR: (solid, ν/cm−1) 603 (m), 636 (w), 661 (m), 671 (m), 700 (m), 729 (s), 741 (s), 767 (s),
783 (s), 790 (s), 813 (s), 901 (w), 1029 (m), 1045 (w), 1052 (m), 1064 (w), 1100 (w), 1117 (w),
1156 (w), 1172 (w), 1197 (w), 1234 (w), 1245 (w), 1257 (w), 1309 (w), 1332 (w), 1339 (w), 1384
(w), 1398 (w), 1456 (m), 1482 (m), 1512 (w), 1559 (m), 1575 (w), 1602 (m), 1609 (m), 1700
(w), 2356 (w), 3095 (w), 3999 (w). MS: MALDI-TOF m/z 706.4 (calc. for [M˘2PF6]+ 691.1),
830.7 (calc. for [M−PF6]+ 836.1). UV-VIS: (H2O, 1.0 x 10−5 mol dm−3) λ / nm 264 (ε /
dm3 mol−1 cm−1 31100), 286 sh (22300), 323 (16100), 334 (17050), 362 (14150), 362 (14150).
EA: Found C 38.73, H 3.21, N 8.53; C32H26CrF18N6P3·H2O requires C 38.45, H 2.82, N 8.41.
6.4.3.14 [Cr(LT6)(4′-(4-tolyl)tpy)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
OMe
OMe
The compound was prepared by the same method as Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, starting
with [Cr(4′-(4-tolyl)tpy)Cl3] (34.8 mg, 72.2 µmol) and CF3SO3H (0.5 ml, 5.6 mmol) in the first
step, and then 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -bis(4-methoxyphenyl)aniline (LT6) (42.6 mg,
79.4 µmol) and a reaction time of 6 h in the second step. [Cr(LT11)(4′-(4-tolyl)tpy)][CF3SO3]3
was isolated as a dark red solid (85.7 mg, 63.1 µmol, 43.7 %).
EA: Found C 52.77, H 3.85, N 6.99; C60H45CrF9N7S3O11·MeOH requires C 52.66, H 3.55, N
7.05.
6.4.3.15 [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
The compound was prepared by the same method as Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, starting
with [Cr(4′-(4-tolyl)tpy)Cl3] (48.2 mg, 0.100 mmol) and CF3SO3H (0.36 ml, 4.0 mmol) in the
first step, and then 6,6′′-dimethyl-4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (LT4) (38.7 mg, 0.110 mmol)
and a reaction time of 5 h 30 min in the second step. [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3 was
isolated as an orange solid. The crude product was recrystallised from EtOH (31.7 mg, 0.0185
mmol, 19.4 %).
IR: (solid, ν/cm−1) 516 (m), 571 (m), 593 (w), 633 (s), 691 (w), 728 (w), 747 (w), 755 (w),
788 (m), 802 (m), 818 (m), 883 (w), 1000 (m), 1027 (s), 1099 (w), 1121 (m), 1141 (s), 1196
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(w), 1223 (s), 1247 (s), 1369 (w), 1408 (w), 1433 (m), 1480 (w), 1540 (w), 1545 (m), 1570 (w),
1607 (m), 3084 (m), 3498 (w). EA: Found C 49.35, H 3.62, N 7.18; C49H38CrF9N60O9S3·H2O
requires C 49.38, H 3.38, N 7.05.
6.4.3.16 [Cr(4′-(4-tolyl)tpy)(LT4)][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
The crude product of [Cr(4′-(4-tolyl)tpy)(LT4)][CF3SO3]3 (66.0 mg, 0.0511 mmol) was dissolved
in MeOH, filtered and the filtrate poured into a MeOH solution of excess NH4PF6. The yellow
precipitate that formed was separated by filtration, and was washed with hexane and Et2O.
[Cr(4′-(4-tolyl)tpy)(LT4)][PF6]3 was isolated as a yellow powder (43.4 mg, 3.72 µmol, 6.61 %)
IR: (solid, ν/cm−1) 505 (s), 555 (s), 591 (w), 637 (w), 663 (w), 691 (w), 740 (m), 748 (m), 788
(s), 817 (s), 826 (s), 829 (s), 1015 (w), 1029 (m), 1036 (m), 1096 (w), 1167 (w), 1194 (w), 1248
(w), 1276 (w), 1374 (w), 1407 (w), 1436 (m), 1480 (m), 1549 (m), 1572 (w), 1600 (m), 3116 (w).
EA: Found C 46.16, H 3.86, N 6.93; C46H38CrF18N6P3S·2H2O requires C 46.13, H 3.54, N 7.02.
6.4.3.17 [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
The compound was prepared by the same method as [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, starting
with [Cr(4′-(4-tolyl)Cl3] (91.9 mg, 0.191 mmol) and CF3SO3H (1.7 ml, 7.6 mmol) in the first
step, and then 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -diphenylaniline (LT5) (100 mg, 0.210 mmol)
and a reaction time of 5 h 30 min in the second step. [Cr(4′-(4-tolyl)tpy)(LT5)][CF3SO3]3 was
isolated as a dark red solid (236 mg, 0.182 mmol, 95.2 %).
IR: (solid, ν/cm−1) 573 (m), 635 (s), 662 (m), 693 (m), 725 (w), 755 (m), 786 (m), 823 (w), 846
(w), 885 (w), 1026 (s), 1068 (w), 1096 (m), 1147 (s), 1198 (m), 1222 (s), 1244 (s), 1336 (w), 1367
(w), 1423 (m), 1464 (m), 1475 (m), 1478 (m), 1520 (w), 1538 (m), 1564 (m), 1569 (m), 1579 (m),
1602 (m), 3071 (w), 3498 (w). EA: Found C 51.99, H 3.36, N 7.42; C58H41CrF9N7S3O9·2H2O
requires C 52.17, H 3.45, N 7.42.
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6.4.3.18 [Cr(LT2)(LT5)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
The compound was prepared by the same method as [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, starting
with [Cr(LT2)Cl3] (104 mg, 0.191 mmol) and CF3SO3H (1.7 ml, 7.6 mmol) in the first step,
and then 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N -diphenylaniline (LT5) (100 mg, 0.210 mmol) and
a reaction time of 5 h 30 min in the second step. [Cr(LT2)(LT5)][CF3SO3]3 was isolated as a
dark red solid (64.9 mg, 47.7 µmol, 50.0 %).
IR: (solid, ν/cm−1) 500 (s), 505 (s), 571 (m), 604 (m), 633 (s), 661 (m), 692 (m), 717 (w), 727
(m), 754 (m), 768 (m), 787 (m), 826 (w), 839 (w), 890 (w), 1025 (s), 1095 (m), 1144 (m), 1201
(m), 1223 (m), 1242 (s), 1333 (w), 1367 (w), 1419 (m), 1436 (m), 1477 (m), 1522 (w), 1540
(m), 1569 (m), 1578 (m), 1601 (m), 3066 (w), 3492 (w). EA: Found C 54.12, H 3.29, N 7.38;
C63H43CrF9N7S3O9·1.5H2O requires C 54.51, H 3.34, N 7.06.
6.4.3.19 [Cr(5,5′′-Me2tpy)(LT4)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
A microwave vial was charged with [Cr(LT4)(CF3SO3)3] (29.6 mg, 34.8 µmol), 5,5′′-dimethyl-
2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy) (10 mg, 38.3 µmol) and MeCN (4 ml). The reaction mixture
was heated in the microwave reactor at 150 ◦C and 11 bar for 2 h. Then the solvent was
evaporated and one part of the batch was isolated as yellow triflate-salt (17.5 mg, 15.7 µmol,
45.2 %). The remaining of the batch was used for different solubility tests.
IR: (solid, ν/cm−1) 520 (m), 572 (m), 634 (s), 704 (w), 730 (w), 743 (w), 758 (w), 792 (w),
802 (m), 804 (m), 809 (m), 857 (w), 879 (w), 994 (w), 1026 (w), 1102 (w), 1118 (w), 1145 (m),
1149 (m), 1150 (m), 1154 (m), 1174 (m), 1224 (m), 1244 (m), 1271 (m), 1333 (w), 1366 (w),
1393 (w), 1456 (w), 1489 (w), 1524 (w), 1602 (m), 1616 (w), 1631 (w), 3094 (w). EA: Found
C 47.26, H 3.92, N 7.46; C44H36CrF9N6O9S3·MeOH requires C 47.24, H 3.52, N 7.35.
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6.4.3.20 [Cr(LT1)(LT4)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
The compound was prepared by the same method as [Cr(4′-(4-tolyl)tpy)2][CF3SO3]3, start-
ing with [Cr(LT4)Cl3] (21 mg, 41.2 µmol) and CF3SO3H (0.3 ml, 3.3 mmol) in the first step,
and then 4′-(4-(tert-butyl)phenyl)-2,2′:6′,2′′-terpyridine (LT1) (16.6 mg, 45.3 µmol) and a re-
action time of 6 h in the second step. The crude product was recrystallised from EtOH.
[Cr(LT1)(LT4)][CF3SO3]3 was isolated as an orange solid (10.2 mg, 8.39 µmol, 20.4 %).
IR: (solid, ν/cm−1) 500 (w), 520 (m), 547 (w), 572 (m), 631 (s), 662 (w), 688 (w), 716 (w), 727
(w), 743 (w), 755 (w), 790 (m), 813 (m), 837 (w), 849 (w), 885 (w), 931 (w), 997 (w), 1026 (s),
1045 (w), 1059 (w), 1067 (w), 1098 (w), 1155 (s), 1223 (s), 1244 (s), 1271 (s), 1366 (w), 1406
(w), 1436 (m), 1480 (m), 1520 (w), 1531 (w), 1543 (w), 1569 (w), 1602 (m), 1633 (w), 2968 (w),
3085 (w). EA: Found C 50.41, H 4.07, N 7.03; C52H44CrF9N6O9S3·1.5 H2O requires C 50.24,
H 3.81, N 6.76.
6.4.3.21 [Cr(LT2)2][PF6]3
N
N
N
N
N
N
Cr
3+
3PF6-
The compound was prepared by the same method as [Cr(tpy)2][PF6]3, starting with [Cr(LT2)Cl3]
(104 mg, 0.191 mmol) and CF3SO3H (0.78 ml, 7.6 mmol) in the first step, and then 4′-([1,1′-
biphenyl]-4-yl)-2,2′:6′,2′′-terpyridine (LT2) (81.0 mg, 0.210 mmol) and a reaction time of 7 h in
the second step. To exchange the counter ion the crude [Cr(LT2)2][CF3SO3]3 was dissolved in
methanol, filtered and poured into a MeOH solution of excess NH4PF6. [Cr(LT2)2][PF6]3 was
isolated as an orange solid (93.7 mg, 0.0744 mmol, 39.0 %)
IR: (solid, ν/cm−1) 501 (s), 508 (s), 513 (s), 546 (m), 555 (s), 663 (w), 693 (m), 699 (w), 727
(m), 740 (m), 759 (m), 766 (m), 787 (m), 828 (s), 1005 (w), 1028 (w), 1097 (w), 1156 (w), 1165
(w), 1247 (w), 1301 (w), 1369 (w), 1406 (w), 1432 (w), 1479 (m), 1542 (w), 1599 (m), 3085 (w).
EA: Found C 51.02, H 3.27, N 7.03; C54H38CrF18N6P3·0.5H2O requires C 51.19, H 3.10, N 6.63.
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6.4.3.22 [Cr(LT5)(LT10)][CF3SO3]3
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N COOH
COOH
4-([2,2′:6′,2′′-terpyridin]-4′-yl)phthalic acid (LT10) (17.5 mg, 40.0 µmol) was suspended in MeCN
(8 ml) and heated at reflux. After 1 h some of the ligand was dissolved and the solution turned
pale yellow. Then [Cr(LT4) (CF3SO3)3] (17.5 mg, 44.0 µmol) was added and heated the reac-
tion at reflux for 10 h. The crude product was filtered and the solvent evaporated, to yield a
dark red powder (40.1 mg, 29.2 µmol, 73 %).
IR: (solid, ν/cm−1) 501 (s), 513 (s), 571 (m), 613 (m), 636 (s), 689 (w), 699 (m), 729 (w), 744
(w), 758 (m), 786 (m), 827 (w), 977 (w), 993 (m), 1026 (s), 1068 (w), 1097 (m), 1154 (s), 1224
(s), 1245 (s), 1336 (w), 1419 (w), 1478 (m), 1489 (w), 1520 (w), 1532 (w), 1541 (w), 1559 (w),
1569 (m), 1580 (m), 1599 (m), 1712 (w), 2921 (w), 3067 (w). EA: Found C 49.50, H 3.56, N
7.15; C59H39CrF9N7O13S3·3H2O requires C 49.65, H 3.18, N 6.87.
6.4.3.23 [Cr(4′-(4-tolyl)tpy)(5,5′′-Me2tpy)][CF3SO3]3 (trial)
N
N
N
N
N
N
Cr
3+
3CF3SO3-
N
N
N
N
N
N
Cr
3+
3CF3SO3-
and/ or
A microwave vial was charged with [Cr(4′-(4-tolyl)tpy)(CF3SO3)3] (28.6 mg, 34.8 µmol), 5,5′′-
dimethyl-2,2′:6′,2′′-terpyridine (5,5′′-Me2tpy) (10 mg, 38.3 µmol) and 4 ml MeCN. The reaction
was heated in the microwave reactor at 150◦C at 11 bar for 1 h. Then the solvent was evaporated
and redissolved in MeOH. The solution was filtered and evaporated to dryness. The bulk
product could not be obtained pure and X-ray growing trials gave the homoleptic [Cr(4′-(4-
tolyl)tpy)2][CF3SO3]3 (3.3, p. 43).
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6.5 Synthesis of the bis(terpyridine)cobalt(III) complexes
6.5.1 [Co(tpy)2][PF6]3
N
N
N
N
N
N
Co
3+
3PF6-
Co(OAc)2·4H2O (53.2 mg, 0.214 mmol) and tpy (101 mg, 0.433 mmol) were dissolved in
CHCl3/MeOH (9:1, 20 ml). The orange solution was stirred at room temperature for 50 min,
the colour turned to dark red. An excess of NH4PF6 in MeOH was added to precipitate the
intermediate. The precipitation was collected by filtration through celite, and washed in MeOH
and Et2O. The residue was redissolved in MeCN, and the solvent removed by evaporation. The
intermediate [Co(tpy)2][PF6]2 was isolated as a brown solid. [Co(tpy)2][PF6]2 was suspended
in water (10 ml) and a saturated solution of aqueous Br2 (10 drops neat Br2 in 10 ml H2O)
was added. The orange reaction mixture was stirred for 20 h at room temperature. An excess
of NH4PF6 in H2O was added and stirred for 20 min. The precipitation was filtered trough
celite and washed with H2O, EtOH and Et2O. The residue was redissolved with MeCN, and
the solvent removed by evaporation. [Co(tpy)2][PF6]3 was isolated as an orange solid (61.9 mg,
0.0645 mmol, 30.1 %).
1H-NMR (250 MHz, 298 K, MeCN-d3) δ/ppm = 9.14  8.95 (m, 6H), 8.59 (dd, J = 7.9, 1.5
Hz, 4H), 8.22 (td, J = 7.8, 1.3 Hz, 4H), 7.47  7.36 (m, 4H), 7.22 (dd, J = 5.8, 1.3 Hz, 4H). 1H
NMR spectroscopic data agree with literature data.162
6.5.2 [Co(LT3)2][PF6]3
N
N
2 3
4
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6
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N
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2
1 8a
4a
43
8 7
6
5
A
B C
The compound was prepared by the same method as [Co(tpy)2][PF6]3. Co(OAc)2·4H2O (99.6
mg, 0.400 mmol) and 4′-(naphthalen-2-yl)-2,2′:6′,2′′-terpyridine (LT3) (290 mg, 0.806 mmol)
were dissolved in CHCl3/MeOH (9:1, 40 ml) and stirred at room temperature for 1 h. The dark
red intermediate [Co(4′-(4-tolyl)tpy)2][PF6]2 was then suspended in H2O (20 ml) and oxidised
by adding a saturated solution of aqueous Br2 (20 drops neat Br2 in 20 ml H2O) and stirring
for 23 h at room temperature. [Co(LT3)2][PF6]3 was isolated as an orange solid (409 mg, 0.337
mmol, 84.3 %).
1H-NMR (500 MHz, 295 K, MeCN-d3) δ/ppm = 9.43 (s, 4H, B3), 8.97 (d, J = 2.0 Hz, 2H,
C1), 8.78 (dt, J = 8.0, 1.0 Hz, 4H, A3), 8.41 (dd, J = 8.6, 2.0 Hz, 2H, C3), 8.39  8.33 (m, 2H,
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C4), 8.34  8.23 (m, 6H, A4&C8), 8.20  8.12 (m, 2H, C5), 7.84  7.74 (m, 4H, C6&7), 7.52 
7.42 (m, 8H, A4&5). 13C{1H}-NMR (126 MHz, 295 K, MeCN-d3) δ/ppm = 125.4 (C3), 126.5
(B3), 128.3 (A3), 128.8 (C6/7), 129.1 (C5), 129.9 (C6/7), 130.4 (C8), 130.7 (C1), 131.1 (C4),
131.9 (A5/6), 133.2 (C2), 134.3 (C8a), 136.0 (C4a), 144.2 (A4), 153.5 (A5/6), 157.2 (two signals,
A2&B2), 158.7 (B4).
IR: (solid, ν/cm−1) 500 (w), 553 (s), 567 (w), 590 (w), 610 (w), 620 (w), 628 (w), 654 (w),
663 (m), 667 (m), 670 (w), 688 (w), 695 (m), 725 (s), 741 (s), 749 (s), 757 (s), 784 (s), 826 (s),
904 (w), 948 (w), 970 (w), 1031 (w), 1049 (w), 1060 (w), 1101 (w), 1135 (w), 1169 (w), 1203
(w), 1223 (w), 1252 (w), 1297 (w), 1364 (w), 1423 (w), 1444 (w), 1482 (m), 1559 (m), 1609
(m), 3102 (w). EA: Found C 48.52, H 2.83, N 6.93; C50H34CoF18N6P3·H2O requires C 48.80,
H 2.95, N 6.83.
6.5.3 [Co(4`-(4-tolyl)tpy)2][PF6]3
N
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The compound was prepared by the same method as [Co(tpy)2][PF6]3. Co(OAc)2·4H2O (99.6
mg, 0.400 mmol) and 4′-(p-tolyl)-2,2′:6′,2′′-terpyridine (4′-(4-tolyl)tpy) (261 mg, 0.806 mmol)
were dissolved in CHCl3/ MeOH (9:1, 40 ml) and stirred at room temperature for 1 h. The dark
red intermediate [Co(4′-(4-tolyl)tpy)2][PF6] was then suspended in H2O (20 ml) and oxidised
by adding a saturated solution of aqueous Br2 (20 drops neat Br2 in 20 ml H2O) and stirring
for 23 h at room temperature. [Co(4′-(4-tolyl)2][PF6]3 was isolated as an orange solid (437 mg,
0.383 mmol, 95.8 %).
1H-NMR (500 MHz, 295 K, MeCN-d3) δ/ppm = 9.24 (s, 4H, B3), 8.71 (ddd, J = 7.9, 1.5, 0.6
Hz, 4H, A3), 8.29  8.21 (m, 8H, A4&C2 ), 7.68 (dd, J = 8.5, 0.7 Hz, 4H, C3), 7.45  7.41 (m,
4H, A5), 7.39 (ddd, J = 5.8, 1.4, 0.6 Hz, 4H, A6), 2.58 (s, 6H, CMe). 13C{1H}-NMR (126
MHz, 295 K, MeCN-d3) δ/ppm = 158.8 (B4), 157.3 (B2), 157.1 (A2), 153.4 (A6), 144.7 (C4),
144.1 (A4), 133.1 (C1), 131.8 (A5), 131.7 (C3), 129.4 (C2), 128.2 (A3), 126.0 (B3), 21.6 (CMe).
IR: (solid, ν/cm−1) 500 (s), 503 (s), 556 (s), 625 (w), 654 (w), 662 (m), 695 (w), 716 (m), 727
(m), 742 (m), 751 (m), 786 (s), 820 (s), 833 (s), 879 (w), 899 (w), 976 (w), 1017 (w), 1030 (m),
1060 (w), 1104 (w), 1170 (w), 1197 (w), 1251 (w), 1374 (w), 1405 (w), 1424 (w), 1435 (m), 1484
(m), 1558 (w), 1604 (m), 1617 (m), 3097 (w).
Conclusion
The synthesis and characterisation of 25 new chromium(III) complexes with polypyridyl lig-
ands have been presented in this PhD-thesis (7 tris(diimine)chromium(III) complexes and 18
bis(terpyridine)chromium(III) complexes). A new three step synthesis route for the preparation
of {Cr(tpy)2}3+ complexes was developed. Starting with anhydrous CrCl3, {Cr(tpy)Cl3} was
prepared, followed by exchange of the Cl− counter anions to CF3SO−3 to yield
{Cr(tpy)(CF3SO3)3}. In the last step, the second tpy ligand is added to get {Cr(tpy)2}3+.
The successive addition of the two tpy ligands gives the possibility to synthesise heteroleptic
{Cr(tpyA)(tpyB)}3+ complexes. These are the first reported examples of heteroleptic
bis(terpyridine)chromium(III) complexes. The structures of several heteroleptic complexes
could be confirmed with X-ray analysis. Altogether, 17 crystal structures (homoleptic and het-
eroleptic, 6 tris(diimine)chromium(III) complexes and 12 bis(terpyridine)chromium(III) com-
plexes) could be determined.
Despite the fact that the Cr3+ ion (d3) is widely recognised as a kinetically inert metal cen-
tre, we observed a sensitive liability of the complexes in the presence of F− or in an alkaline
environment. The residues of these decompositions could be confirmed as {Cr(tpy)F3} and
{Cr(tpy)(OH)3} respectively. These findings led to an explanation of the photoluminescence
observations done previously. It was already known that the photoluminescence properties of
{Cr(tpy)2}3+ are quite different from those of {Cr(bpy)3}3+. We found that the majority of the
observed emission could be assigned as deriving from small quantities of neutral or protonated
free ligand.
The {Cr(tpy)2}3+ complexes containing at least one N,N -diphenylaniline-tpy showed a broad
and solvatochromic absorption. Although the broad absorption makes these complexes strong
candidates for DSC applications, all trials were unsuccessful. Also, the application of
{Cr(bpy)3}3+ complexes in LEC devices was unsuccessful.
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Appendix A:
X-ray structures: CIF file labels and CCDC numbers
Table 6.1: CIF files labels and CCDC number (P = preliminary data):
compound: CIF file label CCDC number
tris(diimine)chromium(III) complexes
[Cr(bpy)3][PF6]3·MeCN JS132
[Cr(bpy)2(phen)][PF6]3·3MeCN JS145
[Cr(bpy)2(5,5′-Me2bpy)][PF6]3·2Me2CO JS202 P
4{[Cr(4,4′-Me2bpy)2(bpy)][PF6]3}·12MeCN·H2O JS217
[Cr(4,4′-Me2bpy)2(bpy)][PF6]3·2MeCN JS217
[Cr(5,5′-Me2bpy)3][PF6]3 JS227 P
bis(terpyridine)chromium(III) complexes
2{[Cr(tpy)2][PF6]3}·5MeCN JS274 981376
[Cr(4′-(4-tolyl)tpy)2][CF3SO3)3]3·2MeCN JS323
[Cr(LT1)2][CF3SO3)3]3 JS357 P
5{[Cr(LT5)2][CF3SO3]3}·MeCN JS388
[Cr(5,5′′-Me2tpy)2)][CF3SO3]3·H2O JS383
[Cr(LT11)(HLT11)][PF6]4 JS258 P
[Cr(tpy)(4′-(4-tolyl)tpy)][PF6]3 ·3MeCN JS275 981377
[Cr(tpy)(HLT11)][PF6]4 JS294 P
[Cr(tpy)(5,5′′-Me2tpy)][PF6]3·3MeCN JS295 981378
[Cr(tpy)(LT7)][PF6]3·Me2CO JS299
[Cr(tpy)(LT8)][PF6]3 JS301 P
[Cr(tpy)(LT9)][PF6]3·2MeCN JS303
2{[H2LT4][CF3SO3]2}·Et2O JS360
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